NOTE 1 – ORGANIZATION AND DESCRIPTION\rOF BUSINESS
\r\r\r\r
MariMed Inc. (the “Company”), a\rDelaware corporation, develops and manages state-of-the-art, regulatory-compliant facilities for the cultivation, production, and\rdispensing of legal cannabis and cannabis-infused products. Such facilities, located in multiple states, are leased to the Company’s\rclients in the emerging cannabis industry. Along with operational oversight, the Company provides its clients with legal, accounting,\rhuman resources, business development, and other corporate and administrative services.
\r\r\r\r
The Company also provides professional consultative\rservices in all aspects of cannabis licensing procurement. To date, the Company has secured, on behalf of its clients, 11 cannabis\rlicenses across five states—two in Delaware, two in Illinois, one in Nevada, three in Maryland and three in Massachusetts.\rAccordingly, the Company has developed over 300,000 square feet of seed-to-sale cannabis facilities across these five states.
\r\r\r\r
In addition, the Company licenses precision-dosed,\rcannabis-infused products to treat specific medical conditions or to achieve a certain result. These products are licensed under\rthe brand names Kalm Fusion™ and Nature’s Heritage™, both of which were developed by the Company, and Betty’s\rEddies™, acquired in October 2017. The Company also has exclusive sublicensing rights in certain states to distribute vaporizer\rpens developed by Lucid Mood™, as well as the clinically-tested medicinal cannabis strains developed in Israel by Tikun Olam™.
\r\r\r\r
The Company’s stock is quoted on the\rOTCQB market under the ticker symbol MRMD.
\r\r\r\r
The Company was originally incorporated in\rJanuary 2011 under the name Worlds Online Inc., using the ticker symbol WORX. In early 2017, the Company name and ticker were changed\rto its current name and ticker. At inception, the Company had operated an online portal that offered multi-user virtual environments\rto users. These operations were effectively ceased in early 2014.
\r\r\r\r
The Company has entered into several transactions\rto develop its business, and more recently to carry out its strategic decision to transition from a professional management and\radvisory company that provides cannabis licensing, operational consulting, and real estate services, to a direct owner of cannabis\rlicenses and operator of seed-to-sale operations. These transactions are summarized below and disclosed in further detail in Note\r3 – Acquisitions.
\r\r\r\r
In May 2014, the Company, through its subsidiary\rMariMed Advisors Inc., acquired Sigal Consulting LLC, a company operating in the cannabis industry. This transaction was accounted\rfor as a purchase acquisition where the Company was both the legal and accounting acquirer. In June 2017, the minority interest\rin MariMed Advisors Inc. was merged into the Company.
\r\r\r\r
In May 2018, the Company acquired iRollie LLC,\ra manufacturer of branded cannabis products and accessories for consumers, and custom product and packaging for companies in the\rcannabis industry.
\r\r\r\r
In July 2018, the Company contracted to acquire\rAgriMed Industries of PA LLC (“AgriMed”), an entity that holds a license for the cultivation of cannabis into medical\rmarijuana products in the state of Pennsylvania. In February 2019, the Company filed a complaint against this entity for specific\rperformance of their obligations under the purchase agreement.
\r\r\r\r
In October 2018, the Company entered into a\rpurchase agreement to acquire its two cannabis-licensed clients, KPG of Anna LLC and KPG of Harrisburg LLC, currently operating\rmedical marijuana dispensaries in the state of Illinois. As of December 31, 2018, the Company had not yet received legislative\rapproval – required for all ownership changes of cannabis licensees – and therefore these entities were not consolidated\rin the Company’s financial statements as of such date. The Company anticipates approval will be obtained, and the transaction\rconsummated, in 2019
\r\r\r\r
In October 2018, the Company’s cannabis-licensed\rclient with cultivation and dispensary operations in Massachusetts, ARL Healthcare Inc. (“ARL”), filed a plan of entity\rconversion with the state to convert from a non-profit entity to a for-profit corporation, with the Company as the sole shareholder\rof the for-profit corporation. On November 30, 2018, the conversion plan was approved by the secretary of state, and effective\rDecember 1, 2018, ARL was consolidated into the Company as a wholly-owned subsidiary.
\r\r\r\r
In November 2018, the Company issued a letter\rof intent to acquire The Harvest Foundation LLC, its cannabis-licensed client with cultivation operations in the state of Nevada.\rThe acquisition is conditioned upon legislative approval of the transaction which is expected to occur in May 2019.
\r\r\r\r
In December 2018, the Company entered into\ra memorandum of understanding to merge with Kind Therapeutics USA LLC, its cannabis-licensed client in the state of Maryland.\rThe parties expect the merger agreement to be finalized, and the transaction approved by the state legislature in 2019
"}]},{"name":"rpt:f-104","factDimensions":{"xbrl:concept":"us-gaap:SignificantAccountingPoliciesTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rNOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING\rPOLICIES
\r\r\r\r
Basis of Presentation
\r\r\r\r
The accompanying consolidated financial statements\rhave been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”).
\r\r\r\r
Certain reclassifications have been made to\rprior periods’ data to conform to the current period presentation. These reclassifications had no effect on consolidated\rincome (losses) or cash flows.
\r\r\r\r
Principles of Consolidation
\r\r\r\r
The accompanying condensed consolidated financial\rstatements at December 31, 2018 and 2017 and for the years then ended include the accounts of MariMed Inc. and the following majority-owned\rsubsidiaries.
\r\r\r\r
| Subsidiary: | \r\r | Percentage Owned | \r||
| MariMed Advisors Inc. | \r\r | \r | 100.0 | \r% |
| Mia Development LLC | \r\r | \r | 89.5 | \r% |
| Mari Holdings IL LLC | \r\r | \r | 60.0 | \r% |
| Mari Holdings MD LLC | \r\r | \r | 97.4 | \r% |
| Mari Holdings NV LLC | \r\r | \r | 100.0 | \r% |
| Hartwell Realty Holdings LLC | \r\r | \r | 100.0 | \r% |
| iRollie LLC | \r\r | \r | 100.0 | \r% |
| ARL Healthcare Inc. | \r\r | \r | 100.0 | \r% |
\r\r
Intercompany transactions have been eliminated\rupon consolidation.
\r\r\r\r
Use of Estimates
\r\r\r\r
The preparation of financial statements in\rconformity with GAAP requires management to make estimates and assumptions that affect the reported amounts within the financial\rstatements and disclosures thereof. Actual results could differ from these estimates or assumptions.
\r\r\r\r
Cash Equivalents
\r\r\r\r
The Company considers all highly liquid investments\rwith a maturity date of three months or less to be cash equivalents. The fair values of these investments approximate their carrying\rvalues.
\r\r\r\r
The Company’s cash and cash equivalents\rare maintained with recognized financial institutions located in the United States. In the normal course of business, the Company\rmay carry balances with certain financial institutions that exceed federally insured limits. The Company has not experienced losses\ron balances in excess of such limits and management believes the Company is not exposed to significant risks in that regard.
\r\r\r\r
Accounts Receivable
\r\r\r\r
Accounts receivable consist of trade receivables\rand are carried at their estimated collectible amounts.
\r\r\r\r
The Company provides credit to its clients\rin the form of payment terms. The Company limits its credit risk by performing credit evaluations of its clients and maintaining\ra reserve, if deemed necessary, for potential credit losses. Such evaluations include the review of a client’s outstanding\rbalances with consideration towards such client’s historical collection experience, as well as prevailing economic and market\rconditions and other factors. Based on such evaluations, the Company recorded a reserve of $150,000 at December 31, 2018.
\r\r\r\r
The accounts receivable balances of two clients\rconstituted 84% of total accounts receivable at December 31, 2018. The balances of these two clients represented 79% of total accounts\rreceivable at December 31, 2017.
\r\r\r\r
Investments
\r\r\r\r
The Company classifies its investments as available-for-sale-investments.\rInvestments are comprised of equity holding of private companies These investments are recorded at fair value on the Company’s\rconsolidated balance sheet, with changes to fair value, if any, included in comprehensive income. Investments are evaluated for\rother-than-temporary impairment and are written down if such impairments are deemed to have occurred.
\r\r\r\r
Revenue Recognition
\r\r\r\r
On January 1, 2018, the Company adopted the\rFinancial Accounting Standards Board’s Accounting Standards Codification (“ASC”) 606, Revenue from Contract\rwith Customers, as amended by subsequently issued Accounting Standards Updates. This revenue standard requires an entity to\rrecognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration that it\rexpects to be entitled to in exchange for those goods or services. The recognition of revenue is determined by performing the following\rconsecutive steps:
\r\r\r\r
| \r | ● | \rIdentify the contract(s) with a customer; |
| \r | ● | \rIdentify the performance obligations in the contract(s); |
| \r | ● | \rDetermine the transaction price; |
| \r | ● | \rAllocate the transaction price to the performance obligations in the contract(s); and |
| \r | ● | \rRecognize revenue as the performance obligation is satisfied. |
\r\r
Additionally, when another party is involved\rin providing goods or services to the Company’s clients, a determination is made as to who—the Company or the other\rparty—is acting in the capacity as the principal in the sale transaction, and who is merely the agent arranging for goods\ror services to be provided by the other party.
\r\r\r\r
The Company is typically considered the principal\rif it controls the specified good or service before such good or service is transferred to its client. The Company may also be\rdeemed to be the principal even if it engages another party (an agent) to satisfy some of the performance obligations on its behalf,\rprovided the Company (i) takes on certain responsibilities, obligations and risks, (ii) possesses certain abilities and discretion,\ror (iii) other relevant indicators of the sale. If deemed an agent, the Company would not recognize revenue for the performance\robligations it does not satisfy.
\r\r\r\r
The adoption of this standard did not have\ra significant impact on the Company’s consolidated operating results, and accordingly no restatement has been made to prior\rperiod reported amounts.
\r\r\r\r
The Company’s main sources of revenue\rare comprised of the following:
\r\r\r\r
| \r | ● | \rReal Estate – the Company generates rental income and additional rental fees from leasing its regulatory-compliant legal cannabis facilities to its clients, which are cannabis-licensed operating companies. Rental income is generally a fixed amount per month that escalates over the respective lease terms, while additional rental fees are based on a percentage of tenant revenues that exceed a specified amount. |
| \r | \r | |
| \r | ● | \rManagement – the Company receives fees for providing its clients with corporate services and operational oversight of their cannabis cultivation, production, and dispensary operations. These fees are based on a percentage of such clients’ revenue, and are recognized after services have been performed. |
| \r | \r | |
| \r | ● | \rSupply Procurement – the Company maintains volume discounts with top national vendors of cultivation and production resources, supplies, and equipment, which the Company acquires and resells to its clients or third parties within the cannabis industry. The Company recognizes this revenue after the acceptance of goods by the purchaser. |
| \r | \r | |
| \r | ● | \rLicensing – the Company’s derives revenue from the sale of precision-dosed, cannabis-infused products, such as Kalm Fusion™ and Betty’s Eddies™, to legal dispensaries throughout the United States. The recognition of this revenue occurs when the products are delivered. |
| \r | \r | |
| \r | ● | \rConsulting – the Company assists third-parties parties in securing cannabis licenses, and provides advisory services in the areas of facility design and development, and cultivation and dispensing best practices. The revenues associated with these services are recognized as the services are performed. |
\r\r
Research and Development Costs
\r\r\r\r
Research and development costs are charged\rto operations as incurred.
\r\r\r\r
Property and Equipment
\r\r\r\r
Property and equipment are stated at cost less\raccumulated depreciation, with depreciation recognized on a straight-line basis over the shorter of the estimated useful life of\rthe asset or the lease term, if applicable. When assets are retired or disposed, the cost and accumulated depreciation are removed\rfrom the accounts, and any resulting gains or losses are included in income. Repairs and maintenance are charged to expense in\rthe period incurred.
\r\r\r\r
The estimated useful lives of property and\requipment are generally as follows: buildings and building improvements, seven to thirty-nine years; tenant improvements, the remaining\rduration of the related lease; furniture and fixtures, seven years; machinery and equipment, five to ten years. Land is not depreciated.
\r\r\r\r
The Company’s property and equipment\rare individually reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset\rmay not be recoverable. An impairment exists when the carrying amount of an asset exceeds the aggregate projected future cash flows\rover the anticipated holding period on an undiscounted basis. An impairment loss is measured based on the excess of the asset’s\rcarrying amount over its estimated fair value.
\r\r\r\r
Impairment analyses are based on management’s\rcurrent plans, intended holding periods and available market information at the time the analyses are prepared. If these criteria\rchange, the Company’s evaluation of impairment losses may be different and could have a material impact to the consolidated\rfinancial statements.
\r\r\r\r
For the years ended December 31, 2018 and 2017,\rbased on its impairment analyses, the Company did not have any impairment losses.
\r\r\r\r
Impairment of Long-Lived Assets
\r\r\r\r
The Company evaluates the recoverability of\rits fixed assets and other assets in accordance with ASC 360-10-15, Impairment or Disposal of Long-Lived Assets. Impairment\rof long-lived assets is recognized when the net book value of such assets exceeds their expected cash flows, in which case the\rassets are written down to fair value, which is determined based on discounted future cash flows or appraised values.
\r\r\r\r
Fair Value of Financial Instruments
\r\r\r\r
The Company follows the provisions of ASC 820,\rFair Value Measurement, to measure the fair value of its financial instruments, and ASC 825, Financial Instruments, for\rdisclosures on the fair value of its financial instruments. To increase consistency and comparability in fair value measurements\rand related disclosures, ASC 820 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to\rmeasure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in\ractive markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value\rhierarchy defined by ASC 820 are:
\r\r\r\r
| Level 1 | \rQuoted market prices available in active markets for identical assets or liabilities as of the reporting date. |
| \r | |
| Level 2 | \rPricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. |
| \r | |
| Level 3 | \rPricing inputs that are generally observable inputs and not corroborated by market data. |
\r\r
The carrying amounts of the Company’s\rfinancial assets and liabilities, such as cash and accounts payable approximate their fair values due to the short maturity of\rthese instruments.
\r\r\r\r
The fair value of option and warrant issuances\rare determined using the Black-Scholes pricing model and employing several inputs such as the expected life of instrument, the\rexercise price, the expected risk-free interest rate, the expected dividend yield, the value of the Company’s common stock\ron issuance date, and the expected volatility of such common stock. The following table summarizes the range of inputs used by\rthe Company during the prior two fiscal years:
\r\r\r\r
| \r | \r | 2018 | \r\r | \r | 2017 | \r|||
| Life of instrument | \r\r | \r | 0.5 to 5.0 years | \r\r | \r | \r | 3.0 to 5.0 years | \r|
| Volatility factors | \r\r | \r | 1.019 to 2.086 | \r\r | \r | \r | 0.963 to 1.095 | \r|
| Risk-free interest rates | \r\r | \r | 1.65% to 3.07% | \r\r | \r | \r | 1.79% to 2.08% | \r|
| Dividend yield | \r\r | \r | 0% | \r\r | \r | \r | 0% | \r
\r\r
The expected life of an instrument is calculated\rusing the simplified method pursuant to Staff Accounting Bulletin Topic 14, Share-Based Payment, which allows for using\rthe mid-point between the vesting date and expiration date. The volatility factors are based on the historical two-year movement\rof the Company’s common stock prior to an instrument’s issuance date. The risk-free interest rate is based on U.S.\rTreasury rates with maturity periods similar to the expected instruments life on the issuance date.
\r\r\r\r
The Company amortizes the fair value of option\rand warrant issuances on a straight-line basis over the requisite service period of each instrument.
\r\r\r\r
Extinguishment of Liabilities
\r\r\r\r
The Company accounts for extinguishment of\rliabilities in accordance with ASC 405-20, Extinguishments of Liabilities. When the conditions for extinguishment are met,\rthe liabilities are written down to zero and a gain or loss is recognized.
\r\r\r\r
Stock-Based Compensation
\r\r\r\r
The Company accounts for stock-based compensation\rusing the fair value method as set forth in ASC 718, Compensation—Stock Compensation, which requires a public entity\rto measure the cost of employee services received in exchange for an equity award based on the fair value of the award on the grant\rdate, with limited exceptions. Such value will be incurred as compensation expense over the period an employee is required to provide\rservice in exchange for the award, usually the vesting period. No compensation cost is recognized for equity awards for which employees\rdo not render the requisite service.
\r\r\r\r
Income Taxes
\r\r\r\r
The Company accounts for income taxes in accordance\rwith ASC 740, Income Taxes. Deferred income tax assets and liabilities are determined based upon differences between the\rfinancial reporting and tax basis of assets and liabilities, and are measured using the enacted tax rates and laws that will be\rin effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent\rmanagement concludes it is more likely than not that the assets will not be realized. The effect on deferred tax assets and liabilities\rof a change in tax rates is recognized in the consolidated statements of operations in the period that includes the enactment date.
\r\r\r\r
ASC 740 prescribes a comprehensive model for\rhow companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected\rto be taken on a tax return. The Company did not take any uncertain tax positions and had no adjustments to unrecognized income\rtax liabilities or benefits for the years ended December 31, 2018 and 2017.
\r\r\r\r
Related Party Transactions
\r\r\r\r
The Company follows ASC 850, Related Party\rDisclosures, for the identification of related parties and disclosure of related party transactions.
\r\r\r\r
In accordance with ASC 850, the Company’s\rfinancial statements include disclosures of material related party transactions, other than compensation arrangements, expense\rallowances, and other similar items in the ordinary course of business, as well as transactions that are eliminated in the preparation\rof financial statements.
\r\r\r\r
Comprehensive Income
\r\r\r\r
The Company reports comprehensive income and\rits components following guidance set forth by ASC 220, Comprehensive Income, which establishes standards for the reporting\rand display of comprehensive income and its components in the consolidated financial statements. There were no items of comprehensive\rincome applicable to the Company during the period covered in the financial statements.
\r\r\r\r
Earnings Per Share
\r\r\r\r
Earnings per common share is computed pursuant\rto ASC 260, Earnings Per Share. Basic earnings per share is computed by dividing net income by the weighted average number\rof shares of common stock outstanding during the period. Diluted net income per share is computed by dividing net income by the\rsum of the weighted average number of shares of common stock outstanding plus the weighted average number of potentially dilutive\rsecurities during the period.
\r\r\r\r
As of December 31, 2018 and 2017, there were\r18,916,211 and 9,045,311, respectively, of potentially dilutive securities in the form of options and warrants. Also as of such\rdates, there were (i) zero and 500,000 shares, respectively, of subscriptions on convertible preferred stock, (ii) $3,350,000 and\r$1,350,000, respectively, of convertible promissory notes, and (iii) approximately $8.6 million and zero, respectively, of convertible\rdebentures payable, that were potentially dilutive, and whose conversion into common stock is based on a discount to the market\rvalue of common stock on or about the future conversion date. For the years ended December 31, 2018 and 2017, all potentially dilutive\rsecurities had an anti-dilutive effect on earnings per share, and in accordance with ASC 260, were excluded from the diluted net\rincome per share calculation, resulting in identical calculations of basic and fully diluted net income per share. These securities\rmay dilute earnings per share in the future.
\r\r\r\r
Commitments and Contingencies
\r\r\r\r
The Company follows ASC 450, Contingencies,\rwhich requires the Company to assess the likelihood that a loss will be incurred from the occurrence or non-occurrence of one or\rmore future events. Such assessment inherently involves an exercise of judgment. In assessing possible loss contingencies from\rlegal proceedings or unasserted claims, the Company evaluates the perceived merits of such proceedings or claims, and of the relief\rsought or expected to be sought.
\r\r\r\r
If the assessment of a contingency indicates\rthat it is probable that a material loss will be incurred and the amount of the liability can be estimated, then the estimated\rliability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material\rloss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent\rliability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. Loss contingencies\rconsidered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.
\r\r\r\r
While not assured, management does not believe,\rbased upon information available at this time, that a loss contingency will have material adverse effect on the Company’s\rfinancial position, results of operations, or cash flows.
\r\r\r\r
Beneficial Conversion Features on Convertible\rDebt
\r\r\r\r
Convertible instruments\rthat are not bifurcated as a derivative pursuant to ASC 815, Derivatives and Hedging, and not accounted for as a separate\requity component under the cash conversion guidance are evaluated to determine whether their conversion prices create an embedded\rbeneficial conversion feature at inception, or may become beneficial in the future due to potential adjustments.
\r\r\r\r
A beneficial conversion feature is a nondetachable\rconversion feature that is “in-the-money” at the commitment date. The in-the-money portion, also known as the intrinsic\rvalue of the option, is recorded in equity, with an offsetting discount to the carrying amount of convertible debt to which it\ris attached. The discount is amortized to interest expense over the life of the debt with adjustments to amortization upon full\ror partial conversions of the debt.
\r\r\r\r
Risk and Uncertainties
\r\r\r\r
The Company is subject to risks common to companies\roperating within the legal and medical marijuana industries, including, but not limited to, federal laws, government regulations\rand jurisdictional laws.
\r\r\r\r
Noncontrolling Interests
\r\r\r\r
Noncontrolling interests represent third-party\rminority ownership of the Company’s consolidated subsidiaries. Net income attributable to noncontrolling interests is shown\rin the consolidated statements of operations; the value of net assets owned by noncontrolling interests are presented as a component\rof equity within the balance sheets.
\r\r\r\r
Off-Balance Sheet Arrangements
\r\r\r\r
The Company does not have any off-balance sheet\rarrangements.
\r\r\r\r
Recent Accounting Pronouncements
\r\r\r\r
In February 2016, the Financial Accounting\rStandards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842),\rwhich modifies accounting for lessees by requiring the recording of right-of-use lease assets and lease liabilities for operating\rleases and disclosing key information about leasing arrangements. The Company is currently implementing the requirements of Topic\r842, which is effective for the Company starting on January 1, 2019. Most of the Company’s operating leases are subject to\rthis new standard whose impact will be reflected by an increase in the Company’s total assets and total liabilities relative\rto such amount prior to adoption.
\r\r\r\r
In November 2016, the FASB issued ASU No. 2016-18,\rStatement of Cash Flows (Topic 230): Restricted Cash, which enhances and clarifies the guidance on the classification and\rpresentation of restricted cash in the statement of cash flows. Topic 230 will be effective in 2019 and its impact is dependent\rupon the level of restricted cash of the Company, which at this time is insignificant.
\r\r\r\r
In January\r2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350) which simplifies goodwill impairment testing\rby requiring that such periodic testing be performed by comparing the fair value of a reporting unit with its carrying amount and\rrecognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. The\rCompany is currently evaluating the impact of Topic 350 on its consolidated financial statements and related disclosures, which\ris effective for fiscal years, including interim periods, beginning after December 15, 2019.
\r\r\r\r
In June 2018, the FASB issued ASU 2018-07,\rCompensation - Stock Compensation (Topic 718): Improvement to Nonemployee Share-Based Payment Accounting, which is part\rof the FASB’s simplification initiative to maintain or improve the usefulness of the information provided to the users of\rfinancial statements while reducing cost and complexity in financial reporting. This update provides consistency in the accounting\rfor share-based payments to nonemployees with that of employees. This update is effective for interim and annual reporting periods\rbeginning after December 15, 2018, and the Company is currently evaluating its financial statement impact.
\r\r\r\r
In addition to the above, the Company has\rreviewed all other recently issued, but not yet effective, accounting pronouncements, and does not believe the future adoption\rof any such pronouncements will have a material impact on its financial condition or the results of its operations.
"}]},{"name":"rpt:f-105","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rNOTE 9 – PROPERTY AND EQUIPMENT
\r\r\r\r
At December 31, 2018 and 2017, property and\requipment consisted of the following:
\r\r\r\r
| \r | \r | 2018 | \r\r | \r | 2017 | \r|||
| Land | \r\r | $ | \r3,392,710 | \r\r | \r | $ | \r3,392,710 | \r|
| Buildings and building improvements | \r\r | \r | 13,566,144 | \r\r | \r | \r | 3,918,359 | \r|
| Tenant improvements | \r\r | \r | 5,348,882 | \r\r | \r | \r | 2,260,512 | \r|
| Furniture and fixtures | \r\r | \r | 114,160 | \r\r | \r | \r | 95,815 | \r|
| Machinery and equipment | \r\r | \r | 1,632,351 | \r\r | \r | \r | 506,464 | \r|
| Construction in progress | \r\r | \r | 12,205,447 | \r\r | \r | \r | 17,279,949 | \r|
| \r | \r | \r | 36,259,694 | \r\r | \r | \r | 27,453,809 | \r|
| Less: accumulated depreciation | \r\r | \r | (2,159,830 | \r) | \r\r | \r | (1,498,878 | \r) |
| Property and equipment, net | \r\r | $ | \r34,099,864 | \r\r | \r | $ | \r25,954,931 | \r
\r\r
During the years ended December 31, 2018 and\r2017, additions to property and equipment were approximately $8.9 million and $21.0 million, respectively.
\r\r\r\r
The 2017 additions were primarily comprised\rof (i) the purchase of properties in Hagerstown, MD, and Middleborough, MA, (ii) the purchase of land and property in New Bedford,\rMA, (iii) the start of construction at these three locations, and (iv) continuing improvements at the Lewes, DE, Anna, IL, and\rHarrisburg, IL locations. The 2018 additions consisted primarily of the continued buildout of both locations in MA and the location\rin MD.
\r\r\r\r
The 2017 construction in progress balance of\rapproximately $17.3 million consisted of the following:
\r\r\r\r
| \r | · | \r$11.2 million – Hagerstown, MD building, machinery, improvements, and fixtures; |
| \r | · | \r$5.0 million – New Bedford, MA building and improvements; and |
| \r | · | \r$1.1 million – Middleborough, MA building |
\r\r
During 2018, the $11.2 million of Hagerstown,\rMD construction in progress was placed into service, and the 2018 construction in progress balance of approximately $12.2 million\rwas primarily comprised of:
\r\r\r\r
| \r | · | \r$9.8 million – New Bedford, MA building, improvements and machinery; and |
| \r | · | \r$2.4 million – Middleborough, MA building, improvements and fixtures. |
\r\r
Depreciation expense for the years ended December\r31, 2018 and 2017 was approximately $658,000 and $363,000, respectively.
"}]},{"name":"rpt:f-106","factDimensions":{"xbrl:concept":"us-gaap:RelatedPartyTransactionsDisclosureTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rNOTE 18 – RELATED PARTY TRANSACTIONS
\r\r\r\r
As disclosed in Note 3 – Acquisitions,\rthe current CEO and CFO of the Company were part of the ownership group from whom Sigal Consulting LLC was acquired in May 2014.\rThe 49% ownership in the Company’s subsidiary, MariMed Advisors Inc., which this ownership group acquired as part of the\rpurchase price, was acquired by the Company from this ownership group in June 2017 in exchange for 75 million shares of the Company’s\rcommon stock.
\r\r\r\r
In September 2017, the former CEO of the Company,\rwho is a currently a board member, exercised options to purchase 4.5 million shares of common stock at an exercise price of $0.01\rper share. This individual’s aggregate exercise price of $45,000 was paid via the surrender of 90,000 shares of common stock.
\r\r\r\r
In October 2017, the Company acquired certain\rassets of the Betty’s Eddies™ brand of cannabis-infused products, as disclosed in Note 3 – Acquisitions,\rfrom a company that is minority-owned by the Company’s chief operating officer.
\r\r\r\r
In December 2017 and January 2018, options\rto purchase 400,000 shares of commons stock at an exercise price of $0.025 were forfeited by the CEO and by an independent board\rmember (200,000 shares forfeited by each individual).
\r\r\r\r
In January 2018, the Company granted options\rto purchase 1.45 million shares of common stock to the Company’s board members at exercise prices ranging from $0.14 to $0.77\rand expiring between December 2020 and December 2022. The fair value of these options on grant date of approximately $458,000 was\ramortized over the six-month vesting period.
\r\r\r\r
The Company’s current corporate offices\rare leased from a company owned by a related party under a 10-year lease that commenced August 2018 and contains a five-year extension\roption. Previous to this lease, the Company’s former corporate offices were also leased from a company owned by a related\rparty. For the years ended December 31, 2018 and 2017, expenses incurred under these leases approximated $78,000 and $24,000, respectively.
\r\r\r\r
The outstanding Due To Related Parties balances\rat December 31, 2018 and 2017 of approximately $276,000 and $401,000, respectively, were comprised of amounts owed of approximately\r(i) $81,000 and $33,000, respectively, to the Company’s CEO and CFO, (ii) $135,000 and $153,000, respectively, to two companies\rpartially owned by these officers, and (iii) $60,000 and $215,000, respectively, to two shareholders of the Company. Such amounts\rowed are not subject to repayment schedules and are expected to be repaid during 2019.
\r\r\r\r
The outstanding Due From Related Parties\rbalance at December 31, 2017 of approximately $135,000 (current and long-term balances in the aggregate) was comprised of\ran advance of approximately $120,000 to a company partially owned by the Company’s CEO and CFO, and an advance to a shareholder.\rDuring 2018, the amount owed by the shareholder was repaid, and the $120,000 amount owed by the related company remained outstanding\rat December 31, 2018.
"}]},{"name":"rpt:f-107","factDimensions":{"xbrl:concept":"us-gaap:CommitmentsAndContingenciesDisclosureTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rNOTE 19 – COMMITMENTS AND CONTINGENCIES
\r\r\r\r
Operating Lease Commitments
\r\r\r\r
The Company leases facilities under several\roperating leases that contain rent holidays and customary escalations of lease payments for the type of facilities being leased.\rThe Company recognizes rent expense on a straight-line basis over the expected lease term, including cancelable option periods\rwhich the Company fully expected to exercise. The differences between amounts paid and amounts expensed are recorded under Deferred\rRents Payable on the balance sheet. Certain leases require the payment of property taxes, insurance and/or maintenance costs\rin addition to the rent payments.
\r\r\r\r
The location of the Company’s leased\rfacilities and descriptions of the lease agreements are as follows:
\r\r\r\r
| \r | ● | \rDelaware – 4,000 square feet of retail space in a multi-use building under a five-year lease that commenced in October 2016 and contains a five-year option to extend the term. The Company developed the space into a cannabis dispensary which is subleased to its cannabis-licensed client. Also in Delaware, in March 2019, the Company entered into a lease of a 100,000 square foot warehouse that it intends to construct into a cultivation and processing facility to be subleased to the same Delaware client. The lease term is 10 years, with an option to extend the term for three additional five-year periods. |
| \r | \r | |
| \r | ● | \rNevada – 10,000 square feet of an industrial building that the Company built-out into a cannabis cultivation facility and is subleased to the Company’s cannabis-licensed client under a sub-lease which is coterminous with the Company’s lease for 10 years expiring in 2024. |
\r\r
| \r | ● | \rMassachusetts – 10,000 square feet of office space which the Company utilizes as its corporate offices under a 10-year lease with a related party expiring in 2028 which contain a 5-year extension option. |
\r\r
| \r | ● | \rMaryland – a 2,700 square foot 2-unit apartment under a lease that expires in July 2020 with an option to renew for a two-year term. |
\r\r
For the years ended December 31, 2018 and 2017,\rrent expense approximated $436,000 and $183,000, respectively.
\r\r\r\r
Future minimum lease payments as of December\r31, 2018 under all non-cancelable operating leases having an initial or remaining term of more than one year were:
\r\r\r\r
| 2019 | \r\r | $ | \r398,731 | \r|
| 2020 | \r\r | \r | 797,120 | \r|
| 2021 | \r\r | \r | 894,450 | \r|
| 2022 | \r\r | \r | 882,068 | \r|
| 2023 | \r\r | \r | 858,136 | \r|
| Thereafter | \r\r | \r | 4,547,028 | \r|
| Total | \r\r | $ | \r8,377,533 | \r
\r\r
Terminated Employment Agreement
\r\r\r\r
An employment agreement with the former CEO\rof the Company that provided this individual with salary, car allowances, stock options, life insurance, and other employee benefits,\rwas terminated in 2017.
\r\r\r\r
The Company maintained an accrual of approximately\r$1,043,000 at December 31, 2018 and 2017 for any amounts that may be owed under this agreement, although the Company contends\rthat such agreement is not valid.
"}]},{"name":"rpt:f-108","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rStock options outstanding and exercisable as\rof December 31, 2018 were:
\r\r\r\r
| Exercise Price | \r\r | \r | Shares Under Option | \r\r | \r | Remaining | \r||||||||
| per Share | \r\r | \r | Outstanding | \r\r | \r | Exercisable | \r\r | \r | Life in Years | \r|||||
| $ | \r0.08 | \r\r | \r | \r | 250,000 | \r\r | \r | \r | 250,000 | \r\r | \r | \r | 0.08 | \r|
| $ | \r0.08 | \r\r | \r | \r | 100,000 | \r\r | \r | \r | 100,000 | \r\r | \r | \r | 0.97 | \r|
| $ | \r0.13 | \r\r | \r | \r | 200,000 | \r\r | \r | \r | 200,000 | \r\r | \r | \r | 1.50 | \r|
| $ | \r0.14 | \r\r | \r | \r | 650,000 | \r\r | \r | \r | 650,000 | \r\r | \r | \r | 2.00 | \r|
| $ | \r0.15 | \r\r | \r | \r | 1,000,000 | \r\r | \r | \r | 1,000,000 | \r\r | \r | \r | 0.74 | \r|
| $ | \r0.25 | \r\r | \r | \r | 1,000,000 | \r\r | \r | \r | 1,000,000 | \r\r | \r | \r | 0.74 | \r|
| $ | \r0.26 | \r\r | \r | \r | 50,000 | \r\r | \r | \r | 50,000 | \r\r | \r | \r | 2.25 | \r|
| $ | \r0.33 | \r\r | \r | \r | 50,000 | \r\r | \r | \r | 25,000 | \r\r | \r | \r | 2.19 | \r|
| $ | \r0.35 | \r\r | \r | \r | 1,000,000 | \r\r | \r | \r | 1,000,000 | \r\r | \r | \r | 0.74 | \r|
| $ | \r0.45 | \r\r | \r | \r | 190,000 | \r\r | \r | \r | 190,000 | \r\r | \r | \r | 2.76 | \r|
| $ | \r0.55 | \r\r | \r | \r | 100,000 | \r\r | \r | \r | 100,000 | \r\r | \r | \r | 1.74 | \r|
| $ | \r0.55 | \r\r | \r | \r | 100,000 | \r\r | \r | \r | 100,000 | \r\r | \r | \r | 1.74 | \r|
| $ | \r0.55 | \r\r | \r | \r | 20,000 | \r\r | \r | \r | 20,000 | \r\r | \r | \r | 2.02 | \r|
| $ | \r0.63 | \r\r | \r | \r | 300,000 | \r\r | \r | \r | 300,000 | \r\r | \r | \r | 3.00 | \r|
| $ | \r0.77 | \r\r | \r | \r | 300,000 | \r\r | \r | \r | 300,000 | \r\r | \r | \r | 4.00 | \r|
| $ | \r0.90 | \r\r | \r | \r | 50,000 | \r\r | \r | \r | 50,000 | \r\r | \r | \r | 4.37 | \r|
| $ | \r0.95 | \r\r | \r | \r | 50,000 | \r\r | \r | \r | 10,000 | \r\r | \r | \r | 4.00 | \r|
| $ | \r2.32 | \r\r | \r | \r | 300,000 | \r\r | \r | \r | - | \r\r | \r | \r | 4.70 | \r|
| $ | \r2.45 | \r\r | \r | \r | 2,000,000 | \r\r | \r | \r | 2,000,000 | \r\r | \r | \r | 5.85 | \r|
| $ | \r2.50 | \r\r | \r | \r | 100,000 | \r\r | \r | \r | - | \r\r | \r | \r | 4.66 | \r|
| $ | \r2.65 | \r\r | \r | \r | 200,000 | \r\r | \r | \r | - | \r\r | \r | \r | 4.73 | \r|
| $ | \r2.85 | \r\r | \r | \r | 75,000 | \r\r | \r | \r | - | \r\r | \r | \r | 3.95 | \r|
| $ | \r2.85 | \r\r | \r | \r | 100,000 | \r\r | \r | \r | - | \r\r | \r | \r | 4.95 | \r|
| $ | \r3.00 | \r\r | \r | \r | 25,000 | \r\r | \r | \r | - | \r\r | \r | \r | 4.96 | \r|
| $ | \r3.73 | \r\r | \r | \r | 200,000 | \r\r | \r | \r | - | \r\r | \r | \r | 4.94 | \r|
| \r | \r | \r | \r | \r | 8,310,000 | \r\r | \r | \r | 7,425,000 | \r\r | \r | \r | \r |
NOTE 20 – SUBSEQUENT EVENTS
\r\r\r\r
GenCanna Debentures Conversion
\r\r\r\r
In February 2019, the Company converted the\rentire $30 million investment in subordinated secured convertible debentures of GenCanna plus accrued interest through the conversion\rdate into common stock of GenCanna equal to a 33.5% ownership interest on a fully diluted basis. As a result of the conversion,\rthe Company will account for this investment in accordance with the equity method.
\r\r\r\r
Also during this month, the Company’s\rCEO was appointed to GenCanna’s board.
\r\r\r\r
Acquisitions
\r\r\r\r
In February 2019, the Company contracted to\rpurchase a 70% interest in Meditaurus LLC, a company established by Dr. Jokubas Ziburkas who holds a PhD in neuroscience and is\ra leading authority on hemp-based CBD and the endocannabinoid system. Meditaurus currently operates in the United States and Europe\rand has developed proprietary CBD formulations sold under its Florance brand.
\r\r\r\r
Real Estate
\r\r\r\r
In March 2019, the Company entered into a lease\rwith an option to purchase a 100,000 square foot warehouse located in Milford, Delaware. The lease term is 10 years, with an option\rto extend the term for three additional five-year periods. Build-out of the first 60,000 square feet into a cultivation and processing\rfacility has commenced, and is expected to be completed by October 2019.
\r\r\r\r
Investment
\r\r\r\r
In January 2019, the Company entered into an\ragreement with Maryland Health & Wellness Center Inc. (“MHWC”, an entity that has been pre-approved for a cannabis\rdispensing license, to provide MHWC with a construction loan of $300,000 in connection with the buildout of MHWC’s proposed\rdispensary location. MHWC issued a promissory note to the Company for the amount of the loan at a rate of 8% per annum that matures\rin January 2023, provided however, upon the two year anniversary of the date of final state approval of MHWC’s dispensing\rlicense, the Company shall have the right, subject to state approval, to convert the note into shares of MHWC’s common stock\rwhich shall be equivalent to 20% ownership of MWHC.
\r\r\r\r
Consulting Agreement
\r\r\r\r
At the same time as the aforementioned investment\rin MHWC, the Company entered into a consulting services agreement with MHWC whereby the Company will provide advisory and oversight\rservices to MHWC over a three-year period relating to the development, administration, operation, and management of MHWC's proposed\rdispensary in Maryland. The Company’s fee for such services shall be equal to 20% of MHWC’s net income of the business,\ras defined in the agreement.
\r\r\r\r
Promissory Note Issuance
\r\r\r\r
In March 2019, the Company raised $6 million\rfrom the issuance a of promissory note bearing interest at the rate of 10% per annum. This note is due and payable in January 2020.
\r\r\r\r
Conversion of Note Receivable
\r\r\r\r
In January, the Company’s note receivable\rbalance of approximately $258,000 from Chooze Corp. was converted into a 2.7% ownership interest in Chooze. As of the conversion\rdate, the Company will account for this investment in accordance with the provisions of ASC 321, Investments – Equity\rSecurities.
\r\r\r\r
Equity Transactions
\r\r\r\r
| \r | ● | \rThe Company sold 799,995 shares of common stock at a price of $3.25 per share resulting in aggregate proceeds of $2.6 million. |
| \r | \r | |
| \r | ● | \rWarrants to purchased 22,000 shares of common stock were exercised at exercise prices of $0.50 to $0.40. The Company received exercise proceeds of $15,800 from these exercises. |
| \r | \r | |
| \r | ● | \rOptions to purchase 50,000 shares of common stock were exercised at an exercise price of $0.26 per share. The Company received exercise proceeds of $13,000 from this exercise. |
| \r | \r | |
| \r | ● | \rOptions to purchase 350,000 shares of common stock were exercised on a cashless basis with the exercise prices paid via the surrender of 139,985 shares of common stock. |
| \r | \r | |
| \r | ● | \rThe holder of the $10M Debentures converted $600,000 of principal and approximately $97,000 of accrued interest into 233,194 shares of common stock at conversion prices ranging from $2.90 and $3.06 per share. |
| \r | \r | |
| \r | ● | \rThe Company issued 97,136 shares of common stock associated with the same number common stock subscriptions outstanding on December 31, 2018. |
Use of Estimates
\r\r\r\r
The preparation of financial statements in\rconformity with GAAP requires management to make estimates and assumptions that affect the reported amounts within the financial\rstatements and disclosures thereof. Actual results could differ from these estimates or assumptions.
"}]},{"name":"rpt:f-161","factDimensions":{"xbrl:concept":"us-gaap:CashAndCashEquivalentsPolicyTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rCash Equivalents
\r\r\r\r
The Company considers all highly liquid investments\rwith a maturity date of three months or less to be cash equivalents. The fair values of these investments approximate their carrying\rvalues.
\r\r\r\r
The Company’s cash and cash equivalents\rare maintained with recognized financial institutions located in the United States. In the normal course of business, the Company\rmay carry balances with certain financial institutions that exceed federally insured limits. The Company has not experienced losses\ron balances in excess of such limits and management believes the Company is not exposed to significant risks in that regard.
"}]},{"name":"rpt:f-162","factDimensions":{"xbrl:concept":"us-gaap:ResearchAndDevelopmentExpensePolicy","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rResearch and Development Costs
\r\r\r\r
Research and development costs are charged\rto operations as incurred.
"}]},{"name":"rpt:f-163","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentPolicyTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rProperty and Equipment
\r\r\r\r
Property and equipment are stated at cost less\raccumulated depreciation, with depreciation recognized on a straight-line basis over the shorter of the estimated useful life of\rthe asset or the lease term, if applicable. When assets are retired or disposed, the cost and accumulated depreciation are removed\rfrom the accounts, and any resulting gains or losses are included in income. Repairs and maintenance are charged to expense in\rthe period incurred.
\r\r\r\r
The estimated useful lives of property and\requipment are generally as follows: buildings and building improvements, seven to thirty-nine years; tenant improvements, the remaining\rduration of the related lease; furniture and fixtures, seven years; machinery and equipment, five to ten years. Land is not depreciated.
\r\r\r\r
The Company’s property and equipment\rare individually reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset\rmay not be recoverable. An impairment exists when the carrying amount of an asset exceeds the aggregate projected future cash flows\rover the anticipated holding period on an undiscounted basis. An impairment loss is measured based on the excess of the asset’s\rcarrying amount over its estimated fair value.
\r\r\r\r
Impairment analyses are based on management’s\rcurrent plans, intended holding periods and available market information at the time the analyses are prepared. If these criteria\rchange, the Company’s evaluation of impairment losses may be different and could have a material impact to the consolidated\rfinancial statements.
\r\r\r\r
For the years ended December 31, 2018 and\r2017, based on its impairment analyses, the Company did not have any impairment losses.
"}]},{"name":"rpt:f-164","factDimensions":{"xbrl:concept":"us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rImpairment of Long-Lived Assets
\r\r\r\r
The Company evaluates the recoverability of\rits fixed assets and other assets in accordance with ASC 360-10-15, Impairment or Disposal of Long-Lived Assets. Impairment\rof long-lived assets is recognized when the net book value of such assets exceeds their expected cash flows, in which case the\rassets are written down to fair value, which is determined based on discounted future cash flows or appraised values.
"}]},{"name":"rpt:f-165","factDimensions":{"xbrl:concept":"us-gaap:FairValueOfFinancialInstrumentsPolicy","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rFair Value of Financial Instruments
\r\r\r\r
The Company follows the provisions of ASC 820,\rFair Value Measurement, to measure the fair value of its financial instruments, and ASC 825, Financial Instruments, for\rdisclosures on the fair value of its financial instruments. To increase consistency and comparability in fair value measurements\rand related disclosures, ASC 820 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to\rmeasure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in\ractive markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value\rhierarchy defined by ASC 820 are:
\r\r\r\r
| Level 1 | \rQuoted market prices available in active markets for identical assets or liabilities as of the reporting date. |
| \r | |
| Level 2 | \rPricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. |
| \r | |
| Level 3 | \rPricing inputs that are generally observable inputs and not corroborated by market data. |
\r\r
The carrying amounts of the Company’s\rfinancial assets and liabilities, such as cash and accounts payable approximate their fair values due to the short maturity of\rthese instruments.
\r\r\r\r
The fair value of option and warrant issuances\rare determined using the Black-Scholes pricing model and employing several inputs such as the expected life of instrument, the\rexercise price, the expected risk-free interest rate, the expected dividend yield, the value of the Company’s common stock\ron issuance date, and the expected volatility of such common stock. The following table summarizes the range of inputs used by\rthe Company during the prior two fiscal years:
\r\r\r\r
| \r | \r | 2018 | \r\r | \r | 2017 | \r|||
| Life of instrument | \r\r | \r | 0.5 to 5.0 years | \r\r | \r | \r | 3.0 to 5.0 years | \r|
| Volatility factors | \r\r | \r | 1.019 to 2.086 | \r\r | \r | \r | 0.963 to 1.095 | \r|
| Risk-free interest rates | \r\r | \r | 1.65% to 3.07% | \r\r | \r | \r | 1.79% to 2.08% | \r|
| Dividend yield | \r\r | \r | 0% | \r\r | \r | \r | 0% | \r
\r\r
The expected life of an instrument is calculated\rusing the simplified method pursuant to Staff Accounting Bulletin Topic 14, Share-Based Payment, which allows for using\rthe mid-point between the vesting date and expiration date. The volatility factors are based on the historical two-year movement\rof the Company’s common stock prior to an instrument’s issuance date. The risk-free interest rate is based on U.S.\rTreasury rates with maturity periods similar to the expected instruments life on the issuance date.
\r\r\r\r
The Company amortizes the fair value of option\rand warrant issuances on a straight-line basis over the requisite service period of each instrument.
"}]},{"name":"rpt:f-166","factDimensions":{"xbrl:concept":"MRMD:ExtinguishmentOfLiabilitiesPolicyTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rExtinguishment of Liabilities
\r\r\r\r
The Company accounts for extinguishment of\rliabilities in accordance with ASC 405-20, Extinguishments of Liabilities. When the conditions for extinguishment are met,\rthe liabilities are written down to zero and a gain or loss is recognized.
"}]},{"name":"rpt:f-167","factDimensions":{"xbrl:concept":"us-gaap:IncomeTaxPolicyTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rIncome Taxes
\r\r\r\r
The Company accounts for income taxes in accordance\rwith ASC 740, Income Taxes. Deferred income tax assets and liabilities are determined based upon differences between the\rfinancial reporting and tax basis of assets and liabilities, and are measured using the enacted tax rates and laws that will be\rin effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent\rmanagement concludes it is more likely than not that the assets will not be realized. The effect on deferred tax assets and liabilities\rof a change in tax rates is recognized in the consolidated statements of operations in the period that includes the enactment date.
\r\r\r\r
ASC 740 prescribes a comprehensive model for\rhow companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or\rexpected to be taken on a tax return. The Company did not take any uncertain tax positions and had no adjustments to unrecognized\rincome tax liabilities or benefits for the years ended December 31, 2018 and 2017.
"}]},{"name":"rpt:f-168","factDimensions":{"xbrl:concept":"MRMD:RelatedPartyTransactionsPolicyTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rRelated Party Transactions
\r\r\r\r
The Company follows ASC 850, Related Party\rDisclosures, for the identification of related parties and disclosure of related party transactions.
\r\r\r\r
In accordance with ASC 850, the Company’s\rfinancial statements include disclosures of material related party transactions, other than compensation arrangements, expense\rallowances, and other similar items in the ordinary course of business, as well as transactions that are eliminated in the preparation\rof financial statements.
"}]},{"name":"rpt:f-169","factDimensions":{"xbrl:concept":"us-gaap:ComprehensiveIncomePolicyPolicyTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rComprehensive Income
\r\r\r\r
The Company reports comprehensive income and\rits components following guidance set forth by ASC 220, Comprehensive Income, which establishes standards for the reporting\rand display of comprehensive income and its components in the consolidated financial statements. There were no items of comprehensive\rincome applicable to the Company during the period covered in the financial statements.
"}]},{"name":"rpt:f-170","factDimensions":{"xbrl:concept":"us-gaap:EarningsPerSharePolicyTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rEarnings Per Share
\r\r\r\r
Earnings per common share is computed pursuant\rto ASC 260, Earnings Per Share. Basic earnings per share is computed by dividing net income by the weighted average number\rof shares of common stock outstanding during the period. Diluted net income per share is computed by dividing net income by the\rsum of the weighted average number of shares of common stock outstanding plus the weighted average number of potentially dilutive\rsecurities during the period.
\r\r\r\r
As of December 31, 2018 and 2017, there were\r18,916,211 and 9,045,311, respectively, of potentially dilutive securities in the form of options and warrants. Also as of such\rdates, there were (i) zero and 500,000 shares, respectively, of subscriptions on convertible preferred stock, (ii) $3,350,000\rand $1,350,000, respectively, of convertible promissory notes, and (iii) approximately $8.6 million and zero, respectively, of\rconvertible debentures payable, that were potentially dilutive, and whose conversion into common stock is based on a discount\rto the market value of common stock on or about the future conversion date. For the years ended December 31, 2018 and 2017, all\rpotentially dilutive securities had an anti-dilutive effect on earnings per share, and in accordance with ASC 260, were excluded\rfrom the diluted net income per share calculation, resulting in identical calculations of basic and fully diluted net income per\rshare. These securities may dilute earnings per share in the future.
"}]},{"name":"rpt:f-171","factDimensions":{"xbrl:concept":"us-gaap:CommitmentsAndContingenciesPolicyTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rCommitments and Contingencies
\r\r\r\r
The Company follows ASC 450, Contingencies,\rwhich requires the Company to assess the likelihood that a loss will be incurred from the occurrence or non-occurrence of one or\rmore future events. Such assessment inherently involves an exercise of judgment. In assessing possible loss contingencies from\rlegal proceedings or unasserted claims, the Company evaluates the perceived merits of such proceedings or claims, and of the relief\rsought or expected to be sought.
\r\r\r\r
If the assessment of a contingency indicates\rthat it is probable that a material loss will be incurred and the amount of the liability can be estimated, then the estimated\rliability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material\rloss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent\rliability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. Loss contingencies\rconsidered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.
\r\r\r\r
While not assured, management does not believe,\rbased upon information available at this time, that a loss contingency will have material adverse effect on the Company’s\rfinancial position, results of operations, or cash flows.
"}]},{"name":"rpt:f-172","factDimensions":{"xbrl:concept":"us-gaap:ConcentrationRiskCreditRisk","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rRisk and Uncertainties
\r\r\r\r
The Company is subject to risks common to companies\roperating within the legal and medical marijuana industries, including, but not limited to, federal laws, government regulations\rand jurisdictional laws.
\r\r\r\r"}]},{"name":"rpt:f-173","factDimensions":{"xbrl:concept":"us-gaap:OffBalanceSheetCreditExposurePolicyPolicyTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rOff-Balance Sheet Arrangements
\r\r\r\r
The Company does not have any off-balance\rsheet arrangements.
"}]},{"name":"rpt:f-174","factDimensions":{"xbrl:concept":"us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rRecent Accounting Pronouncements
\r\r\r\r
In February 2016, the Financial Accounting\rStandards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842),\rwhich modifies accounting for lessees by requiring the recording of right-of-use lease assets and lease liabilities for operating\rleases and disclosing key information about leasing arrangements. The Company is currently implementing the requirements of Topic\r842, which is effective for the Company starting on January 1, 2019. Most of the Company’s operating leases are subject to\rthis new standard whose impact will be reflected by an increase in the Company’s total assets and total liabilities relative\rto such amount prior to adoption.
\r\r\r\r
In November 2016, the FASB issued ASU No. 2016-18,\rStatement of Cash Flows (Topic 230): Restricted Cash, which enhances and clarifies the guidance on the classification and\rpresentation of restricted cash in the statement of cash flows. Topic 230 will be effective in 2019 and its impact is dependent\rupon the level of restricted cash of the Company, which at this time is insignificant.
\r\r\r\r
In January\r2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350) which simplifies goodwill impairment testing\rby requiring that such periodic testing be performed by comparing the fair value of a reporting unit with its carrying amount and\rrecognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. The\rCompany is currently evaluating the impact of Topic 350 on its consolidated financial statements and related disclosures, which\ris effective for fiscal years, including interim periods, beginning after December 15, 2019.
\r\r\r\r
In June 2018, the FASB issued ASU 2018-07,\rCompensation - Stock Compensation (Topic 718): Improvement to Nonemployee Share-Based Payment Accounting, which is part\rof the FASB’s simplification initiative to maintain or improve the usefulness of the information provided to the users of\rfinancial statements while reducing cost and complexity in financial reporting. This update provides consistency in the accounting\rfor share-based payments to nonemployees with that of employees. This update is effective for interim and annual reporting periods\rbeginning after December 15, 2018, and the Company is currently evaluating its financial statement impact.
\r\r\r\r
In addition to the above, the Company has\rreviewed all other recently issued, but not yet effective, accounting pronouncements, and does not believe the future adoption\rof any such pronouncements will have a material impact on its financial condition or the results of its operations.
"}]},{"name":"rpt:f-175","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensation","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"5760617","decimals":0}]},{"name":"rpt:f-176","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensation","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1078253","decimals":0}]},{"name":"rpt:f-177","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensation","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsOneMember"},"factValues":[{"value":"74000","decimals":0}]},{"name":"rpt:f-178","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensation","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsOneMember","us-gaap:StatementScenarioAxis":"MRMD:MarchTwoThousandAndNineteenMember"},"factValues":[{"value":"159000","decimals":0}]},{"name":"rpt:f-179","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensation","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsOneMember"},"factValues":[{"value":"3900000","decimals":0}]},{"name":"rpt:f-180","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensation","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsOneMember","us-gaap:StatementScenarioAxis":"MRMD:DecemberTwoThousandAndTwentyMember"},"factValues":[{"value":"5900000","decimals":0}]},{"name":"rpt:f-181","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensation","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsOneMember","us-gaap:StatementScenarioAxis":"MRMD:MarchTwoThousandAndNineteenMember"},"factValues":[{"value":"58000","decimals":0}]},{"name":"rpt:f-182","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensation","xbrl:period":"2018-01-01T00:00:00/2018-02-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TitleOfIndividualAxis":"us-gaap:ChiefExecutiveOfficerMember"},"factValues":[{"value":"458000","decimals":0}]},{"name":"rpt:f-183","factDimensions":{"xbrl:concept":"us-gaap:AccountsPayableCurrent","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2831658","decimals":0}]},{"name":"rpt:f-184","factDimensions":{"xbrl:concept":"us-gaap:AccountsPayableCurrent","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"3915430","decimals":0}]},{"name":"rpt:f-185","factDimensions":{"xbrl:concept":"us-gaap:AccruedLiabilitiesCurrent","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1405336","decimals":0}]},{"name":"rpt:f-186","factDimensions":{"xbrl:concept":"us-gaap:AccruedLiabilitiesCurrent","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1588368","decimals":0}]},{"name":"rpt:f-187","factDimensions":{"xbrl:concept":"us-gaap:AccruedLiabilitiesCurrent","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TypeOfArrangementAxis":"MRMD:EmploymentAgreementMember"},"factValues":[{"value":"1043000","decimals":0}]},{"name":"rpt:f-188","factDimensions":{"xbrl:concept":"us-gaap:AccruedLiabilitiesCurrent","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TypeOfArrangementAxis":"MRMD:EmploymentAgreementMember"},"factValues":[{"value":"1043000","decimals":0}]},{"name":"rpt:f-189","factDimensions":{"xbrl:concept":"us-gaap:DebtDisclosureTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rNOTE 10 – DEBT
\r\r\r\r
Mortgages
\r\r\r\r
In November 2017, the Company entered into\ra 10-year mortgage agreement with Bank of New England for the purchase of a 138,000 square foot industrial property in New Bedford,\rMassachusetts, within which the Company has built a 70,000 square foot cannabis cultivation and processing facility that is leased\rto ARL. From the start of the mortgage through May 2019, the Company is required to make monthly payments of interest-only at a\rrate equal to the monthly prime rate plus 2%, with a floor of 6.25%. From May 2019 to May 2024, the Company shall make principal\rand interest payments at a rate equal to the prime rate on May 2, 2019 plus 2%, with a floor of 6.25%. Principal and interest payments\rshall continue from May 2024 through the end of the lease at a rate equal to the prime rate on May 2, 2024 plus 2%, with a floor\rof 6.25%. At December 2018 and 2017, the principal balance on this mortgage was approximately $4.9 million and $2.9 million, respectively.\r
\r\r\r\r
The Company maintains another mortgage with\rBank of New England for the 2016 purchase of a 45,070 square foot building in Wilmington, Delaware which was developed into a cannabis\rseed-to-sale facility and is currently leased to the Company’s cannabis-licensed client in the state. The mortgage matures\rin 2031 with monthly principal and interest payments at a rate of 5.25% through September 2021, and thereafter the rate adjusting\revery five years to the then prime rate plus 1.5% with a floor of 5.25%. At December 31, 2018 and 2017, the principal balance on\rthis mortgage was approximately $1.8 million and $1.9 million, respectively.
\r\r\r\r
In 2016, the Company entered into a mortgage\ragreement with DuQuoin State Bank (“DSB”) for the purchase of two properties that it developed into two 3,400 square\rfoot free-standing retail dispensaries that are currently leased to the KPGs. On May 5th of each year, this mortgage\ris due to be repaid unless it is renewed for another year at a rate determined at the discretion of DSB’s executive committee.\rAt December 31, 2018 and 2017, the principal balance on this mortgage was approximately $850,000 and $869,000, respectively.
\r\r\r\r
Promissory Notes
\r\r\r\r
In September 2018, the Company raised $3,000,000\rfrom the issuance of a secured promissory note bearing interest at the rate of 10% per annum, with interest payable monthly. The\rnote is due and payable in September 2019, however the Company may elect to prepay the note in whole or part at any time after\rDecember 17, 2018 without premium or penalty.
\r\r\r\r
The Company issued three-year warrants, which\rwere attached to this promissory note, to the lender’s designees to purchase 750,000 shares of the Company’s common\rstock at an exercise price of $1.80 per share. The Company recorded a discount on the note of approximately $1.5 million from the\rallocation of note proceeds to the warrants based on the fair value of such warrants on the issuance date. During 2018, approximately\r$882,000 of the warrant discount was amortized to interest expense. At December 31, 2018, the carrying value of this note, net\rof remaining warrant discount of approximately $630,000, was approximately $2.37 million.
\r\r\r\r
During the year ended 2017, the Company raised\r$9,475,000 from the issuance of promissory notes with interest rates ranging from 4.5% to 12%, all with maturity dates of 12 months\ror less from the date of issue.
\r\r\r\r
During 2018, holders of previously issued promissory\rnotes with principal balances of $1,075,000 converted such promissory notes into 1,568,375 shares of common stock at conversion\rprices ranging from $0.65 to $0.90 per share. The conversions resulted in the recording of non-cash losses of approximately $829,000\rin the aggregate, based on the market value of the common stock on the conversion dates.
\r\r\r\r
In August 2017, $2.05 million in principal\rand approximately $262,000 of accrued interest on promissory notes were converted into 4,385,823 shares of common stock at a conversion\rprice of $0.53 per share. Based on the market value of the common stock on the conversion date, the Company recorded a non-cash\rloss on conversion of approximately $451,000.
\r\r\r\r
During 2018, the Company issued 2,596,313 shares\rof common stock and subscriptions on 79,136 shares of common stock to retire promissory notes with principal balances of\r$7,495,000 and approximately $95,000 of accrued interest. The Company recorded non-cash losses of approximately $2.5 million based\ron the fair value of the common stock on the retirement dates.
\r\r\r\r
During 2017, the Company issued 5,385,823 share\rof commons stock to retire promissory notes with principal balances of $2,300,000 and approximately $312,000 of accrued interest.\rThe Company recorded a non-cash loss of approximately $841,000 based on the fair value of the common stock on the retirement dates.
\r\r\r\r
During 2018 the Company repaid $700,000 of\rpromissory notes. No repayments debt occurred during the same period in 2017.
\r\r\r\r
The aggregate scheduled maturities of the Company’s\rtotal debt outstanding, inclusive of the promissory notes and mortgages described within this Note 10 – Debt, and\rthe convertible debentures described in the following Note 11 – Debentures Payable, as of December 31, 2018 were:
\r\r\r\r
| 2019 | \r\r | $ | \r5,154,404 | \r|
| 2020 | \r\r | \r | 9,070,954 | \r|
| 2021 | \r\r | \r | 235,827 | \r|
| 2022 | \r\r | \r | 251,543 | \r|
| 2023 | \r\r | \r | 268,338 | \r|
| Thereafter | \r\r | \r | 5,544,226 | \r|
| Total | \r\r | \r | 20,525,292 | \r|
| Less discounts | \r\r | \r | (5,553,339 | \r) |
| \r | \r | $ | \r14,971,953 | \r
Principles of Consolidation
\r\r\r\r
The accompanying condensed consolidated financial\rstatements at December 31, 2018 and 2017 and for the years then ended include the accounts of MariMed Inc. and the following majority-owned\rsubsidiaries.
\r\r\r\r
| Subsidiary: | \r\r | Percentage Owned | \r||
| MariMed Advisors Inc. | \r\r | \r | 100.0 | \r% |
| Mia Development LLC | \r\r | \r | 89.5 | \r% |
| Mari Holdings IL LLC | \r\r | \r | 60.0 | \r% |
| Mari Holdings MD LLC | \r\r | \r | 97.4 | \r% |
| Mari Holdings NV LLC | \r\r | \r | 100.0 | \r% |
| Hartwell Realty Holdings LLC | \r\r | \r | 100.0 | \r% |
| iRollie LLC | \r\r | \r | 100.0 | \r% |
| ARL Healthcare Inc. | \r\r | \r | 100.0 | \r% |
\r\r
Intercompany transactions have been eliminated\rupon consolidation.
"}]},{"name":"rpt:f-198","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentSharesIssued1","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"1568375"}]},{"name":"rpt:f-199","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentSharesIssued1","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"4385823"}]},{"name":"rpt:f-200","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentSharesIssued1","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:DebtInstrumentAxis":"MRMD:ConvertiblePromissoryNotesOneMember"},"factValues":[{"value":"1000000"}]},{"name":"rpt:f-201","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentSharesIssued1","xbrl:period":"2018-09-01T00:00:00/2018-10-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:DebtInstrumentAxis":"MRMD:ConvertiblePromissoryNotesMember"},"factValues":[{"value":"750000"}]},{"name":"rpt:f-202","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentSharesIssued1","xbrl:period":"2018-12-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:DebtInstrumentAxis":"MRMD:ConvertiblePromissoryNotesMember"},"factValues":[{"value":"1568375"}]},{"name":"rpt:f-203","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentSharesIssued1","xbrl:period":"2017-08-01T00:00:00/2017-09-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:DebtInstrumentAxis":"MRMD:ConvertiblePromissoryNotesMember"},"factValues":[{"value":"4385823"}]},{"name":"rpt:f-204","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentSharesIssued1","xbrl:period":"2018-11-01T00:00:00/2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:DebtInstrumentAxis":"MRMD:ConvertibleDebenturesMember","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember"},"factValues":[{"value":"324675"}]},{"name":"rpt:f-205","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentSharesIssued1","xbrl:period":"2018-11-01T00:00:00/2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember"},"factValues":[{"value":"524360"}]},{"name":"rpt:f-206","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentSharesIssued1","xbrl:period":"2018-12-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember"},"factValues":[{"value":"524360"}]},{"name":"rpt:f-207","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentSharesIssued1","xbrl:period":"2018-01-01T00:00:00/2018-02-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementClassOfStockAxis":"MRMD:SeriesAconvertiblePreferredMember"},"factValues":[{"value":"970989"}]},{"name":"rpt:f-208","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentSharesIssued1","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:DebtInstrumentAxis":"MRMD:PromissoryNoteMember"},"factValues":[{"value":"2596313"}]},{"name":"rpt:f-209","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentSharesIssued1","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:CommonStockOneMember"},"factValues":[{"value":"1568375"}]},{"name":"rpt:f-210","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentSharesIssued1","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:DebtInstrumentAxis":"MRMD:PromissoryNotesMember"},"factValues":[{"value":"5385823"}]},{"name":"rpt:f-211","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentSharesIssued1","xbrl:period":"2018-11-01T00:00:00/2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:DebtInstrumentAxis":"MRMD:ConvertibleDebenturesMember","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember","us-gaap:TypeOfArrangementAxis":"MRMD:SecuritiesPurchaseAgreementMember"},"factValues":[{"value":"500000000"}]},{"name":"rpt:f-212","factDimensions":{"xbrl:concept":"MRMD:NoncontrollingInterestsPolicyTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rNoncontrolling Interests
\r\r\r\r
Noncontrolling interests represent third-party\rminority ownership of the Company’s consolidated subsidiaries. Net income attributable to noncontrolling interests is shown\rin the consolidated statements of operations; the value of net assets owned by noncontrolling interests are presented as a component\rof equity within the balance sheets.
"}]},{"name":"rpt:f-213","factDimensions":{"xbrl:concept":"us-gaap:Depreciation","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"657854","decimals":0}]},{"name":"rpt:f-214","factDimensions":{"xbrl:concept":"us-gaap:Depreciation","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"362691","decimals":0}]},{"name":"rpt:f-215","factDimensions":{"xbrl:concept":"us-gaap:BasisOfAccountingPolicyPolicyTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rBasis of Presentation
\r\r\r\r
The accompanying consolidated financial statements\rhave been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”).
\r\r\r\r
Certain reclassifications have been made to\rprior periods’ data to conform to the current period presentation. These reclassifications had no effect on consolidated\rincome (losses) or cash flows.
"}]},{"name":"rpt:f-216","factDimensions":{"xbrl:concept":"MRMD:LongTermMortgagesPayable","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"5532397","decimals":0}]},{"name":"rpt:f-217","factDimensions":{"xbrl:concept":"MRMD:LongTermMortgagesPayable","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"7411634","decimals":0}]},{"name":"rpt:f-218","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised","xbrl:period":"2017-09-01T00:00:00/2017-10-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:TitleOfIndividualAxis":"us-gaap:ChiefExecutiveOfficerMember"},"factValues":[{"value":"4500000"}]},{"name":"rpt:f-219","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"654602"}]},{"name":"rpt:f-220","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"4710000"}]},{"name":"rpt:f-221","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsTwoMember"},"factValues":[{"value":"4500000"}]},{"name":"rpt:f-222","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsTwoMember"},"factValues":[{"value":"460000"}]},{"name":"rpt:f-223","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:TitleOfIndividualAxis":"us-gaap:ChiefExecutiveOfficerMember"},"factValues":[{"value":"400000"}]},{"name":"rpt:f-224","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:TitleOfIndividualAxis":"us-gaap:ChiefExecutiveOfficerMember"},"factValues":[{"value":"400000"}]},{"name":"rpt:f-225","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised","xbrl:period":"2018-01-01T00:00:00/2018-02-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:TitleOfIndividualAxis":"us-gaap:ChiefExecutiveOfficerMember"},"factValues":[{"value":"1450000"}]},{"name":"rpt:f-226","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember"},"factValues":[{"value":"760000"}]},{"name":"rpt:f-227","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember"},"factValues":[{"value":"4800000"}]},{"name":"rpt:f-228","factDimensions":{"xbrl:concept":"us-gaap:CommonStockSharesSubscriptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementClassOfStockAxis":"MRMD:SubscribedCommonStockMember"},"factValues":[{"value":"95000","decimals":0}]},{"name":"rpt:f-229","factDimensions":{"xbrl:concept":"us-gaap:CommonStockSharesSubscriptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementClassOfStockAxis":"MRMD:SubscribedCommonStockMember","us-gaap:AwardDateAxis":"MRMD:SeptemberTwoThousandEighteenThroughJanuaryTwoThousandNineteenMember"},"factValues":[{"value":"74160","decimals":0}]},{"name":"rpt:f-230","factDimensions":{"xbrl:concept":"dei:TradingSymbol","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"MRMD"}]},{"name":"rpt:f-231","factDimensions":{"xbrl:concept":"us-gaap:PreferredStockSharesSubscribedButUnissuedSubscriptionsReceivable","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"500","decimals":0}]},{"name":"rpt:f-232","factDimensions":{"xbrl:concept":"us-gaap:PreferredStockSharesSubscribedButUnissuedSubscriptionsReceivable","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-233","factDimensions":{"xbrl:concept":"us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"370000","decimals":0}]},{"name":"rpt:f-234","factDimensions":{"xbrl:concept":"us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"169123","decimals":0}]},{"name":"rpt:f-235","factDimensions":{"xbrl:concept":"us-gaap:PaymentsToAcquirePropertyPlantAndEquipment","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"8924311","decimals":0}]},{"name":"rpt:f-236","factDimensions":{"xbrl:concept":"us-gaap:PaymentsToAcquirePropertyPlantAndEquipment","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"20975763","decimals":0}]},{"name":"rpt:f-237","factDimensions":{"xbrl:concept":"dei:DocumentFiscalYearFocus","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"2018"}]},{"name":"rpt:f-238","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromNotesPayable","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"3206338","decimals":0}]},{"name":"rpt:f-239","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromNotesPayable","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"9475000","decimals":0}]},{"name":"rpt:f-240","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromNotesPayable","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:DebtInstrumentAxis":"MRMD:ConvertiblePromissoryNotesOneMember"},"factValues":[{"value":"9475000","decimals":0}]},{"name":"rpt:f-241","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromNotesPayable","xbrl:period":"2019-03-01T00:00:00/2019-04-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember"},"factValues":[{"value":"6000000","decimals":0}]},{"name":"rpt:f-242","factDimensions":{"xbrl:concept":"dei:EntitySmallBusiness","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"true"}]},{"name":"rpt:f-243","factDimensions":{"xbrl:concept":"dei:EntityEmergingGrowthCompany","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"true"}]},{"name":"rpt:f-244","factDimensions":{"xbrl:concept":"dei:EntityExTransitionPeriod","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"false"}]},{"name":"rpt:f-245","factDimensions":{"xbrl:concept":"us-gaap:CashAndCashEquivalentsAtCarryingValue","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1290231","decimals":0}]},{"name":"rpt:f-246","factDimensions":{"xbrl:concept":"us-gaap:CashAndCashEquivalentsAtCarryingValue","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"4104315","decimals":0}]},{"name":"rpt:f-247","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rStock-Based Compensation
\r\r\r\r
The Company accounts for stock-based compensation\rusing the fair value method as set forth in ASC 718, Compensation—Stock Compensation, which requires a public entity\rto measure the cost of employee services received in exchange for an equity award based on the fair value of the award on the\rgrant date, with limited exceptions. Such value will be incurred as compensation expense over the period an employee is required\rto provide service in exchange for the award, usually the vesting period. No compensation cost is recognized for equity awards\rfor which employees do not render the requisite service.
"}]},{"name":"rpt:f-248","factDimensions":{"xbrl:concept":"us-gaap:NetIncomeLoss","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-13604068","decimals":0}]},{"name":"rpt:f-249","factDimensions":{"xbrl:concept":"us-gaap:NetIncomeLoss","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-1194083","decimals":0}]},{"name":"rpt:f-250","factDimensions":{"xbrl:concept":"us-gaap:Investments","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-251","factDimensions":{"xbrl:concept":"us-gaap:Investments","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1672163","decimals":0}]},{"name":"rpt:f-252","factDimensions":{"xbrl:concept":"us-gaap:Investments","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","invest:InvestmentHoldingAxis":"MRMD:SproutMember"},"factValues":[{"value":"300000","decimals":0}]},{"name":"rpt:f-253","factDimensions":{"xbrl:concept":"us-gaap:Investments","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","invest:InvestmentHoldingAxis":"MRMD:DabTabMember","us-gaap:BusinessAcquisitionAxis":"MRMD:IconicVenturesIncMember"},"factValues":[{"value":"500000","decimals":0}]},{"name":"rpt:f-254","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentAmount1","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1904316","decimals":0}]},{"name":"rpt:f-255","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentAmount1","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"1568","decimals":0}]},{"name":"rpt:f-256","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentAmount1","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"4386","decimals":0}]},{"name":"rpt:f-257","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentAmount1","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2763069","decimals":0}]},{"name":"rpt:f-258","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentAmount1","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"2758683","decimals":0}]},{"name":"rpt:f-259","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentAmount1","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"1092748","decimals":0}]},{"name":"rpt:f-260","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentAmount1","xbrl:period":"2018-12-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:DebtInstrumentAxis":"MRMD:ConvertiblePromissoryNotesMember"},"factValues":[{"value":"829000","decimals":0}]},{"name":"rpt:f-261","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentAmount1","xbrl:period":"2017-08-01T00:00:00/2017-09-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:DebtInstrumentAxis":"MRMD:ConvertiblePromissoryNotesMember"},"factValues":[{"value":"451000","decimals":0}]},{"name":"rpt:f-262","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentAmount1","xbrl:period":"2018-11-01T00:00:00/2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:DebtInstrumentAxis":"MRMD:ConvertibleDebenturesMember","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember"},"factValues":[{"value":"10000000","decimals":0}]},{"name":"rpt:f-263","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentAmount1","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:DebtInstrumentAxis":"MRMD:PromissoryNoteMember"},"factValues":[{"value":"2500000","decimals":0}]},{"name":"rpt:f-264","factDimensions":{"xbrl:concept":"us-gaap:CostOfRevenue","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"4041122","decimals":0}]},{"name":"rpt:f-265","factDimensions":{"xbrl:concept":"us-gaap:CostOfRevenue","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2192812","decimals":0}]},{"name":"rpt:f-266","factDimensions":{"xbrl:concept":"us-gaap:GrossProfit","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"7810793","decimals":0}]},{"name":"rpt:f-267","factDimensions":{"xbrl:concept":"us-gaap:GrossProfit","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"3875041","decimals":0}]},{"name":"rpt:f-268","factDimensions":{"xbrl:concept":"us-gaap:GeneralAndAdministrativeExpense","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"10202731","decimals":0}]},{"name":"rpt:f-269","factDimensions":{"xbrl:concept":"us-gaap:GeneralAndAdministrativeExpense","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2880293","decimals":0}]},{"name":"rpt:f-270","factDimensions":{"xbrl:concept":"us-gaap:MarketingAndAdvertisingExpense","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"292477","decimals":0}]},{"name":"rpt:f-271","factDimensions":{"xbrl:concept":"us-gaap:MarketingAndAdvertisingExpense","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"130087","decimals":0}]},{"name":"rpt:f-272","factDimensions":{"xbrl:concept":"MRMD:Personnel","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1339832","decimals":0}]},{"name":"rpt:f-273","factDimensions":{"xbrl:concept":"MRMD:Personnel","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"737011","decimals":0}]},{"name":"rpt:f-274","factDimensions":{"xbrl:concept":"us-gaap:OperatingExpenses","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"13166825","decimals":0}]},{"name":"rpt:f-275","factDimensions":{"xbrl:concept":"us-gaap:OperatingExpenses","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"3747391","decimals":0}]},{"name":"rpt:f-276","factDimensions":{"xbrl:concept":"us-gaap:OperatingIncomeLoss","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-5356032","decimals":0}]},{"name":"rpt:f-277","factDimensions":{"xbrl:concept":"us-gaap:OperatingIncomeLoss","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"127650","decimals":0}]},{"name":"rpt:f-278","factDimensions":{"xbrl:concept":"us-gaap:GainsLossesOnExtinguishmentOfDebt","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"4133481","decimals":0}]},{"name":"rpt:f-279","factDimensions":{"xbrl:concept":"us-gaap:GainsLossesOnExtinguishmentOfDebt","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"872133","decimals":0}]},{"name":"rpt:f-280","factDimensions":{"xbrl:concept":"us-gaap:GainsLossesOnExtinguishmentOfDebt","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TitleOfIndividualAxis":"MRMD:ThirdPartiesMember"},"factValues":[{"value":"31000","decimals":0}]},{"name":"rpt:f-281","factDimensions":{"xbrl:concept":"us-gaap:GainsLossesOnExtinguishmentOfDebt","xbrl:period":"2018-01-01T00:00:00/2018-02-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementClassOfStockAxis":"MRMD:SeriesAconvertiblePreferredMember"},"factValues":[{"value":"34000","decimals":0}]},{"name":"rpt:f-282","factDimensions":{"xbrl:concept":"us-gaap:GainsLossesOnExtinguishmentOfDebt","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TitleOfIndividualAxis":"MRMD:ThirdPartiesMember"},"factValues":[{"value":"1024000","decimals":0}]},{"name":"rpt:f-283","factDimensions":{"xbrl:concept":"us-gaap:InterestExpense","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"4366295","decimals":0}]},{"name":"rpt:f-284","factDimensions":{"xbrl:concept":"us-gaap:InterestExpense","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"592417","decimals":0}]},{"name":"rpt:f-285","factDimensions":{"xbrl:concept":"us-gaap:NonoperatingIncomeExpense","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"7952641","decimals":0}]},{"name":"rpt:f-286","factDimensions":{"xbrl:concept":"us-gaap:NonoperatingIncomeExpense","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1156712","decimals":0}]},{"name":"rpt:f-287","factDimensions":{"xbrl:concept":"us-gaap:ProfitLoss","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-13308673","decimals":0}]},{"name":"rpt:f-288","factDimensions":{"xbrl:concept":"us-gaap:ProfitLoss","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-1029062","decimals":0}]},{"name":"rpt:f-289","factDimensions":{"xbrl:concept":"us-gaap:ProfitLoss","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:RetainedEarningsMember"},"factValues":[{"value":"-1194083","decimals":0}]},{"name":"rpt:f-290","factDimensions":{"xbrl:concept":"us-gaap:ProfitLoss","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:NoncontrollingInterestMember"},"factValues":[{"value":"165021","decimals":0}]},{"name":"rpt:f-291","factDimensions":{"xbrl:concept":"us-gaap:ProfitLoss","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:NoncontrollingInterestMember"},"factValues":[{"value":"295395","decimals":0}]},{"name":"rpt:f-292","factDimensions":{"xbrl:concept":"us-gaap:ProfitLoss","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:RetainedEarningsMember"},"factValues":[{"value":"-13604068","decimals":0}]},{"name":"rpt:f-293","factDimensions":{"xbrl:concept":"us-gaap:NetIncomeLossAttributableToNoncontrollingInterest","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"295395","decimals":0}]},{"name":"rpt:f-294","factDimensions":{"xbrl:concept":"us-gaap:NetIncomeLossAttributableToNoncontrollingInterest","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"165021","decimals":0}]},{"name":"rpt:f-295","factDimensions":{"xbrl:concept":"us-gaap:EarningsPerShareBasicAndDiluted","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares"},"factValues":[{"value":"-0.071"}]},{"name":"rpt:f-296","factDimensions":{"xbrl:concept":"us-gaap:EarningsPerShareBasicAndDiluted","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares"},"factValues":[{"value":"-0.010"}]},{"name":"rpt:f-297","factDimensions":{"xbrl:concept":"us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"192376020"}]},{"name":"rpt:f-298","factDimensions":{"xbrl:concept":"us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"116275301"}]},{"name":"rpt:f-299","factDimensions":{"xbrl:concept":"us-gaap:IncreaseDecreaseInAccountsReceivable","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"4073482","decimals":0}]},{"name":"rpt:f-300","factDimensions":{"xbrl:concept":"us-gaap:IncreaseDecreaseInAccountsReceivable","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"920877","decimals":0}]},{"name":"rpt:f-301","factDimensions":{"xbrl:concept":"us-gaap:IncreaseDecreaseInOtherReceivables","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1485595","decimals":0}]},{"name":"rpt:f-302","factDimensions":{"xbrl:concept":"us-gaap:IncreaseDecreaseInOtherReceivables","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"74541","decimals":0}]},{"name":"rpt:f-303","factDimensions":{"xbrl:concept":"us-gaap:IncreaseDecreaseDueFromOfficersAndStockholders","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"3387906","decimals":0}]},{"name":"rpt:f-304","factDimensions":{"xbrl:concept":"us-gaap:IncreaseDecreaseDueFromOfficersAndStockholders","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"640238","decimals":0}]},{"name":"rpt:f-305","factDimensions":{"xbrl:concept":"us-gaap:IncreaseDecreaseInOtherCurrentAssets","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-156547","decimals":0}]},{"name":"rpt:f-306","factDimensions":{"xbrl:concept":"us-gaap:IncreaseDecreaseInOtherCurrentAssets","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"341016","decimals":0}]},{"name":"rpt:f-307","factDimensions":{"xbrl:concept":"us-gaap:IncreaseDecreaseInOtherNoncurrentAssets","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-163462","decimals":0}]},{"name":"rpt:f-308","factDimensions":{"xbrl:concept":"us-gaap:IncreaseDecreaseInOtherNoncurrentAssets","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"51044","decimals":0}]},{"name":"rpt:f-309","factDimensions":{"xbrl:concept":"us-gaap:IncreaseDecreaseInAccountsPayable","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"963083","decimals":0}]},{"name":"rpt:f-310","factDimensions":{"xbrl:concept":"us-gaap:IncreaseDecreaseInAccountsPayable","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2359493","decimals":0}]},{"name":"rpt:f-311","factDimensions":{"xbrl:concept":"us-gaap:IncreaseDecreaseInAccruedLiabilities","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"183032","decimals":0}]},{"name":"rpt:f-312","factDimensions":{"xbrl:concept":"us-gaap:IncreaseDecreaseInAccruedLiabilities","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"86245","decimals":0}]},{"name":"rpt:f-313","factDimensions":{"xbrl:concept":"us-gaap:NetCashProvidedByUsedInOperatingActivities","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-2907857","decimals":0}]},{"name":"rpt:f-314","factDimensions":{"xbrl:concept":"us-gaap:NetCashProvidedByUsedInOperatingActivities","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1764841","decimals":0}]},{"name":"rpt:f-315","factDimensions":{"xbrl:concept":"us-gaap:NetCashProvidedByUsedInInvestingActivities","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-40069998","decimals":0}]},{"name":"rpt:f-316","factDimensions":{"xbrl:concept":"us-gaap:NetCashProvidedByUsedInInvestingActivities","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-20923036","decimals":0}]},{"name":"rpt:f-317","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromSaleOfNotesReceivable","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","dei:LegalEntityAxis":"MRMD:ChoozeCorpMember","us-gaap:RelatedPartyTransactionsByRelatedPartyAxis":"MRMD:TwoUnrelatedThirdPartyCompaniesMember"},"factValues":[{"value":"550000","decimals":0}]},{"name":"rpt:f-318","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromSaleOfNotesReceivable","xbrl:period":"2015-10-01T00:00:00/2016-05-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:RelatedPartyTransactionsByRelatedPartyAxis":"MRMD:DelawareCannabisLicenseeMember"},"factValues":[{"value":"700000","decimals":0}]},{"name":"rpt:f-319","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-320","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"200000","decimals":0}]},{"name":"rpt:f-321","factDimensions":{"xbrl:concept":"us-gaap:PaymentsOfCapitalDistribution","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"690917","decimals":0}]},{"name":"rpt:f-322","factDimensions":{"xbrl:concept":"us-gaap:PaymentsOfCapitalDistribution","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"577730","decimals":0}]},{"name":"rpt:f-323","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromStockOptionsExercised","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"39000","decimals":0}]},{"name":"rpt:f-324","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromStockOptionsExercised","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"7500","decimals":0}]},{"name":"rpt:f-325","factDimensions":{"xbrl:concept":"us-gaap:NetCashProvidedByUsedInFinancingActivities","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"45791939","decimals":0}]},{"name":"rpt:f-326","factDimensions":{"xbrl:concept":"us-gaap:NetCashProvidedByUsedInFinancingActivities","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"19879070","decimals":0}]},{"name":"rpt:f-327","factDimensions":{"xbrl:concept":"us-gaap:InterestPaidNet","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1286007","decimals":0}]},{"name":"rpt:f-328","factDimensions":{"xbrl:concept":"us-gaap:InterestPaidNet","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"586584","decimals":0}]},{"name":"rpt:f-329","factDimensions":{"xbrl:concept":"us-gaap:IncomeTaxesPaidNet","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"12584","decimals":0}]},{"name":"rpt:f-330","factDimensions":{"xbrl:concept":"us-gaap:IncomeTaxesPaidNet","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1781","decimals":0}]},{"name":"rpt:f-331","factDimensions":{"xbrl:concept":"us-gaap:StockIssued1","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"7589788","decimals":0}]},{"name":"rpt:f-332","factDimensions":{"xbrl:concept":"us-gaap:StockIssued1","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"300000","decimals":0}]},{"name":"rpt:f-333","factDimensions":{"xbrl:concept":"dei:EntityWellKnownSeasonedIssuer","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"No"}]},{"name":"rpt:f-334","factDimensions":{"xbrl:concept":"dei:EntityVoluntaryFilers","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"No"}]},{"name":"rpt:f-335","factDimensions":{"xbrl:concept":"dei:EntityCurrentReportingStatus","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"Yes"}]},{"name":"rpt:f-336","factDimensions":{"xbrl:concept":"dei:EntityShellCompany","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"false"}]},{"name":"rpt:f-337","factDimensions":{"xbrl:concept":"dei:EntityPublicFloat","xbrl:period":"2018-06-30T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"258400000","decimals":0}]},{"name":"rpt:f-338","factDimensions":{"xbrl:concept":"us-gaap:DeferredRentCreditCurrent","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-339","factDimensions":{"xbrl:concept":"us-gaap:DeferredRentCreditCurrent","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"105901","decimals":0}]},{"name":"rpt:f-340","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"370000","decimals":0}]},{"name":"rpt:f-341","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"MRMD:CommonStockSubscribedButNotIssuedMember"},"factValues":[{"value":"370000","decimals":0}]},{"name":"rpt:f-342","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets","xbrl:period":"2017-10-01T00:00:00/2017-11-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:BettysEddiesMember"},"factValues":[{"value":"1000000","decimals":0}]},{"name":"rpt:f-343","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:CommonStockSubscribedButNotIssuedMember"},"factValues":[{"value":"1000000"}]},{"name":"rpt:f-344","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets","xbrl:period":"2017-10-01T00:00:00/2017-11-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:BusinessAcquisitionAxis":"MRMD:BettysEddiesMember"},"factValues":[{"value":"140000"}]},{"name":"rpt:f-345","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromIssuanceOfSecuredDebt","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2000000","decimals":0}]},{"name":"rpt:f-346","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromIssuanceOfSecuredDebt","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2785841","decimals":0}]},{"name":"rpt:f-347","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromIssuanceOfSecuredDebt","xbrl:period":"2018-11-01T00:00:00/2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:DebtInstrumentAxis":"MRMD:ConvertibleDebenturesMember","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember"},"factValues":[{"value":"9900000","decimals":0}]},{"name":"rpt:f-348","factDimensions":{"xbrl:concept":"us-gaap:SharesIssuedPricePerShare","xbrl:period":"2017-10-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:TitleOfIndividualAxis":"us-gaap:ChiefExecutiveOfficerMember"},"factValues":[{"value":"0.01"}]},{"name":"rpt:f-349","factDimensions":{"xbrl:concept":"us-gaap:SharesIssuedPricePerShare","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","srt:RangeAxis":"srt:MinimumMember"},"factValues":[{"value":"0.18"}]},{"name":"rpt:f-350","factDimensions":{"xbrl:concept":"us-gaap:SharesIssuedPricePerShare","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"0.50"}]},{"name":"rpt:f-351","factDimensions":{"xbrl:concept":"us-gaap:SharesIssuedPricePerShare","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:StatementClassOfStockAxis":"us-gaap:SeriesAPreferredStockMember"},"factValues":[{"value":"1.00"}]},{"name":"rpt:f-352","factDimensions":{"xbrl:concept":"us-gaap:SharesIssuedPricePerShare","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:TitleOfIndividualAxis":"us-gaap:ChiefFinancialOfficerMember"},"factValues":[{"value":"0.025"}]},{"name":"rpt:f-353","factDimensions":{"xbrl:concept":"us-gaap:SharesIssuedPricePerShare","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","srt:RangeAxis":"srt:MinimumMember"},"factValues":[{"value":"0.50"}]},{"name":"rpt:f-354","factDimensions":{"xbrl:concept":"us-gaap:SharesIssuedPricePerShare","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"0.65"}]},{"name":"rpt:f-355","factDimensions":{"xbrl:concept":"us-gaap:SharesIssuedPricePerShare","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:TitleOfIndividualAxis":"us-gaap:ChiefExecutiveOfficerMember"},"factValues":[{"value":"0.025"}]},{"name":"rpt:f-356","factDimensions":{"xbrl:concept":"us-gaap:SharesIssuedPricePerShare","xbrl:period":"2018-01-03T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:TitleOfIndividualAxis":"us-gaap:ChiefExecutiveOfficerMember","srt:RangeAxis":"srt:MinimumMember"},"factValues":[{"value":"0.14"}]},{"name":"rpt:f-357","factDimensions":{"xbrl:concept":"us-gaap:SharesIssuedPricePerShare","xbrl:period":"2018-01-03T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:TitleOfIndividualAxis":"us-gaap:ChiefExecutiveOfficerMember","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"0.77"}]},{"name":"rpt:f-358","factDimensions":{"xbrl:concept":"us-gaap:SharesIssuedPricePerShare","xbrl:period":"2019-03-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember"},"factValues":[{"value":"3.25"}]},{"name":"rpt:f-359","factDimensions":{"xbrl:concept":"us-gaap:SharesIssuedPricePerShare","xbrl:period":"2019-03-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsMember"},"factValues":[{"value":"0.26"}]},{"name":"rpt:f-360","factDimensions":{"xbrl:concept":"us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued","xbrl:period":"2017-06-01T00:00:00/2017-07-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"75000000"}]},{"name":"rpt:f-361","factDimensions":{"xbrl:concept":"us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued","xbrl:period":"2018-04-01T00:00:00/2018-05-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:BusinessAcquisitionAxis":"MRMD:IRollieLLCMember"},"factValues":[{"value":"264317"}]},{"name":"rpt:f-362","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesIssuedForServices","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"3420526"}]},{"name":"rpt:f-363","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesIssuedForServices","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:TitleOfIndividualAxis":"MRMD:ThirdPartiesMember"},"factValues":[{"value":"1007597"}]},{"name":"rpt:f-364","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesIssuedForServices","xbrl:period":"2017-10-01T00:00:00/2017-11-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementClassOfStockAxis":"MRMD:SubscribedCommonStockMember","us-gaap:RelatedPartyTransactionsByRelatedPartyAxis":"MRMD:BettysEddiesMember"},"factValues":[{"value":"370000"}]},{"name":"rpt:f-365","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesIssuedForServices","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:TitleOfIndividualAxis":"MRMD:ThirdPartiesMember"},"factValues":[{"value":"3420526"}]},{"name":"rpt:f-366","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentFaceAmount","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2300000","decimals":0}]},{"name":"rpt:f-367","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentFaceAmount","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"7495000","decimals":0}]},{"name":"rpt:f-368","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentFaceAmount","xbrl:period":"2017-09-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:DebtInstrumentAxis":"MRMD:ConvertiblePromissoryNotesMember"},"factValues":[{"value":"2050000","decimals":0}]},{"name":"rpt:f-369","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentFaceAmount","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TypeOfArrangementAxis":"MRMD:MortgageAgreementMember"},"factValues":[{"value":"2900000","decimals":0}]},{"name":"rpt:f-370","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentFaceAmount","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TypeOfArrangementAxis":"MRMD:MortgageAgreementMember"},"factValues":[{"value":"4900000","decimals":0}]},{"name":"rpt:f-371","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentFaceAmount","xbrl:period":"2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:DebtInstrumentAxis":"MRMD:ConvertibleDebenturesMember","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember"},"factValues":[{"value":"10000000","decimals":0}]},{"name":"rpt:f-372","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentFaceAmount","xbrl:period":"2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember"},"factValues":[{"value":"1400000","decimals":0}]},{"name":"rpt:f-373","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentFaceAmount","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember"},"factValues":[{"value":"1400000","decimals":0}]},{"name":"rpt:f-374","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentFaceAmount","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember","us-gaap:RelatedPartyTransactionsByRelatedPartyAxis":"us-gaap:BeneficialOwnerMember"},"factValues":[{"value":"8600000","decimals":0}]},{"name":"rpt:f-375","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentFaceAmount","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementClassOfStockAxis":"MRMD:SubscribedCommonStockMember"},"factValues":[{"value":"50000","decimals":0}]},{"name":"rpt:f-376","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentFaceAmount","xbrl:period":"2019-03-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember"},"factValues":[{"value":"600000","decimals":0}]},{"name":"rpt:f-377","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentFaceAmount","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TypeOfArrangementAxis":"MRMD:MortgageAgreementMember","srt:StatementGeographicalAxis":"country:DE"},"factValues":[{"value":"1800000","decimals":0}]},{"name":"rpt:f-378","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentFaceAmount","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TypeOfArrangementAxis":"MRMD:MortgageAgreementMember","srt:StatementGeographicalAxis":"country:DE"},"factValues":[{"value":"1900000","decimals":0}]},{"name":"rpt:f-379","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentFaceAmount","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TypeOfArrangementAxis":"MRMD:MortgageAgreementMember","us-gaap:CreditFacilityAxis":"MRMD:DuQuoinStateBankMember"},"factValues":[{"value":"869000","decimals":0}]},{"name":"rpt:f-380","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentFaceAmount","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TypeOfArrangementAxis":"MRMD:MortgageAgreementMember","us-gaap:CreditFacilityAxis":"MRMD:DuQuoinStateBankMember"},"factValues":[{"value":"850000","decimals":0}]},{"name":"rpt:f-381","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestmentOwnershipPercentage","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"1.00"}]},{"name":"rpt:f-382","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestmentOwnershipPercentage","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","dei:LegalEntityAxis":"MRMD:MariHoldingsMDLLCMember","us-gaap:StatementEquityComponentsAxis":"MRMD:ClassAMembershipUnitsMember"},"factValues":[{"value":"0.0305"}]},{"name":"rpt:f-383","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestmentOwnershipPercentage","xbrl:period":"2017-07-01T00:00:00","xbrl:entity":"cik:0001522767","dei:LegalEntityAxis":"MRMD:MariMedAdvisorsIncMember"},"factValues":[{"value":"0.49"}]},{"name":"rpt:f-384","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestmentOwnershipPercentage","xbrl:period":"2018-05-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:BusinessAcquisitionAxis":"MRMD:IRollieLLCMember"},"factValues":[{"value":"1.00"}]},{"name":"rpt:f-385","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestmentOwnershipPercentage","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","dei:LegalEntityAxis":"MRMD:GenCannaGlobalIncMember"},"factValues":[{"value":"0.33"}]},{"name":"rpt:f-386","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestmentOwnershipPercentage","xbrl:period":"2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:DebtInstrumentAxis":"MRMD:ConvertibleDebenturesMember","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember"},"factValues":[{"value":"0.0499"}]},{"name":"rpt:f-387","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestmentOwnershipPercentage","xbrl:period":"2019-03-01T00:00:00","xbrl:entity":"cik:0001522767","dei:LegalEntityAxis":"MRMD:GenCannaGlobalIncMember","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember"},"factValues":[{"value":"0.335"}]},{"name":"rpt:f-388","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestmentOwnershipPercentage","xbrl:period":"2019-03-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember","dei:LegalEntityAxis":"MRMD:MeditaurusLLCMember"},"factValues":[{"value":"0.70"}]},{"name":"rpt:f-389","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestmentOwnershipPercentage","xbrl:period":"2019-02-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember","srt:OwnershipAxis":"MRMD:MarylandHealthWellnessCenterIncMember"},"factValues":[{"value":"0.20"}]},{"name":"rpt:f-390","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestmentOwnershipPercentage","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","srt:ConsolidatedEntitiesAxis":"MRMD:MariMedAdvisorsIncMember"},"factValues":[{"value":"1.00"}]},{"name":"rpt:f-391","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestmentOwnershipPercentage","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","srt:ConsolidatedEntitiesAxis":"MRMD:MiaDevelopmentLLCMember"},"factValues":[{"value":"0.895"}]},{"name":"rpt:f-392","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestmentOwnershipPercentage","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","srt:ConsolidatedEntitiesAxis":"MRMD:MariHoldingsILLLCMember"},"factValues":[{"value":"0.600"}]},{"name":"rpt:f-393","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestmentOwnershipPercentage","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","srt:ConsolidatedEntitiesAxis":"MRMD:MariHoldingsMDLLCMember"},"factValues":[{"value":"0.974"}]},{"name":"rpt:f-394","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestmentOwnershipPercentage","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","srt:ConsolidatedEntitiesAxis":"MRMD:MariHoldingsNVLLCMember"},"factValues":[{"value":"1.00"}]},{"name":"rpt:f-395","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestmentOwnershipPercentage","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","srt:ConsolidatedEntitiesAxis":"MRMD:HartwellRealtyHoldingsLLCMember"},"factValues":[{"value":"1.00"}]},{"name":"rpt:f-396","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestmentOwnershipPercentage","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","srt:ConsolidatedEntitiesAxis":"MRMD:IRollieLLCMember"},"factValues":[{"value":"1.00"}]},{"name":"rpt:f-397","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestmentOwnershipPercentage","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","srt:ConsolidatedEntitiesAxis":"MRMD:ARLHealthcareIncMember"},"factValues":[{"value":"1.00"}]},{"name":"rpt:f-398","factDimensions":{"xbrl:concept":"MRMD:WriteoffOfDeferredRevenue","xbrl:period":"2017-07-01T00:00:00/2017-08-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"227000","decimals":0}]},{"name":"rpt:f-399","factDimensions":{"xbrl:concept":"us-gaap:DepreciationAndAmortization","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"658000","decimals":0}]},{"name":"rpt:f-400","factDimensions":{"xbrl:concept":"us-gaap:DepreciationAndAmortization","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"363000","decimals":0}]},{"name":"rpt:f-401","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentGross","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"27453809","decimals":0}]},{"name":"rpt:f-402","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentGross","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"36259694","decimals":0}]},{"name":"rpt:f-403","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentGross","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:PropertyPlantAndEquipmentByTypeAxis":"us-gaap:LandMember"},"factValues":[{"value":"3392710","decimals":0}]},{"name":"rpt:f-404","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentGross","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:PropertyPlantAndEquipmentByTypeAxis":"MRMD:BuildingsandBuildingImprovementsMember"},"factValues":[{"value":"3918359","decimals":0}]},{"name":"rpt:f-405","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentGross","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:PropertyPlantAndEquipmentByTypeAxis":"MRMD:TenantImprovementsMember"},"factValues":[{"value":"2260512","decimals":0}]},{"name":"rpt:f-406","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentGross","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:PropertyPlantAndEquipmentByTypeAxis":"us-gaap:FurnitureAndFixturesMember"},"factValues":[{"value":"95815","decimals":0}]},{"name":"rpt:f-407","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentGross","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:PropertyPlantAndEquipmentByTypeAxis":"us-gaap:MachineryAndEquipmentMember"},"factValues":[{"value":"506464","decimals":0}]},{"name":"rpt:f-408","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentGross","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:PropertyPlantAndEquipmentByTypeAxis":"us-gaap:LandMember"},"factValues":[{"value":"3392710","decimals":0}]},{"name":"rpt:f-409","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentGross","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:PropertyPlantAndEquipmentByTypeAxis":"MRMD:BuildingsandBuildingImprovementsMember"},"factValues":[{"value":"13566144","decimals":0}]},{"name":"rpt:f-410","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentGross","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:PropertyPlantAndEquipmentByTypeAxis":"MRMD:TenantImprovementsMember"},"factValues":[{"value":"5348882","decimals":0}]},{"name":"rpt:f-411","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentGross","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:PropertyPlantAndEquipmentByTypeAxis":"us-gaap:FurnitureAndFixturesMember"},"factValues":[{"value":"114160","decimals":0}]},{"name":"rpt:f-412","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentGross","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:PropertyPlantAndEquipmentByTypeAxis":"us-gaap:MachineryAndEquipmentMember"},"factValues":[{"value":"1632351","decimals":0}]},{"name":"rpt:f-413","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentGross","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:PropertyPlantAndEquipmentByTypeAxis":"us-gaap:ConstructionInProgressMember"},"factValues":[{"value":"12205447","decimals":0}]},{"name":"rpt:f-414","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentGross","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:PropertyPlantAndEquipmentByTypeAxis":"us-gaap:ConstructionInProgressMember"},"factValues":[{"value":"17279949","decimals":0}]},{"name":"rpt:f-415","factDimensions":{"xbrl:concept":"us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1498878","decimals":0}]},{"name":"rpt:f-416","factDimensions":{"xbrl:concept":"us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2159830","decimals":0}]},{"name":"rpt:f-417","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsOneMember"},"factValues":[{"value":"550000"}]},{"name":"rpt:f-418","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsTwoMember"},"factValues":[{"value":"800000"}]},{"name":"rpt:f-419","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward","xbrl:period":"2014-05-01T00:00:00/2014-06-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:BusinessAcquisitionAxis":"MRMD:SigalConsultingLLCMember","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsMember"},"factValues":[{"value":"300000"}]},{"name":"rpt:f-420","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsOneMember"},"factValues":[{"value":"300000"}]},{"name":"rpt:f-421","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsTwoMember"},"factValues":[{"value":"760000"}]},{"name":"rpt:f-422","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward","xbrl:period":"2019-02-01T00:00:00/2019-03-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsMember"},"factValues":[{"value":"50000"}]},{"name":"rpt:f-423","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward","xbrl:period":"2019-02-01T00:00:00/2019-03-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsOneMember"},"factValues":[{"value":"350000"}]},{"name":"rpt:f-424","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsOneMember","srt:RangeAxis":"srt:MinimumMember"},"factValues":[{"value":"0.26"}]},{"name":"rpt:f-425","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsOneMember","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"0.55"}]},{"name":"rpt:f-426","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsTwoMember","srt:RangeAxis":"srt:MinimumMember"},"factValues":[{"value":"0.01"}]},{"name":"rpt:f-427","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsTwoMember","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"0.03"}]},{"name":"rpt:f-428","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice","xbrl:period":"2014-06-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:BusinessAcquisitionAxis":"MRMD:SigalConsultingLLCMember","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsMember","srt:RangeAxis":"srt:MinimumMember"},"factValues":[{"value":"0.15"}]},{"name":"rpt:f-429","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice","xbrl:period":"2014-06-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:BusinessAcquisitionAxis":"MRMD:SigalConsultingLLCMember","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsMember","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"0.35"}]},{"name":"rpt:f-430","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsOneMember","srt:RangeAxis":"srt:MinimumMember"},"factValues":[{"value":"0.14"}]},{"name":"rpt:f-431","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsOneMember","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"3.73"}]},{"name":"rpt:f-432","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsTwoMember","srt:RangeAxis":"srt:MinimumMember"},"factValues":[{"value":"0.08"}]},{"name":"rpt:f-433","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsTwoMember","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"0.63"}]},{"name":"rpt:f-434","factDimensions":{"xbrl:concept":"MRMD:StockOptionsVestingPeriodDescription","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsOneMember"},"factValues":[{"value":"Vesting from the grant date through March 2019"}]},{"name":"rpt:f-435","factDimensions":{"xbrl:concept":"MRMD:StockOptionsVestingPeriodDescription","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsOneMember"},"factValues":[{"value":"Vesting periods that span six to thirty months"}]},{"name":"rpt:f-436","factDimensions":{"xbrl:concept":"us-gaap:PaymentsForRepurchaseOfCommonStock","xbrl:period":"2017-09-01T00:00:00/2017-10-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TitleOfIndividualAxis":"us-gaap:ChiefExecutiveOfficerMember"},"factValues":[{"value":"90000","decimals":0}]},{"name":"rpt:f-437","factDimensions":{"xbrl:concept":"us-gaap:PaymentsForRepurchaseOfCommonStock","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsTwoMember"},"factValues":[{"value":"90000","decimals":0}]},{"name":"rpt:f-438","factDimensions":{"xbrl:concept":"us-gaap:PaymentsForRepurchaseOfCommonStock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsTwoMember"},"factValues":[{"value":"105398","decimals":0}]},{"name":"rpt:f-439","factDimensions":{"xbrl:concept":"MRMD:NumberOfWarrantsExercised","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:WarrantMember"},"factValues":[{"value":"1000000"}]},{"name":"rpt:f-440","factDimensions":{"xbrl:concept":"us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"120311"}]},{"name":"rpt:f-441","factDimensions":{"xbrl:concept":"us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"8661137"}]},{"name":"rpt:f-442","factDimensions":{"xbrl:concept":"us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:WarrantMember"},"factValues":[{"value":"2300237"}]},{"name":"rpt:f-443","factDimensions":{"xbrl:concept":"us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","srt:RangeAxis":"srt:MinimumMember"},"factValues":[{"value":"0.40"}]},{"name":"rpt:f-444","factDimensions":{"xbrl:concept":"us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"0.62"}]},{"name":"rpt:f-445","factDimensions":{"xbrl:concept":"us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1","xbrl:period":"2018-10-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:DebtInstrumentAxis":"MRMD:ConvertiblePromissoryNotesMember"},"factValues":[{"value":"1.80"}]},{"name":"rpt:f-446","factDimensions":{"xbrl:concept":"us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","srt:RangeAxis":"srt:MinimumMember"},"factValues":[{"value":"0.20"}]},{"name":"rpt:f-447","factDimensions":{"xbrl:concept":"us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"0.40"}]},{"name":"rpt:f-448","factDimensions":{"xbrl:concept":"us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:WarrantMember"},"factValues":[{"value":"0.65"}]},{"name":"rpt:f-449","factDimensions":{"xbrl:concept":"us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:WarrantMember","srt:RangeAxis":"srt:MinimumMember"},"factValues":[{"value":"0.10"}]},{"name":"rpt:f-450","factDimensions":{"xbrl:concept":"us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:WarrantMember","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"1.75"}]},{"name":"rpt:f-451","factDimensions":{"xbrl:concept":"us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1","xbrl:period":"2019-03-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember","srt:RangeAxis":"srt:MinimumMember"},"factValues":[{"value":"0.50"}]},{"name":"rpt:f-452","factDimensions":{"xbrl:concept":"us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1","xbrl:period":"2019-03-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"0.40"}]},{"name":"rpt:f-453","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeOneMember"},"factValues":[{"value":"0.08"}]},{"name":"rpt:f-454","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwoMember"},"factValues":[{"value":"0.08"}]},{"name":"rpt:f-455","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeThreeMember"},"factValues":[{"value":"0.13"}]},{"name":"rpt:f-456","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeFourMember"},"factValues":[{"value":"0.14"}]},{"name":"rpt:f-457","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeFiveMember"},"factValues":[{"value":"0.15"}]},{"name":"rpt:f-458","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeSixMember"},"factValues":[{"value":"0.25"}]},{"name":"rpt:f-459","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeSevenMember"},"factValues":[{"value":"0.26"}]},{"name":"rpt:f-460","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeEightMember"},"factValues":[{"value":"0.33"}]},{"name":"rpt:f-461","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeNineMember"},"factValues":[{"value":"0.35"}]},{"name":"rpt:f-462","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTenMember"},"factValues":[{"value":"0.45"}]},{"name":"rpt:f-463","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeElevenMember"},"factValues":[{"value":"0.55"}]},{"name":"rpt:f-464","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwelveMember"},"factValues":[{"value":"0.55"}]},{"name":"rpt:f-465","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeThirteenMember"},"factValues":[{"value":"0.55"}]},{"name":"rpt:f-466","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeForteenMember"},"factValues":[{"value":"0.63"}]},{"name":"rpt:f-467","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeFifteenMember"},"factValues":[{"value":"0.77"}]},{"name":"rpt:f-468","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeSixteenMember"},"factValues":[{"value":"0.90"}]},{"name":"rpt:f-469","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeSeventeenMember"},"factValues":[{"value":"0.95"}]},{"name":"rpt:f-470","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeEighteenMember"},"factValues":[{"value":"2.32"}]},{"name":"rpt:f-471","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeNinteenMember"},"factValues":[{"value":"2.45"}]},{"name":"rpt:f-472","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyMember"},"factValues":[{"value":"2.50"}]},{"name":"rpt:f-473","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyOneMember"},"factValues":[{"value":"2.65"}]},{"name":"rpt:f-474","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyTwoMember"},"factValues":[{"value":"2.85"}]},{"name":"rpt:f-475","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyThreeMember"},"factValues":[{"value":"2.85"}]},{"name":"rpt:f-476","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyFourMember"},"factValues":[{"value":"3.00"}]},{"name":"rpt:f-477","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePriceBeginningBalance1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyFiveMember"},"factValues":[{"value":"3.73"}]},{"name":"rpt:f-478","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"8310000"}]},{"name":"rpt:f-479","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeOneMember"},"factValues":[{"value":"250000"}]},{"name":"rpt:f-480","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwoMember"},"factValues":[{"value":"100000"}]},{"name":"rpt:f-481","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeThreeMember"},"factValues":[{"value":"200000"}]},{"name":"rpt:f-482","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeFourMember"},"factValues":[{"value":"650000"}]},{"name":"rpt:f-483","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeFiveMember"},"factValues":[{"value":"1000000"}]},{"name":"rpt:f-484","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeSixMember"},"factValues":[{"value":"1000000"}]},{"name":"rpt:f-485","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeSevenMember"},"factValues":[{"value":"50000"}]},{"name":"rpt:f-486","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeEightMember"},"factValues":[{"value":"50000"}]},{"name":"rpt:f-487","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeNineMember"},"factValues":[{"value":"1000000"}]},{"name":"rpt:f-488","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTenMember"},"factValues":[{"value":"190000"}]},{"name":"rpt:f-489","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeElevenMember"},"factValues":[{"value":"100000"}]},{"name":"rpt:f-490","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwelveMember"},"factValues":[{"value":"100000"}]},{"name":"rpt:f-491","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeThirteenMember"},"factValues":[{"value":"20000"}]},{"name":"rpt:f-492","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeForteenMember"},"factValues":[{"value":"300000"}]},{"name":"rpt:f-493","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeFifteenMember"},"factValues":[{"value":"300000"}]},{"name":"rpt:f-494","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeSixteenMember"},"factValues":[{"value":"50000"}]},{"name":"rpt:f-495","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeSeventeenMember"},"factValues":[{"value":"50000"}]},{"name":"rpt:f-496","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeEighteenMember"},"factValues":[{"value":"300000"}]},{"name":"rpt:f-497","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeNinteenMember"},"factValues":[{"value":"2000000"}]},{"name":"rpt:f-498","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyMember"},"factValues":[{"value":"100000"}]},{"name":"rpt:f-499","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyOneMember"},"factValues":[{"value":"200000"}]},{"name":"rpt:f-500","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyTwoMember"},"factValues":[{"value":"75000"}]},{"name":"rpt:f-501","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyThreeMember"},"factValues":[{"value":"100000"}]},{"name":"rpt:f-502","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyFourMember"},"factValues":[{"value":"25000"}]},{"name":"rpt:f-503","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyFiveMember"},"factValues":[{"value":"200000"}]},{"name":"rpt:f-504","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"7425000"}]},{"name":"rpt:f-505","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeOneMember"},"factValues":[{"value":"250000"}]},{"name":"rpt:f-506","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwoMember"},"factValues":[{"value":"100000"}]},{"name":"rpt:f-507","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeThreeMember"},"factValues":[{"value":"200000"}]},{"name":"rpt:f-508","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeFourMember"},"factValues":[{"value":"650000"}]},{"name":"rpt:f-509","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeFiveMember"},"factValues":[{"value":"1000000"}]},{"name":"rpt:f-510","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeSixMember"},"factValues":[{"value":"1000000"}]},{"name":"rpt:f-511","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeSevenMember"},"factValues":[{"value":"50000"}]},{"name":"rpt:f-512","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeEightMember"},"factValues":[{"value":"50000"}]},{"name":"rpt:f-513","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeNineMember"},"factValues":[{"value":"1000000"}]},{"name":"rpt:f-514","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTenMember"},"factValues":[{"value":"190000"}]},{"name":"rpt:f-515","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeElevenMember"},"factValues":[{"value":"100000"}]},{"name":"rpt:f-516","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwelveMember"},"factValues":[{"value":"100000"}]},{"name":"rpt:f-517","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeThirteenMember"},"factValues":[{"value":"20000"}]},{"name":"rpt:f-518","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeForteenMember"},"factValues":[{"value":"300000"}]},{"name":"rpt:f-519","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeFifteenMember"},"factValues":[{"value":"300000"}]},{"name":"rpt:f-520","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeSixteenMember"},"factValues":[{"value":"50000"}]},{"name":"rpt:f-521","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeSeventeenMember"},"factValues":[{"value":"10000"}]},{"name":"rpt:f-522","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeEighteenMember"}},{"name":"rpt:f-523","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeNinteenMember"},"factValues":[{"value":"2000000"}]},{"name":"rpt:f-524","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyMember"}},{"name":"rpt:f-525","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyOneMember"}},{"name":"rpt:f-526","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyTwoMember"}},{"name":"rpt:f-527","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyThreeMember"}},{"name":"rpt:f-528","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyFourMember"}},{"name":"rpt:f-529","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyFiveMember"}},{"name":"rpt:f-530","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeOneMember"},"factValues":[{"value":"P0Y0M29D"}]},{"name":"rpt:f-531","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwoMember"},"factValues":[{"value":"P0Y11M19D"}]},{"name":"rpt:f-532","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeThreeMember"},"factValues":[{"value":"P1Y6M0D"}]},{"name":"rpt:f-533","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeFourMember"},"factValues":[{"value":"P2Y"}]},{"name":"rpt:f-534","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeFiveMember"},"factValues":[{"value":"P0Y8M26D"}]},{"name":"rpt:f-535","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeSixMember"},"factValues":[{"value":"P0Y8M26D"}]},{"name":"rpt:f-536","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeSevenMember"},"factValues":[{"value":"P2Y2M30D"}]},{"name":"rpt:f-537","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeEightMember"},"factValues":[{"value":"P2Y2M8D"}]},{"name":"rpt:f-538","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeNineMember"},"factValues":[{"value":"P0Y8M26D"}]},{"name":"rpt:f-539","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTenMember"},"factValues":[{"value":"P2Y9M3D"}]},{"name":"rpt:f-540","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeElevenMember"},"factValues":[{"value":"P1Y8M26D"}]},{"name":"rpt:f-541","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwelveMember"},"factValues":[{"value":"P1Y8M26D"}]},{"name":"rpt:f-542","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeThirteenMember"},"factValues":[{"value":"P2Y0M7D"}]},{"name":"rpt:f-543","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeForteenMember"},"factValues":[{"value":"P3Y"}]},{"name":"rpt:f-544","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeFifteenMember"},"factValues":[{"value":"P4Y"}]},{"name":"rpt:f-545","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeSixteenMember"},"factValues":[{"value":"P4Y4M13D"}]},{"name":"rpt:f-546","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeSeventeenMember"},"factValues":[{"value":"P4Y"}]},{"name":"rpt:f-547","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeEighteenMember"},"factValues":[{"value":"P4Y8M12D"}]},{"name":"rpt:f-548","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeNinteenMember"},"factValues":[{"value":"P5Y10M6D"}]},{"name":"rpt:f-549","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyMember"},"factValues":[{"value":"P4Y7M28D"}]},{"name":"rpt:f-550","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyOneMember"},"factValues":[{"value":"P4Y8M23D"}]},{"name":"rpt:f-551","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyTwoMember"},"factValues":[{"value":"P3Y11M12D"}]},{"name":"rpt:f-552","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyThreeMember"},"factValues":[{"value":"P4Y11M12D"}]},{"name":"rpt:f-553","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyFourMember"},"factValues":[{"value":"P4Y11M15D"}]},{"name":"rpt:f-554","factDimensions":{"xbrl:concept":"MRMD:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":"MRMD:RangeTwentyFiveMember"},"factValues":[{"value":"P4Y11M8D"}]},{"name":"rpt:f-555","factDimensions":{"xbrl:concept":"us-gaap:OperatingLossCarryforwards","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2826698","decimals":0}]},{"name":"rpt:f-556","factDimensions":{"xbrl:concept":"us-gaap:OperatingLossCarryforwards","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"3121086","decimals":0}]},{"name":"rpt:f-557","factDimensions":{"xbrl:concept":"us-gaap:DeferredTaxAssetsGross","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2815780","decimals":0}]},{"name":"rpt:f-558","factDimensions":{"xbrl:concept":"us-gaap:DeferredTaxAssetsGross","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2168210","decimals":0}]},{"name":"rpt:f-559","factDimensions":{"xbrl:concept":"us-gaap:DeferredTaxAssetsValuationAllowance","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2815780","decimals":0}]},{"name":"rpt:f-560","factDimensions":{"xbrl:concept":"us-gaap:DeferredTaxAssetsValuationAllowance","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2168210","decimals":0}]},{"name":"rpt:f-561","factDimensions":{"xbrl:concept":"us-gaap:DeferredTaxAssetsLiabilitiesNet","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-562","factDimensions":{"xbrl:concept":"us-gaap:DeferredTaxAssetsLiabilitiesNet","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-563","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesAcquisitions","xbrl:period":"2017-06-01T00:00:00/2017-07-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","dei:LegalEntityAxis":"MRMD:MariMedAdvisorsIncMember"},"factValues":[{"value":"75000000"}]},{"name":"rpt:f-564","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesAcquisitions","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"642575"}]},{"name":"rpt:f-565","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesAcquisitions","xbrl:period":"2014-05-01T00:00:00/2014-06-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:BusinessAcquisitionAxis":"MRMD:SigalConsultingLLCMember"},"factValues":[{"value":"31954236"}]},{"name":"rpt:f-566","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesAcquisitions","xbrl:period":"2018-10-01T00:00:00/2018-11-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:BusinessAcquisitionAxis":"MRMD:KPGofAnnaLLCandKPGofHarrisburgLLCMember"},"factValues":[{"value":"1000000"}]},{"name":"rpt:f-567","factDimensions":{"xbrl:concept":"us-gaap:PaymentsForRoyalties","xbrl:period":"2018-08-01T00:00:00/2018-09-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","invest:InvestmentHoldingAxis":"MRMD:VitiprintsMember","us-gaap:TypeOfArrangementAxis":"MRMD:LicensingAgreementMember"},"factValues":[{"value":"250000","decimals":0}]},{"name":"rpt:f-568","factDimensions":{"xbrl:concept":"us-gaap:GoodwillImpairmentLoss","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1331785","decimals":0}]},{"name":"rpt:f-569","factDimensions":{"xbrl:concept":"us-gaap:GoodwillImpairmentLoss","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-570","factDimensions":{"xbrl:concept":"us-gaap:GoodwillImpairmentLoss","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:BettysEddiesMember"}},{"name":"rpt:f-571","factDimensions":{"xbrl:concept":"us-gaap:GoodwillImpairmentLoss","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:BettysEddiesMember"}},{"name":"rpt:f-572","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsOneMember","us-gaap:StatementScenarioAxis":"MRMD:MarchTwoThousandAndNineteenMember"},"factValues":[{"value":"27000"}]},{"name":"rpt:f-573","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:TitleOfIndividualAxis":"us-gaap:ChiefExecutiveOfficerMember"},"factValues":[{"value":"200000"}]},{"name":"rpt:f-574","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:TitleOfIndividualAxis":"us-gaap:ChiefExecutiveOfficerMember"},"factValues":[{"value":"200000"}]},{"name":"rpt:f-575","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember"},"factValues":[{"value":"450000"}]},{"name":"rpt:f-576","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember"},"factValues":[{"value":"200000"}]},{"name":"rpt:f-577","factDimensions":{"xbrl:concept":"MRMD:AgreementTermDescription","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"An employment agreement with the former CEO of the Company that provided this individual with salary, car allowances, stock options, life insurance, and other employee benefits, was terminated in 2017."}]},{"name":"rpt:f-578","factDimensions":{"xbrl:concept":"MRMD:NumberOfSquareFoot","xbrl:period":"2019-04-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"utr:sqft","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember","srt:ProductOrServiceAxis":"us-gaap:RealEstateMember"},"factValues":[{"value":"100000"}]},{"name":"rpt:f-579","factDimensions":{"xbrl:concept":"MRMD:NumberOfSquareFoot","xbrl:period":"2019-04-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"utr:sqft","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember","srt:ProductOrServiceAxis":"us-gaap:RealEstateMember","us-gaap:StatementScenarioAxis":"MRMD:CultivationAndProcessingFacilityMember"},"factValues":[{"value":"60000"}]},{"name":"rpt:f-580","factDimensions":{"xbrl:concept":"us-gaap:AreaOfLand","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"utr:sqft"},"factValues":[{"value":"300000"}]},{"name":"rpt:f-581","factDimensions":{"xbrl:concept":"us-gaap:AreaOfLand","xbrl:period":"2017-12-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"utr:sqft","us-gaap:TypeOfArrangementAxis":"MRMD:MortgageAgreementMember","srt:StatementGeographicalAxis":"country:MA"},"factValues":[{"value":"138000"}]},{"name":"rpt:f-582","factDimensions":{"xbrl:concept":"us-gaap:AreaOfLand","xbrl:period":"2017-12-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"utr:sqft","us-gaap:TypeOfArrangementAxis":"MRMD:MortgageAgreementMember","dei:LegalEntityAxis":"MRMD:ARLHealthcareIncMember"},"factValues":[{"value":"70000"}]},{"name":"rpt:f-583","factDimensions":{"xbrl:concept":"us-gaap:AreaOfLand","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"utr:sqft","us-gaap:TypeOfArrangementAxis":"MRMD:MortgageAgreementMember","srt:StatementGeographicalAxis":"country:DE"},"factValues":[{"value":"45070"}]},{"name":"rpt:f-584","factDimensions":{"xbrl:concept":"us-gaap:AreaOfLand","xbrl:period":"2017-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"utr:sqft","us-gaap:TypeOfArrangementAxis":"MRMD:MortgageAgreementMember","us-gaap:CreditFacilityAxis":"MRMD:DuQuoinStateBankMember"},"factValues":[{"value":"3400"}]},{"name":"rpt:f-585","factDimensions":{"xbrl:concept":"us-gaap:AreaOfLand","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"utr:sqft","srt:StatementGeographicalAxis":"country:DE"},"factValues":[{"value":"45000"}]},{"name":"rpt:f-586","factDimensions":{"xbrl:concept":"us-gaap:AreaOfLand","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"utr:sqft","srt:StatementGeographicalAxis":"country:IL"},"factValues":[{"value":"3400"}]},{"name":"rpt:f-587","factDimensions":{"xbrl:concept":"us-gaap:AreaOfLand","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"utr:sqft","srt:StatementGeographicalAxis":"country:MD"},"factValues":[{"value":"180000"}]},{"name":"rpt:f-588","factDimensions":{"xbrl:concept":"us-gaap:AreaOfLand","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"utr:sqft","srt:StatementGeographicalAxis":"stpr:NV"},"factValues":[{"value":"10000"}]},{"name":"rpt:f-589","factDimensions":{"xbrl:concept":"us-gaap:AreaOfLand","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"utr:sqft","srt:StatementGeographicalAxis":"country:DE","us-gaap:LeaseArrangementTypeAxis":"MRMD:RetailSpaceMember"},"factValues":[{"value":"4000"}]},{"name":"rpt:f-590","factDimensions":{"xbrl:concept":"us-gaap:AreaOfLand","xbrl:period":"2016-11-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"utr:sqft","srt:StatementGeographicalAxis":"country:DE","us-gaap:LeaseArrangementTypeAxis":"MRMD:OperatingLeaseCommitmentsMember"},"factValues":[{"value":"4000"}]},{"name":"rpt:f-591","factDimensions":{"xbrl:concept":"us-gaap:AreaOfLand","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"utr:sqft","srt:StatementGeographicalAxis":"country:DE","us-gaap:AwardDateAxis":"MRMD:MarchTwoThousandNineteenMember"},"factValues":[{"value":"100000"}]},{"name":"rpt:f-592","factDimensions":{"xbrl:concept":"us-gaap:AreaOfLand","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"utr:sqft","srt:StatementGeographicalAxis":"country:MA"},"factValues":[{"value":"10000"}]},{"name":"rpt:f-593","factDimensions":{"xbrl:concept":"us-gaap:AreaOfLand","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"utr:sqft","srt:StatementGeographicalAxis":"country:MD","us-gaap:LeaseArrangementTypeAxis":"MRMD:OperatingLeaseCommitmentsMember"},"factValues":[{"value":"2700"}]},{"name":"rpt:f-594","factDimensions":{"xbrl:concept":"MRMD:LeaseTerm","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","srt:StatementGeographicalAxis":"stpr:NV"},"factValues":[{"value":"P10Y"}]},{"name":"rpt:f-595","factDimensions":{"xbrl:concept":"MRMD:LeaseTerm","xbrl:period":"2016-10-01T00:00:00/2016-11-01T00:00:00","xbrl:entity":"cik:0001522767","srt:StatementGeographicalAxis":"country:DE","us-gaap:LeaseArrangementTypeAxis":"MRMD:OperatingLeaseCommitmentsMember"},"factValues":[{"value":"P5Y"}]},{"name":"rpt:f-596","factDimensions":{"xbrl:concept":"MRMD:LeaseTerm","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","srt:StatementGeographicalAxis":"country:DE","us-gaap:AwardDateAxis":"MRMD:MarchTwoThousandNineteenMember"},"factValues":[{"value":"P10Y"}]},{"name":"rpt:f-597","factDimensions":{"xbrl:concept":"MRMD:LeaseTerm","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","srt:StatementGeographicalAxis":"country:MA"},"factValues":[{"value":"P10Y"}]},{"name":"rpt:f-598","factDimensions":{"xbrl:concept":"MRMD:LeaseTerm","xbrl:period":"2019-03-01T00:00:00/2019-04-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember","srt:ProductOrServiceAxis":"us-gaap:RealEstateMember"},"factValues":[{"value":"P10Y"}]},{"name":"rpt:f-599","factDimensions":{"xbrl:concept":"MRMD:LeaseTerm","xbrl:period":"2018-08-01T00:00:00/2018-09-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"P10Y"}]},{"name":"rpt:f-600","factDimensions":{"xbrl:concept":"MRMD:LeaseExpirationDescription","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","srt:StatementGeographicalAxis":"country:DE"},"factValues":[{"value":"Lease expiring in 2035"}]},{"name":"rpt:f-601","factDimensions":{"xbrl:concept":"MRMD:LeaseExpirationDescription","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","srt:StatementGeographicalAxis":"country:IL"},"factValues":[{"value":"Lease expiring in 2036"}]},{"name":"rpt:f-602","factDimensions":{"xbrl:concept":"MRMD:LeaseExpirationDescription","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","srt:StatementGeographicalAxis":"stpr:NV"},"factValues":[{"value":"Expiring in 2024"}]},{"name":"rpt:f-603","factDimensions":{"xbrl:concept":"MRMD:LeaseExpirationDescription","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","srt:StatementGeographicalAxis":"country:MA"},"factValues":[{"value":"Expiring in 2028 which contain a 5-year extension option."}]},{"name":"rpt:f-604","factDimensions":{"xbrl:concept":"MRMD:LeaseExpirationDescription","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","srt:StatementGeographicalAxis":"country:MD","us-gaap:LeaseArrangementTypeAxis":"MRMD:OperatingLeaseCommitmentsMember"},"factValues":[{"value":"Expires in July 2020 with an option to renew for a two-year term"}]},{"name":"rpt:f-605","factDimensions":{"xbrl:concept":"us-gaap:InterestPayableCurrentAndNoncurrent","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"312000","decimals":0}]},{"name":"rpt:f-606","factDimensions":{"xbrl:concept":"us-gaap:InterestPayableCurrentAndNoncurrent","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"95000","decimals":0}]},{"name":"rpt:f-607","factDimensions":{"xbrl:concept":"us-gaap:InterestPayableCurrentAndNoncurrent","xbrl:period":"2017-09-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:DebtInstrumentAxis":"MRMD:ConvertiblePromissoryNotesMember"},"factValues":[{"value":"262000","decimals":0}]},{"name":"rpt:f-608","factDimensions":{"xbrl:concept":"us-gaap:InterestPayableCurrentAndNoncurrent","xbrl:period":"2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember"},"factValues":[{"value":"36000","decimals":0}]},{"name":"rpt:f-609","factDimensions":{"xbrl:concept":"us-gaap:InterestPayableCurrentAndNoncurrent","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember"},"factValues":[{"value":"36000","decimals":0}]},{"name":"rpt:f-610","factDimensions":{"xbrl:concept":"us-gaap:InterestPayableCurrentAndNoncurrent","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember","us-gaap:RelatedPartyTransactionsByRelatedPartyAxis":"us-gaap:BeneficialOwnerMember"},"factValues":[{"value":"62000","decimals":0}]},{"name":"rpt:f-611","factDimensions":{"xbrl:concept":"us-gaap:InterestPayableCurrentAndNoncurrent","xbrl:period":"2019-03-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember"},"factValues":[{"value":"97000","decimals":0}]},{"name":"rpt:f-612","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentInterestRateDuringPeriod","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:DebtInstrumentAxis":"MRMD:ConvertiblePromissoryNotesMember","srt:RangeAxis":"srt:MinimumMember"},"factValues":[{"value":"0.045"}]},{"name":"rpt:f-613","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentInterestRateDuringPeriod","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:DebtInstrumentAxis":"MRMD:ConvertiblePromissoryNotesMember","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"0.12"}]},{"name":"rpt:f-614","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentInterestRateDuringPeriod","xbrl:period":"2018-09-01T00:00:00/2018-10-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:DebtInstrumentAxis":"MRMD:ConvertiblePromissoryNotesMember"},"factValues":[{"value":"0.10"}]},{"name":"rpt:f-615","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentInterestRateDuringPeriod","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:TypeOfArrangementAxis":"MRMD:MortgageAgreementMember","us-gaap:AwardDateAxis":"MRMD:NovemberTwoThousandSeventeenThroughMayTwoThousandNineteenMember","us-gaap:DebtInstrumentAxis":"us-gaap:PrimeRateMember"},"factValues":[{"value":"0.02"}]},{"name":"rpt:f-616","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentInterestRateDuringPeriod","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:TypeOfArrangementAxis":"MRMD:MortgageAgreementMember","us-gaap:AwardDateAxis":"MRMD:NovemberTwoThousandSeventeenThroughMayTwoThousandNineteenMember","us-gaap:DebtInstrumentAxis":"MRMD:FloorRateMember"},"factValues":[{"value":"0.0625"}]},{"name":"rpt:f-617","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentInterestRateDuringPeriod","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:TypeOfArrangementAxis":"MRMD:MortgageAgreementMember","us-gaap:AwardDateAxis":"MRMD:MayTwoThousandNineteenMember","us-gaap:DebtInstrumentAxis":"us-gaap:PrimeRateMember"},"factValues":[{"value":"0.02"}]},{"name":"rpt:f-618","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentInterestRateDuringPeriod","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:TypeOfArrangementAxis":"MRMD:MortgageAgreementMember","us-gaap:AwardDateAxis":"MRMD:MayTwoThousandNineteenMember","us-gaap:DebtInstrumentAxis":"MRMD:FloorRateMember"},"factValues":[{"value":"0.0625"}]},{"name":"rpt:f-619","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentInterestRateDuringPeriod","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:TypeOfArrangementAxis":"MRMD:MortgageAgreementMember","us-gaap:AwardDateAxis":"MRMD:MayTwoThousandTwentyFourMember","us-gaap:DebtInstrumentAxis":"us-gaap:PrimeRateMember"},"factValues":[{"value":"0.02"}]},{"name":"rpt:f-620","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentInterestRateDuringPeriod","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:TypeOfArrangementAxis":"MRMD:MortgageAgreementMember","us-gaap:AwardDateAxis":"MRMD:MayTwoThousandTwentyFourMember","us-gaap:DebtInstrumentAxis":"MRMD:FloorRateMember"},"factValues":[{"value":"0.0625"}]},{"name":"rpt:f-621","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentInterestRateDuringPeriod","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:TypeOfArrangementAxis":"MRMD:MortgageAgreementMember","srt:StatementGeographicalAxis":"country:DE","us-gaap:AwardDateAxis":"MRMD:SeptemberTwoThousandTwentyOneMember"},"factValues":[{"value":"0.0525"}]},{"name":"rpt:f-622","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentInterestRateDuringPeriod","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:TypeOfArrangementAxis":"MRMD:MortgageAgreementMember","srt:StatementGeographicalAxis":"country:DE","us-gaap:DebtInstrumentAxis":"us-gaap:PrimeRateMember"},"factValues":[{"value":"0.015"}]},{"name":"rpt:f-623","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentInterestRateDuringPeriod","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:TypeOfArrangementAxis":"MRMD:MortgageAgreementMember","srt:StatementGeographicalAxis":"country:DE","us-gaap:DebtInstrumentAxis":"MRMD:FloorRateMember"},"factValues":[{"value":"0.0525"}]},{"name":"rpt:f-624","factDimensions":{"xbrl:concept":"us-gaap:NotesIssued1","xbrl:period":"2018-09-01T00:00:00/2018-10-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:DebtInstrumentAxis":"MRMD:ConvertiblePromissoryNotesMember"},"factValues":[{"value":"3000000","decimals":0}]},{"name":"rpt:f-625","factDimensions":{"xbrl:concept":"us-gaap:RepaymentsOfNotesPayable","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"7000","decimals":0}]},{"name":"rpt:f-626","factDimensions":{"xbrl:concept":"us-gaap:RepaymentsOfNotesPayable","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"0","decimals":0}]},{"name":"rpt:f-627","factDimensions":{"xbrl:concept":"us-gaap:ConversionOfStockSharesConverted1","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"970988"}]},{"name":"rpt:f-628","factDimensions":{"xbrl:concept":"us-gaap:ConversionOfStockSharesConverted1","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:SeriesAConvertiblePreferredStockSubscribedButNotIssuedMember"},"factValues":[{"value":"-500000"}]},{"name":"rpt:f-629","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentConvertibleConversionPrice1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:DebtInstrumentAxis":"MRMD:ConvertiblePromissoryNotesMember","srt:RangeAxis":"srt:MinimumMember"},"factValues":[{"value":"0.65"}]},{"name":"rpt:f-630","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentConvertibleConversionPrice1","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:DebtInstrumentAxis":"MRMD:ConvertiblePromissoryNotesMember","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"0.90"}]},{"name":"rpt:f-631","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentConvertibleConversionPrice1","xbrl:period":"2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:DebtInstrumentAxis":"MRMD:ConvertibleDebenturesMember","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember","srt:RangeAxis":"srt:MinimumMember"},"factValues":[{"value":"3.50"}]},{"name":"rpt:f-632","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentConvertibleConversionPrice1","xbrl:period":"2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:DebtInstrumentAxis":"MRMD:ConvertibleDebenturesMember","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"5.50"}]},{"name":"rpt:f-633","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentConvertibleConversionPrice1","xbrl:period":"2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember","srt:RangeAxis":"srt:MinimumMember"},"factValues":[{"value":"2.23"}]},{"name":"rpt:f-634","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentConvertibleConversionPrice1","xbrl:period":"2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"3.04"}]},{"name":"rpt:f-635","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentConvertibleConversionPrice1","xbrl:period":"2017-12-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember","srt:RangeAxis":"srt:MinimumMember"},"factValues":[{"value":"2.23"}]},{"name":"rpt:f-636","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentConvertibleConversionPrice1","xbrl:period":"2017-12-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"3.04"}]},{"name":"rpt:f-637","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentConvertibleConversionPrice1","xbrl:period":"2018-02-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:StatementClassOfStockAxis":"MRMD:SeriesAconvertiblePreferredMember"},"factValues":[{"value":"0.55"}]},{"name":"rpt:f-638","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentConvertibleConversionPrice1","xbrl:period":"2019-03-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember","srt:RangeAxis":"srt:MinimumMember"},"factValues":[{"value":"2.90"}]},{"name":"rpt:f-639","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentConvertibleConversionPrice1","xbrl:period":"2019-03-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"3.06"}]},{"name":"rpt:f-640","factDimensions":{"xbrl:concept":"us-gaap:IncomeTaxDisclosureTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rNOTE\r17 – INCOME TAXES
\r\r\r\r
For the years ended December 31, 2018 and 2017,\rthe Company’s cumulative net operating losses were approximately $11.6 million and $2.8 million, respectively, and accordingly\ra tax provision was not required for the years then ended.
\r\r\r\r
The reconciliations between the Company's effective\rtax rates and the statutory tax rate for the years ended December 31, 2018 and 2017 were as follows:
\r\r\r\r
| \r | \r | 2018 | \r\r | \r | 2017 | \r|||
| U.S Federal taxes at the statutory rate | \r\r | \r | 21 | \r% | \r\r | \r | 34 | \r% |
| State taxes net of federal benefit | \r\r | \r | 6 | \r% | \r\r | \r | 5 | \r% |
| Valuation allowance | \r\r | \r | (27 | \r)% | \r\r | \r | (39 | \r)% |
| Total | \r\r | \r | 0 | \r% | \r\r | \r | 0 | \r% |
\r\r
The approximate income tax effect of each type\rof temporary difference and carryforward as of December 31, 2018 and 2017 is as follows:
\r\r\r\r
| \r | \r | 2018 | \r\r | \r | 2017 | \r|||
| Deferred tax assets: | \r\r | \r | \r | \r | \r | \r | \r | |
| Net operating loss carryforwards | \r\r | $ | \r3,121,086 | \r\r | \r | $ | \r2,826,698 | \r|
| \r | \r | \r | \r | \r | \r | \r | \r | |
| Deferred tax liabilities: | \r\r | \r | \r | \r | \r | \r | \r | |
| Fixed assets | \r\r | \r | (952,875 | \r) | \r\r | \r | (10,918 | \r) |
| \r | \r | \r | \r | \r | \r | \r | \r | |
| Net deferred tax asset | \r\r | \r | 2,168,210 | \r\r | \r | \r | 2,815,780 | \r|
| Valuation allowance | \r\r | \r | (2,168,210 | \r) | \r\r | \r | (2,815,780 | \r) |
| Total | \r\r | $ | \r- | \r\r | \r | $ | \r- | \r
\r\r
The Company uses the asset and liability method\rto account for income taxes in accordance with ASC 740, Income Taxes. Under this method, deferred income taxes are recognized\rfor the future tax consequences of differences between the tax and financial accounting bases of assets and liabilities at each\rreporting period. Deferred income taxes are based on enacted tax laws and statutory tax rates applicable to the period in which\rthese differences are expected to affect taxable income. A valuation allowance is established when necessary to reduce deferred\rtax assets to the amounts expected to be realized.
\r\r\r\r
The Tax Cuts and Jobs Act (the “TCJA”)\rwas enacted on December 22, 2017. Among other things, the TCJA reduces the U.S. federal corporate tax rate from 35% to 21%, requires\rcompanies to pay a one-time transition tax on earnings of certain foreign subsidiaries that were previously tax deferred, and creates\rnew taxes on certain foreign sourced earnings.
\r\r\r\r
The one-time transition tax is based on the\rCompany’s total post-1986 earnings and profits (“E&P”) for which the Company has previously deferred from\rU.S. income taxes. As of December 31, 2017, the Company recorded a provisional amount for the one-time transition tax liability\rof $36 for its foreign subsidiaries, resulting in an increase of income tax provision of $36. As of December 31, 2018, the Company\rhas completed its calculation of the total post-1986 foreign E&P for these foreign subsidiaries. The Company has recognized\ran additional $16 in its income tax expense for its one-time transition tax liability.
\r\r\r\r
The Company has provided a valuation allowance\ragainst its net deferred tax assets at December 31, 2018 and 2017. Based upon the level of historical U.S. earnings and future\rprojections over the period in which the net deferred tax assets are deductible, at this time, management believes it is more likely\rthan not that the Company will not realize the benefits of these deductible differences.
\r\r\r\r
The federal net operating losses carryforward\rindefinitely, subject to an annual limitation of 80% of taxable income. The state net operating losses expire at various dates\rbeginning in 2031. These tax attributes are subject to an annual limitation from equity shifts, which constitute and change of\rownership as defined under IRC Section 382, which will limit their utilization. The Company has not completed a study through December\r31, 2018 to assess whether an ownership change under Section of 382 of the Code has occurred during 2018, due to the costs and\rcomplexities associated with such a study. The Company may have experienced various ownership changes, as defined by the code,\ras a result of financing transactions. Accordingly, the Company’s ability to utilize the aforementioned carryforwards may\rbe limited.
\r\r\r\r
Management assesses the available positive\rand negative evidence to estimate if sufficient future taxable income will be generated to use the existing deferred tax assets.\rA significant piece of objective negative evidence evaluated was the cumulative losses incurred through the period ended December\r31, 2018. Such objective evidence limits the ability to consider the subjective evidence, such as our projections for future growth.\rOn the basis of this evaluation, as of December 31, 2018, a valuation allowance has been recorded against all net deferred tax\rassets as these assets are more likely than not to be unrealized. The amount of the deferred tax asset considered realizable, however,\rcould be adjusted if estimates of future taxable income during the carryforward period are reduced or increased or if objective\rnegative evidence in the form of cumulative losses is no longer present and additional weight may be given to the subjective evidence\rsuch as our projections for growth.
\r\r\r\r
The Company previously adopted the provision\rfor uncertain tax positions under ASC 740. The adoption did not have an impact on the Company’s retained earnings balance.\rAt December 31, 2018 and 2017, the Company had no recorded liabilities for uncertain tax positions and had no accrued interest\ror penalties related to uncertain tax positions.
\r\r\r\r
The Company files income tax returns in the\rU.S. federal tax jurisdiction and various state jurisdictions. The Company is currently open to examination under the statute\rof limitations by the Internal Revenue Service and state jurisdictions for the tax years ended 2015 through 2018. Since the Company\ris in a U.S. loss carryforward position, carryforward tax attributes generated in prior years may still be adjusted upon future\rexamination if they have or will be used in a future period.
"}]},{"name":"rpt:f-641","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rAt December 31, 2018 and 2017, property and\requipment consisted of the following:
\r\r\r\r
| \r | \r | 2018 | \r\r | \r | 2017 | \r|||
| Land | \r\r | $ | \r3,392,710 | \r\r | \r | $ | \r3,392,710 | \r|
| Buildings and building improvements | \r\r | \r | 13,566,144 | \r\r | \r | \r | 3,918,359 | \r|
| Tenant improvements | \r\r | \r | 5,348,882 | \r\r | \r | \r | 2,260,512 | \r|
| Furniture and fixtures | \r\r | \r | 114,160 | \r\r | \r | \r | 95,815 | \r|
| Machinery and equipment | \r\r | \r | 1,632,351 | \r\r | \r | \r | 506,464 | \r|
| Construction in progress | \r\r | \r | 12,205,447 | \r\r | \r | \r | 17,279,949 | \r|
| \r | \r | \r | 36,259,694 | \r\r | \r | \r | 27,453,809 | \r|
| Less: accumulated depreciation | \r\r | \r | (2,159,830 | \r) | \r\r | \r | (1,498,878 | \r) |
| Property and equipment, net | \r\r | $ | \r34,099,864 | \r\r | \r | $ | \r25,954,931 | \r
The approximate income tax effect of each type\rof temporary difference and carryforward as of December 31, 2018 and 2017 is as follows:
\r\r\r\r
| \r | \r | 2018 | \r\r | \r | 2017 | \r|||
| Deferred tax assets: | \r\r | \r | \r | \r | \r | \r | \r | |
| Net operating loss carryforwards | \r\r | $ | \r3,121,086 | \r\r | \r | $ | \r2,826,698 | \r|
| \r | \r | \r | \r | \r | \r | \r | \r | |
| Deferred tax liabilities: | \r\r | \r | \r | \r | \r | \r | \r | |
| Fixed assets | \r\r | \r | (952,875 | \r) | \r\r | \r | (10,918 | \r) |
| \r | \r | \r | \r | \r | \r | \r | \r | |
| Net deferred tax asset | \r\r | \r | 2,168,210 | \r\r | \r | \r | 2,815,780 | \r|
| Valuation allowance | \r\r | \r | (2,168,210 | \r) | \r\r | \r | (2,815,780 | \r) |
| Total | \r\r | $ | \r- | \r\r | \r | $ | \r- | \r
The reconciliations between the Company's effective\rtax rates and the statutory tax rate for the years ended December 31, 2018 and 2017 were as follows:
\r\r\r\r
| \r | \r | 2018 | \r\r | \r | 2017 | \r|||
| U.S Federal taxes at the statutory rate | \r\r | \r | 21 | \r% | \r\r | \r | 34 | \r% |
| State taxes net of federal benefit | \r\r | \r | 6 | \r% | \r\r | \r | 5 | \r% |
| Valuation allowance | \r\r | \r | (27 | \r)% | \r\r | \r | (39 | \r)% |
| Total | \r\r | \r | 0 | \r% | \r\r | \r | 0 | \r% |
NOTE 3 – ACQUISITIONS
\r\r\r\r
Sigal Consulting LLC
\r\r\r\r
In May 2014, the Company, through its subsidiary\rMariMed Advisors Inc., acquired Sigal Consulting LLC from its ownership group which included the current CEO and CFO of the Company\r(the “Sigal Ownership Group”). The purchase price received by the Sigal Ownership Group was comprised of (i) 31,954,236\rshares of common stock valued at approximately $5.9 million, representing 50% of the Company’s outstanding shares on the\rclosing date, (ii) options to purchase three million shares of the Company’s common stock, exercisable over five years with\rexercise prices ranging from $0.15 to $0.35, and valued at approximately $570,000, and (iii) a 49% ownership interest in MariMed\rAdvisors Inc. The excess of purchase price over the book value of the acquired entity was recorded as goodwill, which was subsequently\rimpaired in full and written down to zero.
\r\r\r\r
In June 2017, the remaining 49% interest of\rMariMed Advisors Inc. was merged into the Company in exchange for an aggregate 75 million shares of common stock to the Sigal Ownership\rGroup.
\r\r\r\r
Betty’s Eddies™
\r\r\r\r
In October 2017, the Company acquired the intellectual\rproperty, formulations, recipes, proprietary equipment, know-how, and other certain assets of Betty’s Eddies™, a brand\rof cannabis-infused fruit chews, from Icky Enterprises LLC, a company partially owned by an officer of the Company (“Icky”).\rThe purchase price was $140,000 plus 1,000,000 shares of the Company’s common stock valued at $370,000 based on the price\rof the common stock on the issuance date. These shares of common stock were issued in June 2018, and accordingly, the shares were\rclassified as Common Stock Subscribed But Not Issued on the December 31, 2017 balance sheet.
\r\r\r\r
The acquisition was accounted for in accordance\rwith ASC 10, Business Combinations. The following table summarizes the allocation of the purchase price to the fair value\rof the assets acquired on the acquisition date:
\r\r\r\r
| Inventory | \r\r | $ | \r46,544 | \r|
| Machinery and equipment | \r\r | \r | 130,255 | \r|
| Goodwill | \r\r | \r | 333,201 | \r|
| Total fair value of consideration | \r\r | $ | \r510,000 | \r
\r\r
The goodwill balance of approximately $333,000\rwas written down in 2018.
\r\r\r\r
As part of the agreement between the parties,\rIcky shall receive royalties based on a percentage of the Company’s sales of the Betty’s Eddies™ product line,\rcommencing at 25% and decreasing to 2.5% as certain sales thresholds are met. For the years ended December 31, 2018 and 2017, such\rroyalties approximated $16,000 and $10,000, respectively.
\r\r\r\r
iRollie LLC
\r\r\r\r
Effective April 2018, the Company entered into\ra purchase agreement whereby 264,317 shares of the Company’s common stock were exchanged for 100% of the ownership interests\rof iRollie LLC, a manufacturer of branded cannabis products and accessories for consumers, and custom product and packaging for\rcompanies in the cannabis industry. The Company acquired, among other assets, iRollie’s entire product line, service offerings,\rclients, and intellectual property, and hired its two co-founders.
\r\r\r\r
The acquisition was accounted for in accordance\rwith ASC 10. The shares of Company common stock valued at $280,176 were issued to iRollie’s former owners in December 2018,\rat which time the Company adjusted the total goodwill generated on the transaction. The following table summarizes the allocation\rof the purchase price to the fair value of the assets acquired:
\r\r\r\r
| Cash and cash equivalents | \r\r | $ | \r13,494 | \r|
| Goodwill | \r\r | \r | 266,682 | \r|
| Total fair value of consideration | \r\r | $ | \r280,176 | \r
\r\r
Prior to the acquisition, iRollie had not been\rgenerating positive cash flow as a stand-alone entity, and in conformity with relevant accounting guidance, the goodwill was written\rdown.
\r\r\r\r
ARL Healthcare Inc.
\r\r\r\r
In October 2018, the Company’s cannabis-licensed\rclient in Massachusetts, ARL Healthcare Inc. (“ARL”), filed a plan of entity conversion with the state to convert from\ra non-profit entity to a for-profit corporation, with the Company as the sole shareholder of the for-profit corporation. ARL holds\rthree cannabis licenses from the state of Massachusetts for the cultivation, production and dispensing of cannabis.
\r\r\r\r
On November 30, 2018, the conversion plan was\rapproved by the secretary of state, and effective December 1, 2018, ARL was consolidated into the Company as a wholly-owned subsidiary.\rAdditionally, the Company’s chief operating officer was appointed as ARL’s sole board member.
\r\r\r\r
The acquisition was accounted for in accordance\rwith ASC 10, Business Combinations. The following table summarizes the allocation of the purchase price to the fair value\rof the assets acquired and liabilities assumed on the acquisition date:
\r\r\r\r
| Equipment | \r\r | $ | \r21,000 | \r|
| Cannabis licenses | \r\r | \r | 180,000 | \r|
| Accounts payable | \r\r | \r | (120,689 | \r) |
| Due to related parties | \r\r | \r | (92,765 | \r) |
| Total identifiable net assets | \r\r | \r | (7,454 | \r) |
| Goodwill | \r\r | \r | 731,902 | \r|
| Total fair value of consideration | \r\r | $ | \r724,448 | \r
\r\r
The total consideration paid by the Company\rwas equal to the forgiveness of amounts owed by the Company to ARL. Accordingly, the transaction gave rise to goodwill of approximately\r$732,000, which the Company wrote down.
\r\r\r\r
AgriMed Industries of PA LLC
\r\r\r\r
In July 2018, the Company entered into a purchase\ragreement to acquire 100% of the ownership interests of AgriMed Industries of PA LLC, an entity that holds a license from the state\rof Pennsylvania for the cultivation of cannabis (“AgriMed”). AgriMed presently develops cannabis products that are\rwholesaled to medical marijuana dispensaries within the state. The purchase price is comprised of $8,000,000, a portion of which\rmay be in the form of the Company’s common stock at the seller’s option, and the assumption of certain liabilities\rof AgriMed not to exceed $700,000. In February 2019, the Company filed a complaint against AgriMed for specific performance of\rtheir obligations under the purchase agreement. The consummation of this transaction is contingent upon the resolution of this\rcomplaint.
\r\r\r\r
KPG of Anna LLC and KPG of Harrisburg\rLLC
\r\r\r\r
In October 2018, the Company entered into a\rpurchase agreement to acquire 100% of the ownership interests of KPG of Anna LLC and KPG of Harrisburg LLC, the Company’s\rtwo cannabis-licensed clients that operate medical marijuana dispensaries in the state of Illinois (both entities collectively,\rthe “KPGs”), from the current ownership group of the KPGs (the “Sellers”). As part of this transaction,\rthe Company will also acquire the Sellers’ ownership interests of Mari Holdings IL LLC, the Company’s subsidiary which\rowns the real estate in which the KPGs’ dispensaries are located (“Mari-IL”).
\r\r\r\r
The purchase price of 1,000,000 shares of the\rCompany’s common stock shall be issued to the Sellers upon the closing of the transaction, which is dependent upon, among\rother closing conditions, the approval by the Illinois Department of Financial and Professional Regulation. Such approval is expected\rto be received by mid-2019. After the transaction is effectuated, the KPGs and Mari-IL will be wholly-owned subsidiaries of the\rCompany.
\r\r\r\r
As of December 31, 2018, the Company had not\ryet received the legislative approval – required for all ownership changes of cannabis licensees – and therefore the\roperations of the KPGs were not consolidated in the Company’s financial statements as of such date. The Company anticipates\rapproval will be obtained, and the transaction consummated, in 2019. When that occurs, the Company expects to consolidate the acquired\rentities in accordance with ASC 10.
\r\r\r\r
The Harvest Foundation LLC
\r\r\r\r
In November 2018, the Company issued a letter\rof intent to acquire 100% of the ownership interests of The Harvest Foundation LLC, the Company’s cannabis-licensed client\rin the state of Nevada. The parties are in the process of negotiating a definitive agreement governing the acquisition following\rthe satisfactory completion of due diligence. The acquisition is conditioned upon the appropriate legislative approval of the transaction,\rwhich is expected to occur in May 2019. Accordingly, the operations of The Harvest Foundation LLC have not been consolidated for\rthe year ended December 31, 2018.
\r\r\r\r
Kind Therapeutics LLC
\r\r\r\r
In December 2018, the Company entered into\ra memorandum of understanding to merge with its cannabis-licensed client in Maryland, Kind Therapeutics LLC. A merger agreement\ris currently being drafted for this transaction, which is intended to qualify as a tax-deferred reorganization under the Internal\rRevenue Code. The parties expect the merger agreement to be finalized, and the transaction approved by the state legislature in\r2019.
"}]},{"name":"rpt:f-674","factDimensions":{"xbrl:concept":"us-gaap:InvestmentHoldingsTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rNOTE 4 – INVESTMENTS
\r\r\r\r
Sprout
\r\r\r\r
During 2018, the Company invested $300,000,\rof a total contracted cash investment of $500,000, and issued 378,259 shares of common stock, valued at approximately $915,000,\rin exchange for 23% ownership in CVP Worldwide LLC (“CVP”). CVP has developed a customer relationship management and\rmarketing platform, branded under the name Sprout, which is specifically designed for companies in the cannabis industry.
\r\r\r\r
The Company shall assist in the ongoing development\rand design of Sprout, and in marketing Sprout to companies within the cannabis industry. The Company shall earn a percentage share\rof Sprout’s revenues generated from sales (i) to the Company’s clients, and (ii) by the Company to third parties. As\rof December 31, 2018, no revenue share was earned by the Company.
\r\r\r\r
The investment has been accounted under the\requity method. For the year ended December 31, 2018 , the Company recorded a charge to net income of approximately $43,000 based\ron its equity in CVP’s net loss during the period of the Company’s ownership. Such amount reduced the carrying value\rof the investment to approximately $1,172,000 at December 31, 2018.
\r\r\r\r
Vitiprints
\r\r\r\r
In August 2018, the Company entered into a\rlicensing agreement for the exclusive worldwide license to use, develop, sublicense, promote, sell or otherwise commercialize in\rany way a patented technology to produce and distribute cannabis products with exceedingly precise dosing at increased production\reconomies (“the Vitiprints License”). The licensing agreement has an initial term of five years, with an option to\rrenew the agreement for successive five-year periods, provided that notice of renewal is delivered prior to the expiration of the\rinitial term or a renewal term.
\r\r\r\r
Pursuant to the agreement, the Company made\ra non-refundable payment of $250,000. This payment was expensed and is included in Cost of Revenues on the financial statements.\rIn addition, the Company shall pay a royalty to Vitiprints equal to 10% of net revenue, as defined, received by the Company from\rcommercialization of the Vitiprints License, with a minimum royalty payment of $250,000. In order to maintain the exclusivity of\rthe license, the Company shall make minimum royalty payments of (i) $500,000 for the year following the first sale date, as defined,\r(ii) $750,000 for the following year, and (iii) $1,000,000 for all remaining years during the initial or renewal terms.
\r\r\r\r
DabTabs™
\r\r\r\r
In December 2018, the Company purchased 2,500,000\rshares of common stock of Iconic Ventures Inc. (“Iconic”) for an aggregate price of $500,000. Iconic, a private company,\rhas developed DabTabs™, a unique solution for cannabinoid vaporization via a convenient portable tablet that provides precisely\rmeasured dosing and acts as a storage system for full spectrum extracts, concentrates and distillates.
\r\r\r\r
The Company’s investment equates to an\rownership percentage in Iconic of less than 15%. The Company was not given a board seat and does not have ability to exert operational\ror financial control over the entity. In accordance with ASC 321, Investments – Equity Securities, the Company elected\rthe measurement alternative to value this equity investment without a readily determinable fair value. Under this alternative measurement\relection, the investment is recorded at its cost minus impairment, if any, plus or minus changes resulting from observable price\rchanges in orderly transactions for the identical or a similar investment in Iconic. Following the Company’s purchase, there\rhas been no impairment to this investment, nor any observable price changes to investments in Iconic. Accordingly, this investment\rwas measured at $500,000 at December 31, 2018.
\r\r\r\r
The Company will continue to apply the alternative\rmeasurement guidance until this investment does not qualify to be so measured. The Company may subsequently elect to measure this\rinvestment at fair value, and if so, shall measure all identical or similar investments in Iconic at fair value. Any subsequent\rchanges in fair value shall be recognized in net income.
"}]},{"name":"rpt:f-675","factDimensions":{"xbrl:concept":"us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rNOTE 8 – NOTES RECEIVABLE
\r\r\r\r
At December 31, 2018 and 2017, notes receivable\rwere comprised of the following:
\r\r\r\r
| \r | \r | 2018 | \r\r | \r | 2017 | \r|||
| First State Compassion Center -12.5% per annum, maturing in 2026 | \r\r | $ | \r578,723 | \r\r | \r | $ | \r624,275 | \r|
| The Healer - 8% per annum, maturing in 2021 | \r\r | \r | 307,429 | \r\r | \r | \r | - | \r|
| Chooze Corp. - 8% per annum, maturing in 2021 | \r\r | \r | 257,687 | \r\r | \r | \r | - | \r|
| Total notes receivable | \r\r | \r | 1,143,839 | \r\r | \r | \r | 624,167 | \r|
| Current portion of First State Compassion Center note receivable | \r\r | \r | 51,462 | \r\r | \r | \r | 45,444 | \r|
| Notes receivable, long-term portion | \r\r | $ | \r1,092,377 | \r\r | \r | $ | \r578,831 | \r
\r\r
The Company loaned approximately $700,000 to\rFirst State Compassion Center, its Delaware cannabis-licensee client, during the period of October 2015 to April 2016. In May 2016,\rthis client issued a 10-year promissory note, as amended, to the Company bearing interest at a compounded rate of 12.5% per annum.\rThe monthly payments of approximately $10,100 will continue through April 2026, at which time the note will be fully paid down.\rAt December 31, 2018 and 2017, the current portion of this note comprised the Note Receivable, Current Portion amounts on\rthe balance sheets, and the long-term portion of approximately $527,000 and $579,000, respectively, was included in the caption\rNotes Receivable, Less Current Portion.
\r\r\r\r
During 2018, the Company loaned an aggregate\rof $550,000 to Chooze Corp. and The Healer, two unrelated third-party companies in the cannabis industry. The loans bear interest\rat 8% per annum and mature in 2021. At December 31, 2018, the aggregate loan balances plus accrued interest approximated $565,000.\rIn January 2019, the note receivable from Chooze Corp. was converted into a 2.7% ownership interest in that entity.
"}]},{"name":"rpt:f-676","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueAcquisitions","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1195561","decimals":0}]},{"name":"rpt:f-677","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueAcquisitions","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"643","decimals":0}]},{"name":"rpt:f-678","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueAcquisitions","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"1194918","decimals":0}]},{"name":"rpt:f-679","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueAcquisitions","xbrl:period":"2014-05-01T00:00:00/2014-06-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:SigalConsultingLLCMember"},"factValues":[{"value":"590000","decimals":0}]},{"name":"rpt:f-680","factDimensions":{"xbrl:concept":"MRMD:PercentageOnOutstandingShares","xbrl:period":"2014-06-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:BusinessAcquisitionAxis":"MRMD:SigalConsultingLLCMember"},"factValues":[{"value":"0.50"}]},{"name":"rpt:f-681","factDimensions":{"xbrl:concept":"MRMD:OptionsExercisableTerm","xbrl:period":"2014-05-01T00:00:00/2014-06-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:BusinessAcquisitionAxis":"MRMD:SigalConsultingLLCMember","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsMember"},"factValues":[{"value":"P5Y"}]},{"name":"rpt:f-682","factDimensions":{"xbrl:concept":"MRMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedValue","xbrl:period":"2014-05-01T00:00:00/2014-06-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:SigalConsultingLLCMember","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsMember"},"factValues":[{"value":"570000","decimals":0}]},{"name":"rpt:f-683","factDimensions":{"xbrl:concept":"MRMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedValue","xbrl:period":"2017-10-01T00:00:00/2017-11-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:BettysEddiesMember"},"factValues":[{"value":"370000","decimals":0}]},{"name":"rpt:f-684","factDimensions":{"xbrl:concept":"us-gaap:MinorityInterestOwnershipPercentageByParent","xbrl:period":"2014-06-01T00:00:00","xbrl:entity":"cik:0001522767","srt:OwnershipAxis":"MRMD:MariMedAdvisorsIncMember"},"factValues":[{"value":"0.49"}]},{"name":"rpt:f-685","factDimensions":{"xbrl:concept":"us-gaap:MinorityInterestOwnershipPercentageByParent","xbrl:period":"2017-07-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:BusinessAcquisitionAxis":"MRMD:SigalConsultingLLCMember","srt:OwnershipAxis":"MRMD:MariMedAdvisorsIncMember"},"factValues":[{"value":"0.49"}]},{"name":"rpt:f-686","factDimensions":{"xbrl:concept":"us-gaap:MinorityInterestOwnershipPercentageByParent","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","srt:OwnershipAxis":"MRMD:CVPWorldwideLLCMember"},"factValues":[{"value":"0.23"}]},{"name":"rpt:f-687","factDimensions":{"xbrl:concept":"us-gaap:MinorityInterestOwnershipPercentageByParent","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","invest:InvestmentHoldingAxis":"MRMD:DabTabMember","srt:OwnershipAxis":"MRMD:IconicVenturesIncMember","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"0.15"}]},{"name":"rpt:f-688","factDimensions":{"xbrl:concept":"us-gaap:MinorityInterestOwnershipPercentageByParent","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","srt:OwnershipAxis":"MRMD:GenCannaMember"},"factValues":[{"value":"0.335"}]},{"name":"rpt:f-689","factDimensions":{"xbrl:concept":"MRMD:NumberOfCommonStockExchanged","xbrl:period":"2017-06-01T00:00:00/2017-07-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:BusinessAcquisitionAxis":"MRMD:SigalConsultingLLCMember","dei:LegalEntityAxis":"MRMD:MariMedAdvisorsIncMember"},"factValues":[{"value":"7500000"}]},{"name":"rpt:f-690","factDimensions":{"xbrl:concept":"MRMD:DescriptionOnRoyaltiesPercentage","xbrl:period":"2017-10-01T00:00:00/2017-11-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:BusinessAcquisitionAxis":"MRMD:BettysEddiesMember"},"factValues":[{"value":"In addition, Icky shall receive royalties based on a percentage of the Company's sales of the Betty's Eddies\u2122 product line, commencing at 25% and decreasing to 2.5% as certain sales thresholds are met. "}]},{"name":"rpt:f-691","factDimensions":{"xbrl:concept":"MRMD:Royalties","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:BettysEddiesMember"},"factValues":[{"value":"16000","decimals":0}]},{"name":"rpt:f-692","factDimensions":{"xbrl:concept":"MRMD:Royalties","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:BettysEddiesMember"},"factValues":[{"value":"10000","decimals":0}]},{"name":"rpt:f-693","factDimensions":{"xbrl:concept":"us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill","xbrl:period":"2018-04-01T00:00:00/2018-05-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:IRollieLLCMember"}},{"name":"rpt:f-694","factDimensions":{"xbrl:concept":"us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired","xbrl:period":"2018-08-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:BusinessAcquisitionAxis":"MRMD:AgriMedIndustriesOfPALLCMember"},"factValues":[{"value":"1.00"}]},{"name":"rpt:f-695","factDimensions":{"xbrl:concept":"us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired","xbrl:period":"2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:BusinessAcquisitionAxis":"MRMD:TheHarvestFoundationLLCMember"},"factValues":[{"value":"1.00"}]},{"name":"rpt:f-696","factDimensions":{"xbrl:concept":"us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired","xbrl:period":"2018-11-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:BusinessAcquisitionAxis":"MRMD:KPGofAnnaLLCandKPGofHarrisburgLLCMember"},"factValues":[{"value":"1.00"}]},{"name":"rpt:f-697","factDimensions":{"xbrl:concept":"us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities","xbrl:period":"2018-08-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:AgriMedIndustriesOfPALLCMember","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"700000","decimals":0}]},{"name":"rpt:f-698","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestments","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","invest:InvestmentHoldingAxis":"MRMD:SproutMember"},"factValues":[{"value":"43000","decimals":0}]},{"name":"rpt:f-699","factDimensions":{"xbrl:concept":"MRMD:ContractedCashInvestment","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","invest:InvestmentHoldingAxis":"MRMD:SproutMember"},"factValues":[{"value":"500000","decimals":0}]},{"name":"rpt:f-700","factDimensions":{"xbrl:concept":"MRMD:NumberOfRevenueSharesEarned","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","srt:OwnershipAxis":"MRMD:CVPWorldwideLLCMember"}},{"name":"rpt:f-701","factDimensions":{"xbrl:concept":"MRMD:NonRefundablePayment","xbrl:period":"2018-09-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","invest:InvestmentHoldingAxis":"MRMD:VitiprintsMember","us-gaap:TypeOfArrangementAxis":"MRMD:LicensingAgreementMember"},"factValues":[{"value":"250000","decimals":0}]},{"name":"rpt:f-702","factDimensions":{"xbrl:concept":"MRMD:PercentageOfRoyaltyOnNetRevenue","xbrl:period":"2018-08-01T00:00:00/2018-09-01T00:00:00","xbrl:entity":"cik:0001522767","invest:InvestmentHoldingAxis":"MRMD:VitiprintsMember","us-gaap:TypeOfArrangementAxis":"MRMD:LicensingAgreementMember"},"factValues":[{"value":"0.10"}]},{"name":"rpt:f-703","factDimensions":{"xbrl:concept":"MRMD:DescriptionOnRoyaltyPayments","xbrl:period":"2018-08-01T00:00:00/2018-09-01T00:00:00","xbrl:entity":"cik:0001522767","invest:InvestmentHoldingAxis":"MRMD:VitiprintsMember","us-gaap:TypeOfArrangementAxis":"MRMD:LicensingAgreementMember"},"factValues":[{"value":"In order to maintain the exclusivity of the license, the Company shall make minimum royalty payments of (i) $500,000 for the year following the first sale date, as defined, (ii) $750,000 for the following year, and (iii) $1,000,000 for all remaining years during the initial or renewal terms."}]},{"name":"rpt:f-704","factDimensions":{"xbrl:concept":"MRMD:NumberOfSharesPurchasedDuringPeriod","xbrl:period":"2018-12-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","invest:InvestmentHoldingAxis":"MRMD:DabTabMember","us-gaap:BusinessAcquisitionAxis":"MRMD:IconicVenturesIncMember"},"factValues":[{"value":"2500000"}]},{"name":"rpt:f-705","factDimensions":{"xbrl:concept":"MRMD:ValueOfShresPurchasedDuringPeriod","xbrl:period":"2018-12-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","invest:InvestmentHoldingAxis":"MRMD:DabTabMember","us-gaap:BusinessAcquisitionAxis":"MRMD:IconicVenturesIncMember"},"factValues":[{"value":"500000","decimals":0}]},{"name":"rpt:f-706","factDimensions":{"xbrl:concept":"MRMD:PaymentsToAcquireSubordinatedSecuredConvertibleDebentures","xbrl:period":"2018-12-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","dei:LegalEntityAxis":"MRMD:GenCannaGlobalIncMember"},"factValues":[{"value":"30000000","decimals":0}]},{"name":"rpt:f-707","factDimensions":{"xbrl:concept":"MRMD:PaymentsToAcquireSubordinatedSecuredConvertibleDebentures","xbrl:period":"2019-02-01T00:00:00/2019-03-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","dei:LegalEntityAxis":"MRMD:GenCannaGlobalIncMember","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember"},"factValues":[{"value":"30000000","decimals":0}]},{"name":"rpt:f-708","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentInterestRateStatedPercentage","xbrl:period":"2016-06-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:RelatedPartyTransactionsByRelatedPartyAxis":"MRMD:DelawareCannabisLicenseeMember"},"factValues":[{"value":"0.125"}]},{"name":"rpt:f-709","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentInterestRateStatedPercentage","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","dei:LegalEntityAxis":"MRMD:GenCannaGlobalIncMember"},"factValues":[{"value":"0.09"}]},{"name":"rpt:f-710","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentInterestRateStatedPercentage","xbrl:period":"2019-04-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember"},"factValues":[{"value":"0.10"}]},{"name":"rpt:f-711","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentInterestRateStatedPercentage","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","srt:OwnershipAxis":"MRMD:ChoozeCorpMember","us-gaap:RelatedPartyTransactionsByRelatedPartyAxis":"MRMD:TwoUnrelatedThirdPartyCompaniesMember"},"factValues":[{"value":"0.08"}]},{"name":"rpt:f-712","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger","xbrl:period":"2018-12-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","dei:LegalEntityAxis":"MRMD:GenCannaGlobalIncMember"},"factValues":[{"value":"0.20"}]},{"name":"rpt:f-713","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentDescription","xbrl:period":"2018-12-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","dei:LegalEntityAxis":"MRMD:GenCannaGlobalIncMember"},"factValues":[{"value":"The Company's option, (i) upon the occurrence of a Liquidity Event, as defined in the GC Debentures, or (ii) after December 31, 2018, upon ten days prior written notice to GenCanna. Conversion of the Company's entire $30 million investment shall equate to at least a 33.3% ownership interest in GenCanna on a fully diluted basis. The conversion price is equal to the lesser of a 20% discount to the price of the Liquidity Event, or the price based on a defined post-money valuation of GenCanna. If a Liquidity Event does not occur on or before June 30, 2020, the Company shall have the option to be redeemed in cash for the principal amount of the GC Debenture plus all accrued and unpaid interest thereon."}]},{"name":"rpt:f-714","factDimensions":{"xbrl:concept":"us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1331785","decimals":0}]},{"name":"rpt:f-715","factDimensions":{"xbrl:concept":"us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-716","factDimensions":{"xbrl:concept":"us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit","xbrl:period":"2014-05-01T00:00:00/2014-06-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:SigalConsultingLLCMember","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsMember"},"factValues":[{"value":"0","decimals":0}]},{"name":"rpt:f-717","factDimensions":{"xbrl:concept":"us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:BettysEddiesMember"},"factValues":[{"value":"333000","decimals":0}]},{"name":"rpt:f-718","factDimensions":{"xbrl:concept":"us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit","xbrl:period":"2018-11-29T00:00:00/2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:ARLHealthcareIncMember"},"factValues":[{"value":"732000","decimals":0}]},{"name":"rpt:f-719","factDimensions":{"xbrl:concept":"us-gaap:SharesOutstanding","xbrl:period":"2017-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:SeriesAConvertiblePreferredStockMember"}},{"name":"rpt:f-720","factDimensions":{"xbrl:concept":"us-gaap:SharesOutstanding","xbrl:period":"2017-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:SeriesAConvertiblePreferredStockSubscribedButNotIssuedMember"},"factValues":[{"value":"300000"}]},{"name":"rpt:f-721","factDimensions":{"xbrl:concept":"us-gaap:SharesOutstanding","xbrl:period":"2017-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"64074683"}]},{"name":"rpt:f-722","factDimensions":{"xbrl:concept":"us-gaap:SharesOutstanding","xbrl:period":"2017-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:CommonStockSubscribedButNotIssuedMember"},"factValues":[{"value":"400000"}]},{"name":"rpt:f-723","factDimensions":{"xbrl:concept":"us-gaap:SharesOutstanding","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:SeriesAConvertiblePreferredStockMember"}},{"name":"rpt:f-724","factDimensions":{"xbrl:concept":"us-gaap:SharesOutstanding","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:SeriesAConvertiblePreferredStockSubscribedButNotIssuedMember"},"factValues":[{"value":"500000"}]},{"name":"rpt:f-725","factDimensions":{"xbrl:concept":"us-gaap:SharesOutstanding","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"176850331"}]},{"name":"rpt:f-726","factDimensions":{"xbrl:concept":"us-gaap:SharesOutstanding","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:CommonStockSubscribedButNotIssuedMember"},"factValues":[{"value":"1000000"}]},{"name":"rpt:f-727","factDimensions":{"xbrl:concept":"us-gaap:SharesOutstanding","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:SeriesAConvertiblePreferredStockMember"}},{"name":"rpt:f-728","factDimensions":{"xbrl:concept":"us-gaap:SharesOutstanding","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:SeriesAConvertiblePreferredStockSubscribedButNotIssuedMember"}},{"name":"rpt:f-729","factDimensions":{"xbrl:concept":"us-gaap:SharesOutstanding","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"211013043"}]},{"name":"rpt:f-730","factDimensions":{"xbrl:concept":"us-gaap:SharesOutstanding","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:CommonStockSubscribedButNotIssuedMember"},"factValues":[{"value":"97136"}]},{"name":"rpt:f-731","factDimensions":{"xbrl:concept":"MRMD:SubscribedSeriesAPreferredStockValue","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"200000","decimals":0}]},{"name":"rpt:f-732","factDimensions":{"xbrl:concept":"MRMD:SubscribedSeriesAPreferredStockValue","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"MRMD:SeriesAConvertiblePreferredStockSubscribedButNotIssuedMember"},"factValues":[{"value":"200","decimals":0}]},{"name":"rpt:f-733","factDimensions":{"xbrl:concept":"MRMD:SubscribedSeriesAPreferredStockValue","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"199800","decimals":0}]},{"name":"rpt:f-734","factDimensions":{"xbrl:concept":"MRMD:SubscribedSeriesPreferredStockShares","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:SeriesAConvertiblePreferredStockSubscribedButNotIssuedMember"},"factValues":[{"value":"200000"}]},{"name":"rpt:f-735","factDimensions":{"xbrl:concept":"us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1004351","decimals":0}]},{"name":"rpt:f-736","factDimensions":{"xbrl:concept":"us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"1004351","decimals":0}]},{"name":"rpt:f-737","factDimensions":{"xbrl:concept":"MRMD:DistributionsDuringPeriodValue","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-690917","decimals":0}]},{"name":"rpt:f-738","factDimensions":{"xbrl:concept":"MRMD:DistributionsDuringPeriodValue","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-577730","decimals":0}]},{"name":"rpt:f-739","factDimensions":{"xbrl:concept":"MRMD:DistributionsDuringPeriodValue","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:NoncontrollingInterestMember"},"factValues":[{"value":"-577730","decimals":0}]},{"name":"rpt:f-740","factDimensions":{"xbrl:concept":"MRMD:DistributionsDuringPeriodValue","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:NoncontrollingInterestMember"},"factValues":[{"value":"-690917","decimals":0}]},{"name":"rpt:f-741","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueOther","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"74160","decimals":0}]},{"name":"rpt:f-742","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueOther","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"1008","decimals":0}]},{"name":"rpt:f-743","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueOther","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"328571","decimals":0}]},{"name":"rpt:f-744","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueOther","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"MRMD:CommonStockSubscribedButNotIssuedMember"},"factValues":[{"value":"-400","decimals":0}]},{"name":"rpt:f-745","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueOther","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"327964","decimals":0}]},{"name":"rpt:f-746","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueOther","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"MRMD:CommonStockSubscribedButNotIssuedMember"},"factValues":[{"value":"74160","decimals":0}]},{"name":"rpt:f-747","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesOther","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"1007597"}]},{"name":"rpt:f-748","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesOther","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:CommonStockSubscribedButNotIssuedMember"},"factValues":[{"value":"-400000"}]},{"name":"rpt:f-749","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesOther","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:CommonStockSubscribedButNotIssuedMember"},"factValues":[{"value":"18000"}]},{"name":"rpt:f-750","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember"},"factValues":[{"value":"4720000"}]},{"name":"rpt:f-751","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember"},"factValues":[{"value":"550000"}]},{"name":"rpt:f-752","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"39000","decimals":0}]},{"name":"rpt:f-753","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"655","decimals":0}]},{"name":"rpt:f-754","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"4710","decimals":0}]},{"name":"rpt:f-755","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"7500","decimals":0}]},{"name":"rpt:f-756","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"2790","decimals":0}]},{"name":"rpt:f-757","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"38435","decimals":0}]},{"name":"rpt:f-758","factDimensions":{"xbrl:concept":"MRMD:PurchaseOfSubsidiaryOwnershipInterestsValue","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"75000","decimals":0}]},{"name":"rpt:f-759","factDimensions":{"xbrl:concept":"MRMD:PurchaseOfSubsidiaryOwnershipInterestsValue","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-760","factDimensions":{"xbrl:concept":"MRMD:PurchaseOfSubsidiaryOwnershipInterestsValue","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"-75000","decimals":0}]},{"name":"rpt:f-761","factDimensions":{"xbrl:concept":"MRMD:PurchaseOfSubsidiaryOwnershipInterestsShares","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"75000000"}]},{"name":"rpt:f-762","factDimensions":{"xbrl:concept":"MRMD:SalesOfSubsidiaryOwnershipInterests","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1150000","decimals":0}]},{"name":"rpt:f-763","factDimensions":{"xbrl:concept":"MRMD:SalesOfSubsidiaryOwnershipInterests","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"1118807","decimals":0}]},{"name":"rpt:f-764","factDimensions":{"xbrl:concept":"MRMD:SalesOfSubsidiaryOwnershipInterests","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:NoncontrollingInterestMember"},"factValues":[{"value":"31193","decimals":0}]},{"name":"rpt:f-765","factDimensions":{"xbrl:concept":"MRMD:PayDownOfPromissoryNotesValue","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"1000","decimals":0}]},{"name":"rpt:f-766","factDimensions":{"xbrl:concept":"MRMD:PayDownOfPromissoryNotesValue","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"690000","decimals":0}]},{"name":"rpt:f-767","factDimensions":{"xbrl:concept":"MRMD:PayDownOfPromissoryNotesValue","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"689000","decimals":0}]},{"name":"rpt:f-768","factDimensions":{"xbrl:concept":"MRMD:PayDownOfPromissoryNotesShares","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"1000000"}]},{"name":"rpt:f-769","factDimensions":{"xbrl:concept":"MRMD:IssuanceOfCommonStockSubscribedValue","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-770","factDimensions":{"xbrl:concept":"MRMD:IssuanceOfCommonStockSubscribedValue","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"1000","decimals":0}]},{"name":"rpt:f-771","factDimensions":{"xbrl:concept":"MRMD:IssuanceOfCommonStockSubscribedValue","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"MRMD:CommonStockSubscribedButNotIssuedMember"},"factValues":[{"value":"-370000","decimals":0}]},{"name":"rpt:f-772","factDimensions":{"xbrl:concept":"MRMD:IssuanceOfCommonStockSubscribedValue","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"369000","decimals":0}]},{"name":"rpt:f-773","factDimensions":{"xbrl:concept":"MRMD:IssuanceOfCommonStockSubscribedShares","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"1000000"}]},{"name":"rpt:f-774","factDimensions":{"xbrl:concept":"MRMD:IssuanceOfCommonStockSubscribedShares","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:CommonStockSubscribedButNotIssuedMember"},"factValues":[{"value":"-1000000"}]},{"name":"rpt:f-775","factDimensions":{"xbrl:concept":"us-gaap:ConversionOfStockAmountConverted1","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"34044","decimals":0}]},{"name":"rpt:f-776","factDimensions":{"xbrl:concept":"us-gaap:ConversionOfStockAmountConverted1","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"971","decimals":0}]},{"name":"rpt:f-777","factDimensions":{"xbrl:concept":"us-gaap:ConversionOfStockAmountConverted1","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"MRMD:SeriesAConvertiblePreferredStockSubscribedButNotIssuedMember"},"factValues":[{"value":"-500","decimals":0}]},{"name":"rpt:f-778","factDimensions":{"xbrl:concept":"us-gaap:ConversionOfStockAmountConverted1","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"33573","decimals":0}]},{"name":"rpt:f-779","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueIssuedForServices","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"3675118","decimals":0}]},{"name":"rpt:f-780","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueIssuedForServices","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"3421","decimals":0}]},{"name":"rpt:f-781","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueIssuedForServices","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"3671697","decimals":0}]},{"name":"rpt:f-782","factDimensions":{"xbrl:concept":"MRMD:ConversionOfEquityAmountConverted","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-783","factDimensions":{"xbrl:concept":"MRMD:ConversionOfEquityAmountConverted","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"222","decimals":0}]},{"name":"rpt:f-784","factDimensions":{"xbrl:concept":"MRMD:ConversionOfEquityAmountConverted","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"-222","decimals":0}]},{"name":"rpt:f-785","factDimensions":{"xbrl:concept":"MRMD:StockIssuedDuringPeriodValueConversionOfDebentures","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1435506","decimals":0}]},{"name":"rpt:f-786","factDimensions":{"xbrl:concept":"MRMD:StockIssuedDuringPeriodValueConversionOfDebentures","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"524","decimals":0}]},{"name":"rpt:f-787","factDimensions":{"xbrl:concept":"MRMD:StockIssuedDuringPeriodValueConversionOfDebentures","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"1434982","decimals":0}]},{"name":"rpt:f-788","factDimensions":{"xbrl:concept":"MRMD:StockIssuedDuringPeriodConversionOfDebenturesShares","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"524360"}]},{"name":"rpt:f-789","factDimensions":{"xbrl:concept":"MRMD:SettlementOfPromissoryNotesValue","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"10094838","decimals":0}]},{"name":"rpt:f-790","factDimensions":{"xbrl:concept":"MRMD:SettlementOfPromissoryNotesValue","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"3827","decimals":0}]},{"name":"rpt:f-791","factDimensions":{"xbrl:concept":"MRMD:SettlementOfPromissoryNotesValue","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"MRMD:CommonStockSubscribedButNotIssuedMember"},"factValues":[{"value":"94963","decimals":0}]},{"name":"rpt:f-792","factDimensions":{"xbrl:concept":"MRMD:SettlementOfPromissoryNotesValue","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"9996048","decimals":0}]},{"name":"rpt:f-793","factDimensions":{"xbrl:concept":"MRMD:SettlementOfPromissoryNotesShares","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"3827374"}]},{"name":"rpt:f-794","factDimensions":{"xbrl:concept":"MRMD:SettlementOfPromissoryNotesShares","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:CommonStockSubscribedButNotIssuedMember"},"factValues":[{"value":"79136"}]},{"name":"rpt:f-795","factDimensions":{"xbrl:concept":"MRMD:ExerciseOfStockOptionsWarrantsShares","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"2142710"}]},{"name":"rpt:f-796","factDimensions":{"xbrl:concept":"MRMD:ExerciseOfStockOptionsWarrants","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"385395","decimals":0}]},{"name":"rpt:f-797","factDimensions":{"xbrl:concept":"MRMD:ExerciseOfStockOptionsWarrants","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:CommonStockMember"},"factValues":[{"value":"2143","decimals":0}]},{"name":"rpt:f-798","factDimensions":{"xbrl:concept":"MRMD:ExerciseOfStockOptionsWarrants","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"383252","decimals":0}]},{"name":"rpt:f-799","factDimensions":{"xbrl:concept":"MRMD:DebenturesReceivableDisclosureTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rNOTE 7 – DEBENTURES RECEIVABLE
\r\r\r\r
During 2018, in a series of transactions, the\rCompany purchased $30 million of subordinated secured convertible debentures (the “GC Debentures”) of GenCanna Global,\rInc., a producer and distributor of agricultural hemp, cannabidiol (CBD) formulations, hemp genetics, and hemp products (“GenCanna”).\rThe GC Debentures bear interest at a compounded rate of 9% per annum and mature three years from issuance.
\r\r\r\r
The GC Debentures are convertible into the\rcommon stock of GenCanna, at the Company’s option, (i) upon the occurrence of a Liquidity Event, as defined in the GC Debentures,\ror (ii) after December 31, 2018, upon ten days prior written notice to GenCanna. Conversion of the Company’s entire $30 million\rinvestment shall equate to at least a 33.3% ownership interest in GenCanna on a fully diluted basis. The conversion price is equal\rto the lesser of a 20% discount to the price of the Liquidity Event, or the price based on a defined post-money valuation of GenCanna.\rIf a Liquidity Event does not occur on or before June 30, 2020, the Company shall have the option to be redeemed in cash for the\rprincipal amount of the GC Debenture plus all accrued and unpaid interest thereon.
\r\r\r\r
Among other provisions of the subscription\ragreement governing this series of transactions, the Company was given the right to appoint a director to GenCanna’s board,\rand agree to fund a $10 million employee bonus pool should GenCanna meet certain 2019 operating targets.
\r\r\r\r
Concurrent with the completion of the GC Debenture\rpurchases, the parties executed a security and pledge agreement whereby the Company was granted a senior security interest on certain\rassets of GenCanna equal in value to 100% or more of the principal and accrued interest on the GC Debentures until such time the\rGC Debentures are paid down, redeemed or converted. Additionally, the Company was granted certain other rights, pursuant to a rights\ragreement, including rights of inspection, financial information, and participation in future security offerings of GenCanna.
\r\r\r\r
For the year ended December 31, 2018, the\rCompany earned and received interest income of approximately $502,000 on the GC Debentures. In February 2019, the Company converted\rthe GC Debentures plus accrued interest through the conversion date into a 33.5% ownership interest in GenCanna on a fully diluted\rbasis, as disclosed in Note 20 – Subsequent Events.
"}]},{"name":"rpt:f-800","factDimensions":{"xbrl:concept":"MRMD:StockOptionsDisclosureTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rNOTE 13 – STOCK OPTIONS
\r\r\r\r
During 2018, the Company granted options to\rpurchase 4.72 million shares of common stock at exercise prices ranging from $0.14 to $3.73 and expiring between December 2020\rand November 2024. Of the total 4.72 million options issued, 3.15 million were vested upon issuance and 1.57 million have vesting\rperiods that span six to thirty months. The fair value of these options, measured on grant date, of approximately $5.9 million\ris being amortized over the respective vesting periods, of which approximately $3.9 million was amortized during the year ended\rDecember 31, 2018.
\r\r\r\r
During 2017, the Company granted options to\rpurchase 550,000 shares of common stock at exercise prices ranging from $0.26 to $0.55, vesting from the grant date through March\r2019, and expiring between September 2020 and October 2021. The fair value of these options, measured on grant date, was approximately\r$159,000, of which approximately $74,000 was amortized in 2017, $58,000 was amortized in 2018, and $27,000 was forfeited prior\rto vesting.
\r\r\r\r
During the years ended December 31, 2018 and\r2017, options to purchase 760,000 and 4,800,000 shares of common stock, respectively, were exercised at exercise prices ranging\rfrom $0.08 to $0.63 per share, and $0.01 to $0.03 per share, respectively. Of these exercised options, during 2018 and 2017, 460,000\rand 4,500,000 options, respectively, were cashless exercises, with the exercise price paid via the surrender of 105,398 and 90,000\rshares of common stock.
\r\r\r\r
The following table summarizes the Company’s\rstock option transactions during the 2018 and 2017 fiscal years:
\r\r\r\r
| \r | \r | Number of \rStock Options | \r \r | \r | Weighted-Average Exercise Price | \r|||
| Outstanding at December 31, 2016 | \r\r | \r | 9,250,000 | \r\r | \r | $ | \r0.100 | \r|
| Granted | \r\r | \r | 550,000 | \r\r | \r | \r | 0.458 | \r|
| Exercised | \r\r | \r | (4,800,000 | \r) | \r\r | \r | 0.011 | \r|
| Forfeited/Expired | \r\r | \r | (200,000 | \r) | \r\r | \r | 0.025 | \r|
| Outstanding at December 31, 2017 | \r\r | \r | 4,800,000 | \r\r | \r | \r | 0.234 | \r|
| Granted | \r\r | \r | 4,720,000 | \r\r | \r | \r | 1.805 | \r|
| Exercised | \r\r | \r | (760,000 | \r) | \r\r | \r | 0.216 | \r|
| Forfeited/Expired | \r\r | \r | (450,000 | \r) | \r\r | \r | 0.433 | \r|
| Outstanding at December 31, 2018 | \r\r | \r | 8,310,000 | \r\r | \r | $ | \r1.117 | \r
\r\r
Stock options outstanding and exercisable as\rof December 31, 2018 were:
\r\r\r\r
| Exercise Price | \r\r | \r | Shares Under Option | \r\r | \r | Remaining | \r||||||||
| per Share | \r\r | \r | Outstanding | \r\r | \r | Exercisable | \r\r | \r | Life in Years | \r|||||
| $ | \r0.08 | \r\r | \r | \r | 250,000 | \r\r | \r | \r | 250,000 | \r\r | \r | \r | 0.08 | \r|
| $ | \r0.08 | \r\r | \r | \r | 100,000 | \r\r | \r | \r | 100,000 | \r\r | \r | \r | 0.97 | \r|
| $ | \r0.13 | \r\r | \r | \r | 200,000 | \r\r | \r | \r | 200,000 | \r\r | \r | \r | 1.50 | \r|
| $ | \r0.14 | \r\r | \r | \r | 650,000 | \r\r | \r | \r | 650,000 | \r\r | \r | \r | 2.00 | \r|
| $ | \r0.15 | \r\r | \r | \r | 1,000,000 | \r\r | \r | \r | 1,000,000 | \r\r | \r | \r | 0.74 | \r|
| $ | \r0.25 | \r\r | \r | \r | 1,000,000 | \r\r | \r | \r | 1,000,000 | \r\r | \r | \r | 0.74 | \r|
| $ | \r0.26 | \r\r | \r | \r | 50,000 | \r\r | \r | \r | 50,000 | \r\r | \r | \r | 2.25 | \r|
| $ | \r0.33 | \r\r | \r | \r | 50,000 | \r\r | \r | \r | 25,000 | \r\r | \r | \r | 2.19 | \r|
| $ | \r0.35 | \r\r | \r | \r | 1,000,000 | \r\r | \r | \r | 1,000,000 | \r\r | \r | \r | 0.74 | \r|
| $ | \r0.45 | \r\r | \r | \r | 190,000 | \r\r | \r | \r | 190,000 | \r\r | \r | \r | 2.76 | \r|
| $ | \r0.55 | \r\r | \r | \r | 100,000 | \r\r | \r | \r | 100,000 | \r\r | \r | \r | 1.74 | \r|
| $ | \r0.55 | \r\r | \r | \r | 100,000 | \r\r | \r | \r | 100,000 | \r\r | \r | \r | 1.74 | \r|
| $ | \r0.55 | \r\r | \r | \r | 20,000 | \r\r | \r | \r | 20,000 | \r\r | \r | \r | 2.02 | \r|
| $ | \r0.63 | \r\r | \r | \r | 300,000 | \r\r | \r | \r | 300,000 | \r\r | \r | \r | 3.00 | \r|
| $ | \r0.77 | \r\r | \r | \r | 300,000 | \r\r | \r | \r | 300,000 | \r\r | \r | \r | 4.00 | \r|
| $ | \r0.90 | \r\r | \r | \r | 50,000 | \r\r | \r | \r | 50,000 | \r\r | \r | \r | 4.37 | \r|
| $ | \r0.95 | \r\r | \r | \r | 50,000 | \r\r | \r | \r | 10,000 | \r\r | \r | \r | 4.00 | \r|
| $ | \r2.32 | \r\r | \r | \r | 300,000 | \r\r | \r | \r | - | \r\r | \r | \r | 4.70 | \r|
| $ | \r2.45 | \r\r | \r | \r | 2,000,000 | \r\r | \r | \r | 2,000,000 | \r\r | \r | \r | 5.85 | \r|
| $ | \r2.50 | \r\r | \r | \r | 100,000 | \r\r | \r | \r | - | \r\r | \r | \r | 4.66 | \r|
| $ | \r2.65 | \r\r | \r | \r | 200,000 | \r\r | \r | \r | - | \r\r | \r | \r | 4.73 | \r|
| $ | \r2.85 | \r\r | \r | \r | 75,000 | \r\r | \r | \r | - | \r\r | \r | \r | 3.95 | \r|
| $ | \r2.85 | \r\r | \r | \r | 100,000 | \r\r | \r | \r | - | \r\r | \r | \r | 4.95 | \r|
| $ | \r3.00 | \r\r | \r | \r | 25,000 | \r\r | \r | \r | - | \r\r | \r | \r | 4.96 | \r|
| $ | \r3.73 | \r\r | \r | \r | 200,000 | \r\r | \r | \r | - | \r\r | \r | \r | 4.94 | \r|
| \r | \r | \r | \r | \r | 8,310,000 | \r\r | \r | \r | 7,425,000 | \r\r | \r | \r | \r |
NOTE 14 – WARRANTS
\r\r\r\r
During the years ended December 31, 2018 and\r2017, the Company issued warrants to purchase 8,661,137 and 3,120,311 shares of common stock, respectively, at exercise prices\rranging from $0.20 to $5.50 per share in 2018 and $0.40 to $0.62 per share in 2017. These warrants generally expire three or five\ryears from issuance date. The Company recorded the fair value of these warrants of approximately $15.7 million in 2018 ($1.8 million\ras compensation expense, $2.8 million as debt discounts, and $11.1 million as equity discounts) and approximately $1.0 million\rin 2017 (all as compensation expense).
\r\r\r\r
During the year ended December 31, 2018, warrants\rto purchase 2,300,237 shares of common stock were exercised, at exercise prices ranging from $0.10 to $1.75 per share. Of these\rexercised warrants, 1,000,000 warrants were cashless exercises, with the exercise price paid via the surrender of 157,527 shares\rof common stock. No warrants were exercised during 2017.
\r\r\r\r
The following table summarizes the Company’s\rwarrant transactions during the 2018 and 2017 fiscal years:
\r\r\r\r
| \r | \r | Number of \rStock Options | \r \r | \r | Weighted-Average Exercise Price | \r|||
| Outstanding at December 31, 2016 | \r\r | \r | 1,125,000 | \r\r | \r | $ | \r0.136 | \r|
| Granted | \r\r | \r | 3,120,311 | \r\r | \r | \r | 0.468 | \r|
| Exercised | \r\r | \r | - | \r\r | \r | \r | - | \r|
| Forfeited/Expired | \r\r | \r | - | \r\r | \r | \r | - | \r|
| Outstanding at December 31, 2017 | \r\r | \r | 4,245,311 | \r\r | \r | \r | 0.380 | \r|
| Granted | \r\r | \r | 8,661,137 | \r\r | \r | \r | 2.548 | \r|
| Exercised | \r\r | \r | (2,300,237 | \r) | \r\r | \r | 0.385 | \r|
| Forfeited/Expired | \r\r | \r | - | \r\r | \r | \r | - | \r|
| Outstanding at December 31, 2018 | \r\r | \r | 10,606,211 | \r\r | \r | $ | \r2.149 | \r
\r\r
At December 31, 2018, warrants to purchase\r10,606,211 shares of common stock were outstanding at exercise prices ranging from $0.12 to $5.50 per share.
"}]},{"name":"rpt:f-802","factDimensions":{"xbrl:concept":"MRMD:NonOperatingIncomeDisclosureTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rNOTE 16 – NON-OPERATING INCOME
\r\r\r\r
In 2017, the Company wrote off approximately\r$227,000 of deferred revenue that represented the conversion of a promissory note issued to a third party by the Company’s\rformer parent, and assumed by the Company in 201l, for future products and services related to the Company’s previous online\rportal business.
"}]},{"name":"rpt:f-803","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestmentQuotedMarketValue","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","invest:InvestmentHoldingAxis":"MRMD:SproutMember"},"factValues":[{"value":"1172000","decimals":0}]},{"name":"rpt:f-804","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionOriginalDebtAmount1","xbrl:period":"2018-12-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","dei:LegalEntityAxis":"MRMD:GenCannaGlobalIncMember"},"factValues":[{"value":"30000000","decimals":0}]},{"name":"rpt:f-805","factDimensions":{"xbrl:concept":"us-gaap:AccruedBonusesCurrent","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","dei:LegalEntityAxis":"MRMD:GenCannaGlobalIncMember","us-gaap:TypeOfArrangementAxis":"MRMD:SubscriptionAgreementMember"},"factValues":[{"value":"10000000","decimals":0}]},{"name":"rpt:f-806","factDimensions":{"xbrl:concept":"us-gaap:InterestExpenseLongTermDebt","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","dei:LegalEntityAxis":"MRMD:ChoozeCorpMember","us-gaap:RelatedPartyTransactionsByRelatedPartyAxis":"MRMD:TwoUnrelatedThirdPartyCompaniesMember"},"factValues":[{"value":"565000","decimals":0}]},{"name":"rpt:f-807","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentPeriodicPayment","xbrl:period":"2015-10-01T00:00:00/2016-05-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:RelatedPartyTransactionsByRelatedPartyAxis":"MRMD:DelawareCannabisLicenseeMember"},"factValues":[{"value":"10100","decimals":0}]},{"name":"rpt:f-808","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentTerm","xbrl:period":"2015-10-01T00:00:00/2016-05-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:RelatedPartyTransactionsByRelatedPartyAxis":"MRMD:DelawareCannabisLicenseeMember"},"factValues":[{"value":"P10Y"}]},{"name":"rpt:f-809","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentTerm","xbrl:period":"2018-11-01T00:00:00/2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:DebtInstrumentAxis":"MRMD:ConvertibleDebenturesMember","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember"},"factValues":[{"value":"P3Y"}]},{"name":"rpt:f-810","factDimensions":{"xbrl:concept":"us-gaap:WarrantsAndRightsOutstandingTerm","xbrl:period":"2018-10-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:DebtInstrumentAxis":"MRMD:ConvertiblePromissoryNotesMember"},"factValues":[{"value":"P3Y"}]},{"name":"rpt:f-811","factDimensions":{"xbrl:concept":"us-gaap:WarrantsAndRightsOutstandingTerm","xbrl:period":"2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:DebtInstrumentAxis":"MRMD:ConvertibleDebenturesMember","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember"},"factValues":[{"value":"P3Y"}]},{"name":"rpt:f-812","factDimensions":{"xbrl:concept":"MRMD:DebtInstrumentDiscountRate","xbrl:period":"2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:DebtInstrumentAxis":"MRMD:ConvertibleDebenturesMember","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember"},"factValues":[{"value":"0.01"}]},{"name":"rpt:f-813","factDimensions":{"xbrl:concept":"MRMD:AccruedUnpaidInterestRate","xbrl:period":"2018-11-01T00:00:00/2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:DebtInstrumentAxis":"MRMD:ConvertibleDebenturesMember","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember"},"factValues":[{"value":"0.10"}]},{"name":"rpt:f-814","factDimensions":{"xbrl:concept":"MRMD:AccruedUnpaidInterestRate","xbrl:period":"2018-12-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember"},"factValues":[{"value":"98000"}]},{"name":"rpt:f-815","factDimensions":{"xbrl:concept":"us-gaap:DebtConversionConvertedInstrumentRate","xbrl:period":"2018-11-01T00:00:00/2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:DebtInstrumentAxis":"MRMD:ConvertibleDebenturesMember","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember"},"factValues":[{"value":"0.80"}]},{"name":"rpt:f-816","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentRedemptionPricePercentage","xbrl:period":"2018-11-01T00:00:00/2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:DebtInstrumentAxis":"MRMD:ConvertibleDebenturesMember","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember"},"factValues":[{"value":"1.10"}]},{"name":"rpt:f-817","factDimensions":{"xbrl:concept":"us-gaap:InterestExpenseDebt","xbrl:period":"2018-12-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TitleOfIndividualAxis":"MRMD:TenMillionHolderMember"},"factValues":[{"value":"36000","decimals":0}]},{"name":"rpt:f-818","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsOneMember"},"factValues":[{"value":"4720000"}]},{"name":"rpt:f-819","factDimensions":{"xbrl:concept":"us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsOneMember"},"factValues":[{"value":"3150000"}]},{"name":"rpt:f-820","factDimensions":{"xbrl:concept":"us-gaap:CommonStockCapitalSharesReservedForFutureIssuance","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsOneMember"},"factValues":[{"value":"1570000"}]},{"name":"rpt:f-821","factDimensions":{"xbrl:concept":"us-gaap:FairValueAdjustmentOfWarrants","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"15700000","decimals":0}]},{"name":"rpt:f-822","factDimensions":{"xbrl:concept":"us-gaap:FairValueAdjustmentOfWarrants","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1000000","decimals":0}]},{"name":"rpt:f-823","factDimensions":{"xbrl:concept":"us-gaap:PaymentsForRepurchaseOfWarrants","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:WarrantMember"},"factValues":[{"value":"157527","decimals":0}]},{"name":"rpt:f-824","factDimensions":{"xbrl:concept":"MRMD:AggregateValueOfcommonStock","xbrl:period":"2017-10-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TitleOfIndividualAxis":"us-gaap:ChiefExecutiveOfficerMember"},"factValues":[{"value":"45000","decimals":0}]},{"name":"rpt:f-825","factDimensions":{"xbrl:concept":"us-gaap:IncreaseDecreaseInOtherOperatingLiabilities","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"98187","decimals":0}]},{"name":"rpt:f-826","factDimensions":{"xbrl:concept":"us-gaap:IncreaseDecreaseInOtherOperatingLiabilities","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-827","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromIssuanceOfCommonStock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"31821001","decimals":0}]},{"name":"rpt:f-828","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromIssuanceOfCommonStock","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"6585800","decimals":0}]},{"name":"rpt:f-829","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromIssuanceOfCommonStock","xbrl:period":"2019-02-01T00:00:00/2019-03-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsMember"},"factValues":[{"value":"13000","decimals":0}]},{"name":"rpt:f-830","factDimensions":{"xbrl:concept":"us-gaap:OtherNonoperatingIncomeExpense","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2858","decimals":0}]},{"name":"rpt:f-831","factDimensions":{"xbrl:concept":"us-gaap:OtherNonoperatingIncomeExpense","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-226940","decimals":0}]},{"name":"rpt:f-832","factDimensions":{"xbrl:concept":"us-gaap:IncomeLossFromEquityMethodInvestments","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-43221","decimals":0}]},{"name":"rpt:f-833","factDimensions":{"xbrl:concept":"us-gaap:IncomeLossFromEquityMethodInvestments","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-834","factDimensions":{"xbrl:concept":"us-gaap:StockholdersEquityNoteDisclosureTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rNOTE 12 – EQUITY
\r\r\r\r
Preferred Stock
\r\r\r\r
In January 2017, the Company increased the\rnumber of authorized shares of preferred stock from 5 million to 50 million shares.
\r\r\r\r
During 2017, the Company issued subscriptions\ron 200,000 shares of Series A convertible preferred stock at $1.00 per share. No subscriptions were issued during 2018.
\r\r\r\r
The Series A convertible preferred stock accrues\ran annual dividend of 6% until conversion. The preferred stock is convertible, along with any accrued dividends, into common stock\rat a twenty-five percent discount to the selling price of the common stock in a qualified offering, as defined in the subscription\ragreement. In addition, the Company has the ability to force the conversion of preferred stock at such time the Company has a market\rcapitalization in excess of $50 million for ten consecutive trading days. In such event, the conversion price shall be a 25% discount\rto the average closing price of the Company’s common stock over the ten trading days prior to the Company’s notice\rof its intent to convert.
\r\r\r\r
In January 2018, all 500,000 shares of subscribed\rSeries A convertible preferred stock were converted into 970,989 shares of common stock at a conversion price of $0.55 per share.\rThe Company recorded a non-cash loss on conversion of approximately $34,000 based on the market value of the common stock on the\rconversion date. No shares were converted during 2017.
\r\r\r\r
Common Stock
\r\r\r\r
In January 2017, the Company increased the\rnumber of authorized shares of common stock from 100 million to 500 million shares.
\r\r\r\r
In June 2017, the Company issued 75 million\rshares of common stock to acquire the remaining 49% interest in its subsidiary MariMed Advisors Inc.
\r\r\r\r
During the year ended December 31, 2018 the\rCompany sold 19,188,981 shares of common stock at prices ranging from $0.50 to $3.00 per share, resulting in total proceeds of\r$31.8 million. During the year ended December 31, 2017, the Company sold 26,672,228 shares of common stock, at prices ranging from\r$0.18 to $0.50 per share, resulting in total proceeds of $6,578,000.
\r\r\r\r
During the years ended December 31, 2018 and\r2017, the Company issued 3,420,526 and 1,007,597 shares, respectively, in exchange for services rendered by third-parties or to\rotherwise settle outstanding obligations. Based on the market value of the common stock on the dates of issuance, the Company recorded\rnon-cash losses on these settlements of approximately $1,024,000 and $31,000, respectively.
\r\r\r\r
As previously disclosed in Note 3 – Acquisitions,\rthe Company issued common stock in 2018 for the acquisition of iRollie (264,317 shares), and in 2017 to acquire of the remaining\r49% interest of MariMed Advisors Inc. (75 million shares) and to purchase certain assets of Betty’s Eddies™ (1 million\rshares).
\r\r\r\r
As previously disclosed in Note 4 – Investments,\rthe Company issued 378,259 shares of common stock as part of the purchase price of the investment in Sprout.
\r\r\r\r
As previously disclosed in Note 10 –\rDebt, during 2018, holders of promissory notes with principal balances of $1,075,000 converted such promissory notes into\r1,568,375 shares of common stock, and holders of promissory notes with principal balances of approximately $7.5 million and $95,000\rof accrued interest received 2,596,313 shares of common stock and subscriptions on 79,136 share of common stock to retire such\rnotes. During 2017, holders of promissory notes with principal balances of $2.05 million and approximately $262,000 of accrued\rinterest converted such promissory notes into 4,385,823 shares of common stock, and holders of promissory notes with principal\rbalances of $2.3 million and approximately 312,000 of accrued interest received 5,385,823 shares of common stock to retire such\rnotes.
\r\r\r\r
As previously disclosed in Note 11 –\rDebentures Payable, the Holder of the $10M Debentures converted $1,400,000 of principal and approximately $36,000 of accrued\rinterest into 524,360 shares of common stock.
\r\r\r\r
As further disclosed in Note 13 – Stock\rOptions, during the years ended December 31, 2018 and 2017, options to purchase 760,000 and 4,800,000 shares of common stock,\rrespectively, were exercised. Of these exercised options, during 2018 and 2017, 460,000 and 4,500,000 options, respectively, were\rcashless exercises.
\r\r\r\r
As further disclosed in Note 14 – Warrants, during\r2018, warrants to purchase 2,300,237 shares of common stock were exercised, of which 1,000,000 warrants were exercised on a cashless\rbasis.
\r\r\r\r
Common Stock Subscribed But Not Issued
\r\r\r\r
At December 31, 2018, there were outstanding\rsubscriptions on 79,136 shares of common stock related to the settlement of a previously issued promissory note with a principal\rbalance of $50,000 and accrued interest of $1,454. These subscriptions had a value of approximately $95,000 based on the market\rvalue of the common stock on the settlement date. Also outstanding on such date were subscriptions on 18,000 shares of common stock,\requivalent to an aggregate amount of $74,160, for the payment of rent for the months of September 2018 through January 2019 for\ra leased property in Massachusetts. The shares of common stock associated with all outstanding subscriptions at December 31, 2018\rwere issued in March 2019.
\r\r\r\r
In October 2017, the Company issued subscriptions\ron 1,000,000 shares of common stock as part of the purchase price of the Betty’s Eddies™ acquired assets as further\rdisclosed in Note 3 – Acquisitions. These subscriptions were valued at $370,000 based on the market value of the common\rstock on the transaction date. The shares of common stock associated with these subscriptions were issued in June 2018.
\r\r\r\r
Membership Interests
\r\r\r\r
In August 2018, an individual member of Mari\rHoldings MD LLC, a majority owned subsidiary of the Company (“Mari-MD”), exchanged his 0.5% membership interest in\rsuch subsidiary for 222,222 shares of the Company’s common stock.
\r\r\r\r
In December 2018, a subscriptions receivable\rbalance of $25,000 related to a member’s interest in a majority-owned subsidiary was written off, with a corresponding reduction\rof such member’s capital contribution account.
\r\r\r\r
During 2017, the Company issued 12,778 Class\rA membership units of Mari-MD for $1,150,000, representing 3.05% ownership of this subsidiary at December 31, 2017.
"}]},{"name":"rpt:f-835","factDimensions":{"xbrl:concept":"us-gaap:PreferredStockDividendRatePercentage","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:StatementClassOfStockAxis":"us-gaap:SeriesAPreferredStockMember"},"factValues":[{"value":"0.06"}]},{"name":"rpt:f-836","factDimensions":{"xbrl:concept":"MRMD:DiscountToSellingPricePercentage","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:StatementClassOfStockAxis":"MRMD:SeriesAconvertiblePreferredMember"},"factValues":[{"value":"0.25"}]},{"name":"rpt:f-837","factDimensions":{"xbrl:concept":"MRMD:CommonStockAcquistionPercentage","xbrl:period":"2017-07-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"0.49"}]},{"name":"rpt:f-838","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentIncreaseAccruedInterest","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementClassOfStockAxis":"MRMD:SubscribedCommonStockMember"},"factValues":[{"value":"1454","decimals":0}]},{"name":"rpt:f-839","factDimensions":{"xbrl:concept":"MRMD:MarketCapitalization","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementClassOfStockAxis":"MRMD:SeriesAconvertiblePreferredMember"},"factValues":[{"value":"50000000","decimals":0}]},{"name":"rpt:f-840","factDimensions":{"xbrl:concept":"MRMD:SubscriptionOutstandingShares","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementClassOfStockAxis":"MRMD:SubscribedCommonStockMember"},"factValues":[{"value":"79136"}]},{"name":"rpt:f-841","factDimensions":{"xbrl:concept":"MRMD:SubscriptionOutstandingShares","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:StatementClassOfStockAxis":"MRMD:SubscribedCommonStockMember","us-gaap:AwardDateAxis":"MRMD:SeptemberTwoThousandEighteenThroughJanuaryTwoThousandNineteenMember"},"factValues":[{"value":"18000"}]},{"name":"rpt:f-842","factDimensions":{"xbrl:concept":"MRMD:ExchangeOfMembershipPercentageForShares","xbrl:period":"2018-08-01T00:00:00/2018-09-01T00:00:00","xbrl:entity":"cik:0001522767","dei:LegalEntityAxis":"MRMD:MariHoldingsMDLLCMember","us-gaap:StatementEquityComponentsAxis":"MRMD:SubsidiaryMember"},"factValues":[{"value":"0.005"}]},{"name":"rpt:f-843","factDimensions":{"xbrl:concept":"MRMD:NumberOfSharesReceivedForExchangeOnMembershipInterest","xbrl:period":"2018-08-01T00:00:00/2018-09-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","dei:LegalEntityAxis":"MRMD:MariHoldingsMDLLCMember","us-gaap:StatementEquityComponentsAxis":"MRMD:SubsidiaryMember"},"factValues":[{"value":"222222"}]},{"name":"rpt:f-844","factDimensions":{"xbrl:concept":"us-gaap:InterestIncomeOther","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"593214","decimals":0}]},{"name":"rpt:f-845","factDimensions":{"xbrl:concept":"us-gaap:InterestIncomeOther","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"80898","decimals":0}]},{"name":"rpt:f-846","factDimensions":{"xbrl:concept":"us-gaap:InterestIncomeOther","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:TypeOfArrangementAxis":"MRMD:GCDebenturesMember"},"factValues":[{"value":"502000","decimals":0}]},{"name":"rpt:f-847","factDimensions":{"xbrl:concept":"us-gaap:ConcentrationRiskPercentage1","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ConcentrationRiskByBenchmarkAxis":"us-gaap:AccountsReceivableMember"},"factValues":[{"value":"0.84"}]},{"name":"rpt:f-848","factDimensions":{"xbrl:concept":"us-gaap:ConcentrationRiskPercentage1","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ConcentrationRiskByBenchmarkAxis":"us-gaap:AccountsReceivableMember"},"factValues":[{"value":"0.79"}]},{"name":"rpt:f-849","factDimensions":{"xbrl:concept":"us-gaap:ConcentrationRiskPercentage1","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ConcentrationRiskByBenchmarkAxis":"us-gaap:SalesRevenueNetMember","us-gaap:ConcentrationRiskByTypeAxis":"us-gaap:CustomerConcentrationRiskMember"},"factValues":[{"value":"0.73"}]},{"name":"rpt:f-850","factDimensions":{"xbrl:concept":"us-gaap:ConcentrationRiskPercentage1","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:ConcentrationRiskByBenchmarkAxis":"us-gaap:SalesRevenueNetMember","us-gaap:ConcentrationRiskByTypeAxis":"us-gaap:CustomerConcentrationRiskMember"},"factValues":[{"value":"0.81"}]},{"name":"rpt:f-851","factDimensions":{"xbrl:concept":"MRMD:NumberOfCommonStockPaidViaSurrender","xbrl:period":"2019-02-01T00:00:00/2019-03-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember","us-gaap:StatementEquityComponentsAxis":"MRMD:OptionsOneMember"},"factValues":[{"value":"139985"}]},{"name":"rpt:f-852","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities","xbrl:period":"2019-02-01T00:00:00/2019-03-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember"},"factValues":[{"value":"10000000","decimals":0}]},{"name":"rpt:f-853","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities","xbrl:period":"2019-02-01T00:00:00/2019-03-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember"},"factValues":[{"value":"233194"}]},{"name":"rpt:f-854","factDimensions":{"xbrl:concept":"us-gaap:InvestmentPolicyTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rInvestments
\r\r\r\r
The Company classifies its investments as\ravailable-for-sale-investments. Investments are comprised of equity holding of private companies These investments are recorded\rat fair value on the Company’s consolidated balance sheet, with changes to fair value, if any, included in comprehensive\rincome. Investments are evaluated for other-than-temporary impairment and are written down if such impairments are deemed to have\roccurred.
"}]},{"name":"rpt:f-855","factDimensions":{"xbrl:concept":"us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rAccounts Receivable
\r\r\r\r
Accounts receivable consist of trade receivables\rand are carried at their estimated collectible amounts.
\r\r\r\r
The Company provides credit to its clients\rin the form of payment terms. The Company limits its credit risk by performing credit evaluations of its clients and maintaining\ra reserve, if deemed necessary, for potential credit losses. Such evaluations include the review of a client’s outstanding\rbalances with consideration towards such client’s historical collection experience, as well as prevailing economic and market\rconditions and other factors. Based on such evaluations, the Company recorded a reserve of $150,000 at December 31, 2018.
\r\r\r\r
The accounts receivable balances of two clients\rconstituted 84% of total accounts receivable at December 31, 2018. The balances of these two clients represented 79% of total\raccounts receivable at December 31, 2017.
"}]},{"name":"rpt:f-856","factDimensions":{"xbrl:concept":"us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":".21"}]},{"name":"rpt:f-857","factDimensions":{"xbrl:concept":"us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"0.34"}]},{"name":"rpt:f-858","factDimensions":{"xbrl:concept":"us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"0.06"}]},{"name":"rpt:f-859","factDimensions":{"xbrl:concept":"us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"0.05"}]},{"name":"rpt:f-860","factDimensions":{"xbrl:concept":"us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"-0.27"}]},{"name":"rpt:f-861","factDimensions":{"xbrl:concept":"us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"-0.39"}]},{"name":"rpt:f-862","factDimensions":{"xbrl:concept":"us-gaap:EffectiveIncomeTaxRateContinuingOperations","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"0.00"}]},{"name":"rpt:f-863","factDimensions":{"xbrl:concept":"us-gaap:EffectiveIncomeTaxRateContinuingOperations","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"0.00"}]},{"name":"rpt:f-864","factDimensions":{"xbrl:concept":"MRMD:DebenturesReceivable","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-865","factDimensions":{"xbrl:concept":"MRMD:DebenturesReceivable","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"30000000","decimals":0}]},{"name":"rpt:f-866","factDimensions":{"xbrl:concept":"MRMD:DebtCollectibleReserve","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:ConcentrationRiskByBenchmarkAxis":"us-gaap:AccountsReceivableMember"},"factValues":[{"value":"150000","decimals":0}]},{"name":"rpt:f-867","factDimensions":{"xbrl:concept":"MRMD:LicensesCost","xbrl:period":"2018-11-29T00:00:00/2018-12-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:ARLHealthcareIncMember"},"factValues":[{"value":"185000","decimals":0}]},{"name":"rpt:f-868","factDimensions":{"xbrl:concept":"MRMD:MortgageAgreementTerm","xbrl:period":"2017-11-01T00:00:00/2017-12-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"P10Y"}]},{"name":"rpt:f-869","factDimensions":{"xbrl:concept":"us-gaap:DebtInstrumentMaturityDateDescription","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:TypeOfArrangementAxis":"MRMD:MortgageAgreementMember","srt:StatementGeographicalAxis":"country:DE"},"factValues":[{"value":"The mortgage matures in 2031"}]},{"name":"rpt:f-870","factDimensions":{"xbrl:concept":"MRMD:DebenturePayableTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rNOTE 11 – DEBENTURES PAYABLE
\r\r\r\r
In October and November 2018, pursuant to a\rsecurities purchase agreement (the “SPA”), the Company sold an aggregate of $10,000,000 convertible debentures bearing\rinterest at the rate of 6% per annum that mature three years from issuance, with a 1% issue discount, resulting in net proceeds\rto the Company of $9,900,000 (the “$10M Debentures”).
\r\r\r\r
The holder of the $10M Debentures (the “Holder”)\rhas the right at any time to convert all or a portion of the $10M Debenture, along with accrued and unpaid interest, into the Company’s\rcommon stock at conversion prices equal to 80% of a calculated average, as determined in the $10M Debentures, of the daily volume-weighted\rprice during the ten consecutive trading days preceding the date of conversion. Notwithstanding this conversion right, the Holder\rshall limit conversions in any given month to certain agreed-upon values based on the conversion price, and the Holder shall also\rbe limited from beneficially owning more than 4.99% of the Company’s outstanding common stock (potentially further limiting\rthe Holder’s conversion right).
\r\r\r\r
The Company shall have the right to redeem\rall or a portion of the $10M Debentures, along with accrued and unpaid interest, at a 10% premium, provided however that the Company\rfirst provide advance written notice to the Holder of its intention to make a redemption, with the Holder allowed to affect one\ror more conversions of the $10M Debentures during such notice period.
\r\r\r\r
Upon a change in control transaction, as defined\rin the $10M Debentures, the Holder may require the Company to redeem all or a portion of the $10M Debentures at a price equal to\r110% of the principal amount of the $10M Debentures plus all accrued and unpaid interest thereon. So long as the $10M Debentures\rare outstanding, in the event the Company enters into a Variable Rate Transaction (“VRT”), as defined in the SPA, the\rHolder may cause the Company to revise the terms of the $10M Debentures to match the terms of the convertible security of such\rVRT. As part of issuance of the $10M Debenture, the Company issued three-year warrants to the Holder to purchase 324,675 shares\rof common stock at exercise prices of $3.50 and $5.50 per share (the “Warrants”).
\r\r\r\r
Pursuant to the terms of a registration rights\ragreement with the Holder, entered into concurrently with the SPA and the $10M Debentures, the Company agreed to provide the Holder\rwith customary registration rights with respect to any potential shares issued pursuant to the terms of the SPA, the $10M Debentures,\rand the Warrants.
\r\r\r\r
Subsequent to the consummation of the SPA and\rrelated agreements, the Company and the Holder executed an addendum to the SPA whereby the Holder agreed to that it would not undertake\ra conversion of all or a portion of the $10M Debentures that would require the Company to issue more shares than the amount of\ravailable authorized shares at the time of conversion, which amount of authorized shares shall not be less than the current authorized\rnumber of 500 million shares of common stock. Such addendum eliminated the requirement to bifurcate and account for the conversion\rfeature of the $10M Debentures as a derivative.
\r\r\r\r
Based on the conversion prices of the $10M\rDebentures in relation to the market value of the Company’s common stock, the $10M Debentures provided the Holder with a\rbeneficial conversion feature, as the embedded conversion option was in-the-money on the commitment date. The intrinsic value of\rthe beneficial conversion feature of approximately $5.6 million was recorded as a discount to the carrying amount of the $10M Debentures,\rwith an offset to additional paid-in-capital.
\r\r\r\r
In addition to the discount related to the\rbeneficial conversion feature, an additional discount of approximately $1.057 million was recorded based on the allocation of proceeds\rto the fair value of the Warrants attached to the debt.
\r\r\r\r
In November and December 2018, the Holder converted\r$1,400,000 of principal and approximately $36,000 of accrued interest into 524,360 shares of common stock at conversion prices\rof $2.23 and $3.04 per share.
\r\r\r\r
During the year ended December 31, 2018, amortization\rof the beneficial conversion feature, after adjustment for the partial conversions, approximated $1.5 million; amortization of\rthe Warrants discount approximated $91,000; and the amortization of original issue discount approximated $9,000. This amortization\rwas charged to interest expense. Additionally, accrued interest expense on the notes for such period approximated $98,000 of which\rapproximately $36,000 was paid prior to the end of the year.
\r\r\r\r
At December 31, 2018, the unamortized balances\rof the beneficial conversion feature, Warrants discount, and original issue discount were approximately $4.1 million, $966,000,\rand $91,000, respectively. Also on such date, the outstanding principal balance on the $10M Debentures was $8.6 million, with\raccrued and unpaid interest of approximately $62,000. Accordingly, at December 31, 2018, the carrying value of the $10M Debentures\rwas approximately $3.6 million.
"}]},{"name":"rpt:f-871","factDimensions":{"xbrl:concept":"MRMD:DebenturesPayable","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-872","factDimensions":{"xbrl:concept":"MRMD:DebenturesPayable","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"3557440","decimals":0}]},{"name":"rpt:f-873","factDimensions":{"xbrl:concept":"us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"5569908","decimals":0}]},{"name":"rpt:f-874","factDimensions":{"xbrl:concept":"us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"5569908","decimals":0}]},{"name":"rpt:f-875","factDimensions":{"xbrl:concept":"MRMD:AmortizationOfWarrants","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1171330","decimals":0}]},{"name":"rpt:f-876","factDimensions":{"xbrl:concept":"MRMD:AmortizationOfWarrants","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-877","factDimensions":{"xbrl:concept":"MRMD:AmortizationOfBeneficialConversionFeature","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1522107","decimals":0}]},{"name":"rpt:f-878","factDimensions":{"xbrl:concept":"MRMD:AmortizationOfBeneficialConversionFeature","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-879","factDimensions":{"xbrl:concept":"us-gaap:DueFromRelatedPartiesNoncurrent","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"119781","decimals":0}]},{"name":"rpt:f-880","factDimensions":{"xbrl:concept":"us-gaap:DueFromRelatedPartiesNoncurrent","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"119781","decimals":0}]},{"name":"rpt:f-881","factDimensions":{"xbrl:concept":"MRMD:IssuanceOfCommonStockSubscriptionNoncash","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"55620","decimals":0}]},{"name":"rpt:f-882","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember"},"factValues":[{"value":"4800000"}]},{"name":"rpt:f-883","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember"},"factValues":[{"value":"8310000"}]},{"name":"rpt:f-884","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber","xbrl:period":"2017-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember"},"factValues":[{"value":"9250000"}]},{"name":"rpt:f-885","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember"},"factValues":[{"value":"1.117"}]},{"name":"rpt:f-886","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice","xbrl:period":"2017-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember"},"factValues":[{"value":"0.100"}]},{"name":"rpt:f-887","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember"},"factValues":[{"value":"1.805"}]},{"name":"rpt:f-888","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember"},"factValues":[{"value":"0.458"}]},{"name":"rpt:f-889","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember"},"factValues":[{"value":"0.216"}]},{"name":"rpt:f-890","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember"},"factValues":[{"value":"0.011"}]},{"name":"rpt:f-891","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember"},"factValues":[{"value":"0.433"}]},{"name":"rpt:f-892","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD/xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember"},"factValues":[{"value":"0.025"}]},{"name":"rpt:f-893","factDimensions":{"xbrl:concept":"us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"5154404","decimals":0}]},{"name":"rpt:f-894","factDimensions":{"xbrl:concept":"us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"9070954","decimals":0}]},{"name":"rpt:f-895","factDimensions":{"xbrl:concept":"us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"235827","decimals":0}]},{"name":"rpt:f-896","factDimensions":{"xbrl:concept":"us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"251543","decimals":0}]},{"name":"rpt:f-897","factDimensions":{"xbrl:concept":"us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"268338","decimals":0}]},{"name":"rpt:f-898","factDimensions":{"xbrl:concept":"us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"5544226","decimals":0}]},{"name":"rpt:f-899","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"11851915","decimals":0}]},{"name":"rpt:f-900","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"6067853","decimals":0}]},{"name":"rpt:f-901","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"us-gaap:RealEstateMember"},"factValues":[{"value":"5798996","decimals":0}]},{"name":"rpt:f-902","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"us-gaap:RealEstateMember"},"factValues":[{"value":"2517225","decimals":0}]},{"name":"rpt:f-903","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"us-gaap:ManagementServiceMember"},"factValues":[{"value":"1581548","decimals":0}]},{"name":"rpt:f-904","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"us-gaap:ManagementServiceMember"},"factValues":[{"value":"1193854","decimals":0}]},{"name":"rpt:f-905","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"MRMD:SupplyProcurementMember"},"factValues":[{"value":"3657909","decimals":0}]},{"name":"rpt:f-906","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"MRMD:SupplyProcurementMember"},"factValues":[{"value":"1936686","decimals":0}]},{"name":"rpt:f-907","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"us-gaap:LicenseAndServiceMember"},"factValues":[{"value":"700173","decimals":0}]},{"name":"rpt:f-908","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"us-gaap:LicenseAndServiceMember"},"factValues":[{"value":"269256","decimals":0}]},{"name":"rpt:f-909","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"MRMD:ConsultingMember"},"factValues":[{"value":"50000","decimals":0}]},{"name":"rpt:f-910","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"MRMD:ConsultingMember"},"factValues":[{"value":"150604","decimals":0}]},{"name":"rpt:f-911","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"MRMD:OtherMember"},"factValues":[{"value":"63289","decimals":0}]},{"name":"rpt:f-912","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"MRMD:OtherMember"},"factValues":[{"value":"228","decimals":0}]},{"name":"rpt:f-913","factDimensions":{"xbrl:concept":"us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"73902","decimals":0}]},{"name":"rpt:f-914","factDimensions":{"xbrl:concept":"us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"73902","decimals":0}]},{"name":"rpt:f-915","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rThe aggregate scheduled maturities of the\rCompany’s total debt outstanding, inclusive of the promissory notes and mortgages described within this Note 10 –\rDebt, and the convertible debentures described in the following Note 11 – Debentures Payable, as of December\r31, 2018 were:
\r\r\r\r
| 2019 | \r\r | $ | \r5,154,404 | \r|
| 2020 | \r\r | \r | 9,070,954 | \r|
| 2021 | \r\r | \r | 235,827 | \r|
| 2022 | \r\r | \r | 251,543 | \r|
| 2023 | \r\r | \r | 268,338 | \r|
| Thereafter | \r\r | \r | 5,544,226 | \r|
| Total | \r\r | \r | 20,525,292 | \r|
| Less discounts | \r\r | \r | (5,553,339 | \r) |
| \r | \r | $ | \r14,971,953 | \r
The following table summarizes the Company’s\rstock option transactions during the 2018 and 2017 fiscal years:
\r\r\r\r
| \r | \r | Number of \rStock Options | \r \r | \r | Weighted-Average Exercise Price | \r|||
| Outstanding at December 31, 2016 | \r\r | \r | 9,250,000 | \r\r | \r | $ | \r0.100 | \r|
| Granted | \r\r | \r | 550,000 | \r\r | \r | \r | 0.458 | \r|
| Exercised | \r\r | \r | (4,800,000 | \r) | \r\r | \r | 0.011 | \r|
| Forfeited/Expired | \r\r | \r | (200,000 | \r) | \r\r | \r | 0.025 | \r|
| Outstanding at December 31, 2017 | \r\r | \r | 4,800,000 | \r\r | \r | \r | 0.234 | \r|
| Granted | \r\r | \r | 4,720,000 | \r\r | \r | \r | 1.805 | \r|
| Exercised | \r\r | \r | (760,000 | \r) | \r\r | \r | 0.216 | \r|
| Forfeited/Expired | \r\r | \r | (450,000 | \r) | \r\r | \r | 0.433 | \r|
| Outstanding at December 31, 2018 | \r\r | \r | 8,310,000 | \r\r | \r | $ | \r1.117 | \r
NOTE 15 – REVENUES
\r\r\r\r
For the years ended December 31, 2018 and 2017,\rthe Company’s revenues were comprised of the following major categories:
\r\r\r\r
| \r | \r | 2018 | \r\r | \r | 2017 | \r|||
| Real estate | \r\r | $ | \r5,798,996 | \r\r | \r | $ | \r2,517,225 | \r|
| Management | \r\r | \r | 1,581,548 | \r\r | \r | \r | 1,193,854 | \r|
| Supply procurement | \r\r | \r | 3,657,909 | \r\r | \r | \r | 1,936,686 | \r|
| Licensing | \r\r | \r | 700,173 | \r\r | \r | \r | 269,256 | \r|
| Consulting | \r\r | \r | 50,000 | \r\r | \r | \r | 150,604 | \r|
| Other | \r\r | \r | 63,289 | \r\r | \r | \r | 228 | \r|
| Total revenues | \r\r | $ | \r11,851,915 | \r\r | \r | $ | \r6,067,853 | \r
\r\r
Revenue from two clients represented 73% and\r81% of total revenues for the years ended December 31, 2018 and 2017, respectively.
"}]},{"name":"rpt:f-918","factDimensions":{"xbrl:concept":"us-gaap:DisaggregationOfRevenueTableTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rFor the years ended December 31, 2018 and 2017,\rthe Company’s revenues were comprised of the following major categories:
\r\r\r\r
| \r | \r | 2018 | \r\r | \r | 2017 | \r|||
| Real estate | \r\r | $ | \r5,798,996 | \r\r | \r | $ | \r2,517,225 | \r|
| Management | \r\r | \r | 1,581,548 | \r\r | \r | \r | 1,193,854 | \r|
| Supply procurement | \r\r | \r | 3,657,909 | \r\r | \r | \r | 1,936,686 | \r|
| Licensing | \r\r | \r | 700,173 | \r\r | \r | \r | 269,256 | \r|
| Consulting | \r\r | \r | 50,000 | \r\r | \r | \r | 150,604 | \r|
| Other | \r\r | \r | 63,289 | \r\r | \r | \r | 228 | \r|
| Total revenues | \r\r | $ | \r11,851,915 | \r\r | \r | $ | \r6,067,853 | \r
Revenue Recognition
\r\r\r\r
On January 1, 2018, the Company adopted the\rFinancial Accounting Standards Board’s Accounting Standards Codification (“ASC”) 606, Revenue from Contract\rwith Customers, as amended by subsequently issued Accounting Standards Updates. This revenue standard requires an entity to\rrecognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration that it\rexpects to be entitled to in exchange for those goods or services. The recognition of revenue is determined by performing the following\rconsecutive steps:
\r\r\r\r
| \r | ● | \rIdentify the contract(s) with a customer; |
| \r | ● | \rIdentify the performance obligations in the contract(s); |
| \r | ● | \rDetermine the transaction price; |
| \r | ● | \rAllocate the transaction price to the performance obligations in the contract(s); and |
| \r | ● | \rRecognize revenue as the performance obligation is satisfied. |
\r\r
Additionally, when another party is involved\rin providing goods or services to the Company’s clients, a determination is made as to who—the Company or the other\rparty—is acting in the capacity as the principal in the sale transaction, and who is merely the agent arranging for goods\ror services to be provided by the other party.
\r\r\r\r
The Company is typically considered the principal\rif it controls the specified good or service before such good or service is transferred to its client. The Company may also be\rdeemed to be the principal even if it engages another party (an agent) to satisfy some of the performance obligations on its behalf,\rprovided the Company (i) takes on certain responsibilities, obligations and risks, (ii) possesses certain abilities and discretion,\ror (iii) other relevant indicators of the sale. If deemed an agent, the Company would not recognize revenue for the performance\robligations it does not satisfy.
\r\r\r\r
The adoption of this standard did not have\ra significant impact on the Company’s consolidated operating results, and accordingly no restatement has been made to prior\rperiod reported amounts.
\r\r\r\r
The Company’s main sources of revenue\rare comprised of the following:
\r\r\r\r
| \r | ● | \rReal Estate – the Company generates rental income and additional rental fees from leasing its regulatory-compliant legal cannabis facilities to its clients, which are cannabis-licensed operating companies. Rental income is generally a fixed amount per month that escalates over the respective lease terms, while additional rental fees are based on a percentage of tenant revenues that exceed a specified amount. |
| \r | \r | |
| \r | ● | \rManagement – the Company receives fees for providing its clients with corporate services and operational oversight of their cannabis cultivation, production, and dispensary operations. These fees are based on a percentage of such clients’ revenue, and are recognized after services have been performed. |
| \r | \r | |
| \r | ● | \rSupply Procurement – the Company maintains volume discounts with top national vendors of cultivation and production resources, supplies, and equipment, which the Company acquires and resells to its clients or third parties within the cannabis industry. The Company recognizes this revenue after the acceptance of goods by the purchaser. |
| \r | \r | |
| \r | ● | \rLicensing – the Company’s derives revenue from the sale of precision-dosed, cannabis-infused products, such as Kalm Fusion™ and Betty’s Eddies™, to legal dispensaries throughout the United States. The recognition of this revenue occurs when the products are delivered. |
| \r | \r | |
| \r | ● | \rConsulting – the Company assists third-parties parties in securing cannabis licenses, and provides advisory services in the areas of facility design and development, and cultivation and dispensing best practices. The revenues associated with these services are recognized as the services are performed. |
The following table summarizes the range of\rinputs used by the Company during the prior two fiscal years:
\r\r\r\r
| \r | \r | 2018 | \r\r | \r | 2017 | \r|||
| Life of instrument | \r\r | \r | 0.5 to 5.0 years | \r\r | \r | \r | 3.0 to 5.0 years | \r|
| Volatility factors | \r\r | \r | 1.019 to 2.086 | \r\r | \r | \r | 0.963 to 1.095 | \r|
| Risk-free interest rates | \r\r | \r | 1.65% to 3.07% | \r\r | \r | \r | 1.79% to 2.08% | \r|
| Dividend yield | \r\r | \r | 0% | \r\r | \r | \r | 0% | \r
The following table summarizes the Company’s\rwarrant transactions during the 2018 and 2017 fiscal years:
\r\r\r\r
| \r | \r | Number of \rStock Options | \r \r | \r | Weighted-Average Exercise Price | \r|||
| Outstanding at December 31, 2016 | \r\r | \r | 1,125,000 | \r\r | \r | $ | \r0.136 | \r|
| Granted | \r\r | \r | 3,120,311 | \r\r | \r | \r | 0.468 | \r|
| Exercised | \r\r | \r | - | \r\r | \r | \r | - | \r|
| Forfeited/Expired | \r\r | \r | - | \r\r | \r | \r | - | \r|
| Outstanding at December 31, 2017 | \r\r | \r | 4,245,311 | \r\r | \r | \r | 0.380 | \r|
| Granted | \r\r | \r | 8,661,137 | \r\r | \r | \r | 2.548 | \r|
| Exercised | \r\r | \r | (2,300,237 | \r) | \r\r | \r | 0.385 | \r|
| Forfeited/Expired | \r\r | \r | - | \r\r | \r | \r | - | \r|
| Outstanding at December 31, 2018 | \r\r | \r | 10,606,211 | \r\r | \r | $ | \r2.149 | \r
Future minimum lease payments as of December\r31, 2018 under all non-cancelable operating leases having an initial or remaining term of more than one year were:
\r\r\r\r
| 2019 | \r\r | $ | \r398,731 | \r|
| 2020 | \r\r | \r | 797,120 | \r|
| 2021 | \r\r | \r | 894,450 | \r|
| 2022 | \r\r | \r | 882,068 | \r|
| 2023 | \r\r | \r | 858,136 | \r|
| Thereafter | \r\r | \r | 4,547,028 | \r|
| Total | \r\r | $ | \r8,377,533 | \r
Beneficial Conversion Features on Convertible\rDebt
\r\r\r\r
Convertible instruments\rthat are not bifurcated as a derivative pursuant to ASC 815, Derivatives and Hedging, and not accounted for as a separate\requity component under the cash conversion guidance are evaluated to determine whether their conversion prices create an embedded\rbeneficial conversion feature at inception, or may become beneficial in the future due to potential adjustments.
\r\r\r\r
A beneficial conversion feature is a nondetachable\rconversion feature that is “in-the-money” at the commitment date. The in-the-money portion, also known as the intrinsic\rvalue of the option, is recorded in equity, with an offsetting discount to the carrying amount of convertible debt to which it\ris attached. The discount is amortized to interest expense over the life of the debt with adjustments to amortization upon full\ror partial conversions of the debt.
"}]},{"name":"rpt:f-1011","factDimensions":{"xbrl:concept":"MRMD:WarrantExpirationDescription","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"warrants generally expire three or five years from issuance date."}]},{"name":"rpt:f-1012","factDimensions":{"xbrl:concept":"MRMD:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationValue","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"5760617","decimals":0}]},{"name":"rpt:f-1013","factDimensions":{"xbrl:concept":"MRMD:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationValue","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"5760617","decimals":0}]},{"name":"rpt:f-1014","factDimensions":{"xbrl:concept":"MRMD:AdjustmentsToAdditionalPaidInCapitalDiscountOnDebenturePayable","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1057833","decimals":0}]},{"name":"rpt:f-1015","factDimensions":{"xbrl:concept":"MRMD:AdjustmentsToAdditionalPaidInCapitalDiscountOnDebenturePayable","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"1057833","decimals":0}]},{"name":"rpt:f-1016","factDimensions":{"xbrl:concept":"MRMD:AdjustmentsToAdditionalPaidInCapitalOtherDiscountOnPromissoryNotes","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1709595","decimals":0}]},{"name":"rpt:f-1017","factDimensions":{"xbrl:concept":"MRMD:AdjustmentsToAdditionalPaidInCapitalOtherDiscountOnPromissoryNotes","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember"},"factValues":[{"value":"1709595","decimals":0}]},{"name":"rpt:f-1018","factDimensions":{"xbrl:concept":"us-gaap:ProvisionForDoubtfulAccounts","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"150000","decimals":0}]},{"name":"rpt:f-1019","factDimensions":{"xbrl:concept":"us-gaap:ProvisionForDoubtfulAccounts","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-1020","factDimensions":{"xbrl:concept":"us-gaap:GainLossOnDispositionOfAssets1","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-2858","decimals":0}]},{"name":"rpt:f-1021","factDimensions":{"xbrl:concept":"us-gaap:GainLossOnDispositionOfAssets1","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-1022","factDimensions":{"xbrl:concept":"us-gaap:PaymentsToAcquireInvestments","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"30000000","decimals":0}]},{"name":"rpt:f-1023","factDimensions":{"xbrl:concept":"us-gaap:PaymentsToAcquireInvestments","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-1024","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"15000","decimals":0}]},{"name":"rpt:f-1025","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"52727","decimals":0}]},{"name":"rpt:f-1026","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"145382","decimals":0}]},{"name":"rpt:f-1027","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-1028","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromCollectionOfNotesReceivable","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"45553","decimals":0}]},{"name":"rpt:f-1029","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromCollectionOfNotesReceivable","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-1030","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromPreviousAcquisition","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"13494","decimals":0}]},{"name":"rpt:f-1031","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromPreviousAcquisition","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-1032","factDimensions":{"xbrl:concept":"MRMD:PaymentsToAcquireOtherInvestmentsOne","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-300000","decimals":0}]},{"name":"rpt:f-1033","factDimensions":{"xbrl:concept":"MRMD:PaymentsToAcquireOtherInvestmentsOne","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-1034","factDimensions":{"xbrl:concept":"us-gaap:PaymentsToAcquireOtherInvestments","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"500000","decimals":0}]},{"name":"rpt:f-1035","factDimensions":{"xbrl:concept":"us-gaap:PaymentsToAcquireOtherInvestments","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-1036","factDimensions":{"xbrl:concept":"us-gaap:RepaymentsOfOtherShortTermDebt","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"700000","decimals":0}]},{"name":"rpt:f-1037","factDimensions":{"xbrl:concept":"us-gaap:RepaymentsOfOtherShortTermDebt","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-1038","factDimensions":{"xbrl:concept":"us-gaap:RepaymentsOfSecuredDebt","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"114141","decimals":0}]},{"name":"rpt:f-1039","factDimensions":{"xbrl:concept":"us-gaap:RepaymentsOfSecuredDebt","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-1040","factDimensions":{"xbrl:concept":"MRMD:ConversionsOfPromissoryNotes","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1075000","decimals":0}]},{"name":"rpt:f-1041","factDimensions":{"xbrl:concept":"MRMD:ConversionsOfPromissoryNotes","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2311953","decimals":0}]},{"name":"rpt:f-1042","factDimensions":{"xbrl:concept":"MRMD:DiscountOnPromissoryNotes","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1709595","decimals":0}]},{"name":"rpt:f-1043","factDimensions":{"xbrl:concept":"MRMD:DiscountOnPromissoryNotes","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-1044","factDimensions":{"xbrl:concept":"MRMD:ConversionsOfDebenturesPayable","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1435506","decimals":0}]},{"name":"rpt:f-1045","factDimensions":{"xbrl:concept":"MRMD:ConversionsOfDebenturesPayable","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-1046","factDimensions":{"xbrl:concept":"MRMD:BeneficialConversionFeatureOnDebenturesPayable","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"5569908","decimals":0}]},{"name":"rpt:f-1047","factDimensions":{"xbrl:concept":"MRMD:BeneficialConversionFeatureOnDebenturesPayable","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-1048","factDimensions":{"xbrl:concept":"MRMD:DiscountOnDebenturesPayable","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1057833","decimals":0}]},{"name":"rpt:f-1049","factDimensions":{"xbrl:concept":"MRMD:DiscountOnDebenturesPayable","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-1050","factDimensions":{"xbrl:concept":"MRMD:OtherInvestment","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"915006","decimals":0}]},{"name":"rpt:f-1051","factDimensions":{"xbrl:concept":"MRMD:OtherInvestment","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-1052","factDimensions":{"xbrl:concept":"MRMD:BusinessAcquisition","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"266682","decimals":0}]},{"name":"rpt:f-1053","factDimensions":{"xbrl:concept":"MRMD:IssuanceOfCommonStockAssociatedWithSubscriptions","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"370000","decimals":0}]},{"name":"rpt:f-1054","factDimensions":{"xbrl:concept":"MRMD:IssuanceOfCommonStockAssociatedWithSubscriptions","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-1055","factDimensions":{"xbrl:concept":"MRMD:SubscriptionsIssuedToAcquireAssets","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-1056","factDimensions":{"xbrl:concept":"MRMD:SubscriptionsIssuedToAcquireAssets","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"370000","decimals":0}]},{"name":"rpt:f-1057","factDimensions":{"xbrl:concept":"MRMD:IssuanceOfCommonStockForPrepaidRent","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"18540","decimals":0}]},{"name":"rpt:f-1058","factDimensions":{"xbrl:concept":"MRMD:IssuanceOfCommonStockForPrepaidRent","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-1059","factDimensions":{"xbrl:concept":"us-gaap:Goodwill","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:BettysEddiesMember"},"factValues":[{"value":"266682","decimals":0}]},{"name":"rpt:f-1060","factDimensions":{"xbrl:concept":"us-gaap:Goodwill","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:IRollieLLCMember"},"factValues":[{"value":"333201","decimals":0}]},{"name":"rpt:f-1061","factDimensions":{"xbrl:concept":"us-gaap:Goodwill","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:ARLHealthcareIncMember"},"factValues":[{"value":"731902","decimals":0}]},{"name":"rpt:f-1062","factDimensions":{"xbrl:concept":"us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:IRollieLLCMember"},"factValues":[{"value":"130255","decimals":0}]},{"name":"rpt:f-1063","factDimensions":{"xbrl:concept":"us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:ARLHealthcareIncMember"},"factValues":[{"value":"21000","decimals":0}]},{"name":"rpt:f-1064","factDimensions":{"xbrl:concept":"us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:IRollieLLCMember"},"factValues":[{"value":"46544","decimals":0}]},{"name":"rpt:f-1065","factDimensions":{"xbrl:concept":"us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:BettysEddiesMember"},"factValues":[{"value":"280176","decimals":0}]},{"name":"rpt:f-1066","factDimensions":{"xbrl:concept":"us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:IRollieLLCMember"},"factValues":[{"value":"510000","decimals":0}]},{"name":"rpt:f-1067","factDimensions":{"xbrl:concept":"us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:ARLHealthcareIncMember"},"factValues":[{"value":"724448","decimals":0}]},{"name":"rpt:f-1068","factDimensions":{"xbrl:concept":"us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:BettysEddiesMember"},"factValues":[{"value":"13494","decimals":0}]},{"name":"rpt:f-1069","factDimensions":{"xbrl:concept":"us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable","xbrl:period":"2018-04-01T00:00:00/2018-05-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:IRollieLLCMember"},"factValues":[{"value":"280176","decimals":0}]},{"name":"rpt:f-1070","factDimensions":{"xbrl:concept":"us-gaap:LeaseAndRentalExpense","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"5400000","decimals":0}]},{"name":"rpt:f-1071","factDimensions":{"xbrl:concept":"us-gaap:LeaseAndRentalExpense","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2800000","decimals":0}]},{"name":"rpt:f-1072","factDimensions":{"xbrl:concept":"us-gaap:LoansAndLeasesReceivableDeferredIncome","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"611000","decimals":0}]},{"name":"rpt:f-1073","factDimensions":{"xbrl:concept":"us-gaap:LoansAndLeasesReceivableDeferredIncome","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2100000","decimals":0}]},{"name":"rpt:f-1074","factDimensions":{"xbrl:concept":"MRMD:DueFromThirdPartiesDisclosureTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rNOTE 6 – DUE FROM THIRD PARTIES
\r\r\r\r
At December 31, 2018 and 2017, the balances\rdue from third parties were comprised the following amounts advanced to the Company’s cannabis-licensed clients for working\rcapital purposes:
\r\r\r\r
| \r | \r | 2018 | \r\r | \r | 2017 | \r|||
| Kind Therapeutics USA Inc. (Maryland licensee) | \r\r | $ | \r2,679,496 | \r\r | \r | $ | \r77,558 | \r|
| KPG of Anna LLC (Illinois licensee) | \r\r | \r | 482,700 | \r\r | \r | \r | 418,305 | \r|
| KPG of Harrisburg LLC (Illinois licensee) | \r\r | \r | 449,385 | \r\r | \r | \r | 382,260 | \r|
| Harvest Foundation LLC (Nevada licensee) | \r\r | \r | 248,796 | \r\r | \r | \r | 40,693 | \r|
| ARL Healthcare Inc. (Massachusetts licensee) | \r\r | \r | - | \r\r | \r | \r | 176,823 | \r|
| Other | \r\r | \r | - | \r\r | \r | \r | 101,279 | \r|
| Total due from third parties | \r\r | $ | \r3,860,377 | \r\r | \r | $ | \r1,196,918 | \r
\r\r
Such amounts are advanced by the Company to\rits clients in order to furnish these companies with additional means by which they can establish their cannabis businesses and\rgrow their operations. The Company has employed this strategy in the past, and is continuing with these companies, whereby all\radvanced amounts are reimbursed as the companies begin to generate positive cash flow.
"}]},{"name":"rpt:f-1075","factDimensions":{"xbrl:concept":"us-gaap:NotesReceivableRelatedPartiesNoncurrent","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"579000","decimals":0}]},{"name":"rpt:f-1076","factDimensions":{"xbrl:concept":"us-gaap:NotesReceivableRelatedPartiesNoncurrent","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"527000","decimals":0}]},{"name":"rpt:f-1077","factDimensions":{"xbrl:concept":"us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners","xbrl:period":"2019-02-01T00:00:00","xbrl:entity":"cik:0001522767","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember","srt:OwnershipAxis":"MRMD:ChoozeCorpMember"},"factValues":[{"value":"0.027"}]},{"name":"rpt:f-1078","factDimensions":{"xbrl:concept":"us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","srt:OwnershipAxis":"MRMD:ChoozeCorpMember","us-gaap:RelatedPartyTransactionsByRelatedPartyAxis":"MRMD:TwoUnrelatedThirdPartyCompaniesMember"},"factValues":[{"value":"0.027"}]},{"name":"rpt:f-1079","factDimensions":{"xbrl:concept":"us-gaap:ConstructionInProgressGross","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"17300000","decimals":0}]},{"name":"rpt:f-1080","factDimensions":{"xbrl:concept":"us-gaap:ConstructionInProgressGross","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"12200000","decimals":0}]},{"name":"rpt:f-1081","factDimensions":{"xbrl:concept":"us-gaap:ConstructionInProgressGross","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","dei:LegalEntityAxis":"MRMD:HagerstownMDMember"},"factValues":[{"value":"11200000","decimals":0}]},{"name":"rpt:f-1082","factDimensions":{"xbrl:concept":"us-gaap:ConstructionInProgressGross","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","dei:LegalEntityAxis":"MRMD:NewBedfordMAMember"},"factValues":[{"value":"9800000","decimals":0}]},{"name":"rpt:f-1083","factDimensions":{"xbrl:concept":"us-gaap:ConstructionInProgressGross","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","dei:LegalEntityAxis":"MRMD:MiddleboroughMAMember"},"factValues":[{"value":"2400000","decimals":0}]},{"name":"rpt:f-1084","factDimensions":{"xbrl:concept":"us-gaap:ConstructionInProgressGross","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","dei:LegalEntityAxis":"MRMD:NewBedfordMAMember"},"factValues":[{"value":"5000000","decimals":0}]},{"name":"rpt:f-1085","factDimensions":{"xbrl:concept":"us-gaap:ConstructionInProgressGross","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","dei:LegalEntityAxis":"MRMD:MiddleboroughMAMember"},"factValues":[{"value":"1100000","decimals":0}]},{"name":"rpt:f-1086","factDimensions":{"xbrl:concept":"us-gaap:ConstructionInProgressGross","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","dei:LegalEntityAxis":"MRMD:HagerstownMDMember"},"factValues":[{"value":"11200000","decimals":0}]},{"name":"rpt:f-1087","factDimensions":{"xbrl:concept":"us-gaap:DeferredTaxLiabilities","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"36","decimals":0}]},{"name":"rpt:f-1088","factDimensions":{"xbrl:concept":"us-gaap:IncreaseDecreaseInIncomeTaxes","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"36","decimals":0}]},{"name":"rpt:f-1089","factDimensions":{"xbrl:concept":"us-gaap:IncreaseDecreaseInIncomeTaxes","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:FairValueByLiabilityClassAxis":"MRMD:OnetimeTransitionTaxLiabilityMember"},"factValues":[{"value":"16","decimals":0}]},{"name":"rpt:f-1090","factDimensions":{"xbrl:concept":"MRMD:PercentageOfTaxableIncomeSubjectToAnnualLimitationOfFederalNetOperatingLossCarryforward","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"0.80"}]},{"name":"rpt:f-1091","factDimensions":{"xbrl:concept":"us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-1092","factDimensions":{"xbrl:concept":"us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense","xbrl:period":"2017-01-01T00:00:00/2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"}},{"name":"rpt:f-1093","factDimensions":{"xbrl:concept":"us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment","xbrl:period":"2018-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"10918","decimals":0}]},{"name":"rpt:f-1094","factDimensions":{"xbrl:concept":"us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"952875","decimals":0}]},{"name":"rpt:f-1095","factDimensions":{"xbrl:concept":"us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:ARLHealthcareIncMember"},"factValues":[{"value":"120689","decimals":0}]},{"name":"rpt:f-1096","factDimensions":{"xbrl:concept":"MRMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLicenses","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:ARLHealthcareIncMember"},"factValues":[{"value":"180000","decimals":0}]},{"name":"rpt:f-1097","factDimensions":{"xbrl:concept":"us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:ARLHealthcareIncMember"},"factValues":[{"value":"92765","decimals":0}]},{"name":"rpt:f-1098","factDimensions":{"xbrl:concept":"us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"MRMD:ARLHealthcareIncMember"},"factValues":[{"value":"7454","decimals":0}]},{"name":"rpt:f-1099","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1800000","decimals":0}]},{"name":"rpt:f-1100","factDimensions":{"xbrl:concept":"MRMD:EquityDiscounts","xbrl:period":"2019-01-01T00:00:00","xbrl:entity":"cik:0001522767","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"11100000","decimals":0}]},{"name":"rpt:f-1101","factDimensions":{"xbrl:concept":"MRMD:ScheduleOfMajorityOwnedSubsidiariesTableTextBlock","xbrl:period":"2018-01-01T00:00:00/2019-01-01T00:00:00","xbrl:entity":"cik:0001522767"},"factValues":[{"value":"\r\rThe accompanying condensed consolidated financial\rstatements at December 31, 2018 and 2017 and for the years then ended include the accounts of MariMed Inc. and the following majority-owned\rsubsidiaries.
\r\r\r\r
| Subsidiary: | \r\r | Percentage Owned | \r||
| MariMed Advisors Inc. | \r\r | \r | 100.0 | \r% |
| Mia Development LLC | \r\r | \r | 89.5 | \r% |
| Mari Holdings IL LLC | \r\r | \r | 60.0 | \r% |
| Mari Holdings MD LLC | \r\r | \r | 97.4 | \r% |
| Mari Holdings NV LLC | \r\r | \r | 100.0 | \r% |
| Hartwell Realty Holdings LLC | \r\r | \r | 100.0 | \r% |
| iRollie LLC | \r\r | \r | 100.0 | \r% |
| ARL Healthcare Inc. | \r\r | \r | 100.0 | \r% |
The following table summarizes the allocation\rof the purchase price to the fair value of the assets acquired on the acquisition date:
\r\r\r\r
| Inventory | \r\r | $ | \r46,544 | \r|
| Machinery and equipment | \r\r | \r | 130,255 | \r|
| Goodwill | \r\r | \r | 333,201 | \r|
| Total fair value of consideration | \r\r | $ | \r510,000 | \r
The following table summarizes the allocation\rof the purchase price to the fair value of the assets acquired:
\r\r\r\r
| Cash and cash equivalents | \r\r | $ | \r13,494 | \r|
| Goodwill | \r\r | \r | 266,682 | \r|
| Total fair value of consideration | \r\r | $ | \r280,176 | \r
The following table summarizes the allocation\rof the purchase price to the fair value of the assets acquired and liabilities assumed on the acquisition date:
\r\r\r\r
| Equipment | \r\r | $ | \r21,000 | \r|
| Cannabis licenses | \r\r | \r | 180,000 | \r|
| Accounts payable | \r\r | \r | (120,689 | \r) |
| Due to related parties | \r\r | \r | (92,765 | \r) |
| Total identifiable net assets | \r\r | \r | (7,454 | \r) |
| Goodwill | \r\r | \r | 731,902 | \r|
| Total fair value of consideration | \r\r | $ | \r724,448 | \r
Future minimum rental receipts for non-cancelable leases and subleases\ras of December 31, 2018 were:
\r\r\r\r
| 2019 | \r\r | $ | \r1,261,181 | \r|
| 2020 | \r\r | \r | 1,287,257 | \r|
| 2021 | \r\r | \r | 1,315,686 | \r|
| 2022 | \r\r | \r | 1,193,990 | \r|
| 2023 | \r\r | \r | 1,179,641 | \r|
| Thereafter | \r\r | \r | 14,571,268 | \r|
| Total | \r\r | $ | \r20,809,023 | \r
At December 31, 2018 and 2017, the balances\rdue from third parties were comprised the following amounts advanced to the Company’s cannabis-licensed clients for working\rcapital purposes:
\r\r\r\r
| \r | \r | 2018 | \r\r | \r | 2017 | \r|||
| Kind Therapeutics USA Inc. (Maryland licensee) | \r\r | $ | \r2,679,496 | \r\r | \r | $ | \r77,558 | \r|
| KPG of Anna LLC (Illinois licensee) | \r\r | \r | 482,700 | \r\r | \r | \r | 418,305 | \r|
| KPG of Harrisburg LLC (Illinois licensee) | \r\r | \r | 449,385 | \r\r | \r | \r | 382,260 | \r|
| Harvest Foundation LLC (Nevada licensee) | \r\r | \r | 248,796 | \r\r | \r | \r | 40,693 | \r|
| ARL Healthcare Inc. (Massachusetts licensee) | \r\r | \r | - | \r\r | \r | \r | 176,823 | \r|
| Other | \r\r | \r | - | \r\r | \r | \r | 101,279 | \r|
| Total due from third parties | \r\r | $ | \r3,860,377 | \r\r | \r | $ | \r1,196,918 | \r
At December 31, 2018 and 2017, notes receivable\rwere comprised of the following:
\r\r\r\r
| \r | \r | 2018 | \r\r | \r | 2017 | \r|||
| First State Compassion Center -12.5% per annum, maturing in 2026 | \r\r | $ | \r578,723 | \r\r | \r | $ | \r624,275 | \r|
| The Healer - 8% per annum, maturing in 2021 | \r\r | \r | 307,429 | \r\r | \r | \r | - | \r|
| Chooze Corp. - 8% per annum, maturing in 2021 | \r\r | \r | 257,687 | \r\r | \r | \r | - | \r|
| Total notes receivable | \r\r | \r | 1,143,839 | \r\r | \r | \r | 624,167 | \r|
| Current portion of First State Compassion Center note receivable | \r\r | \r | 51,462 | \r\r | \r | \r | 45,444 | \r|
| Notes receivable, long-term portion | \r\r | $ | \r1,092,377 | \r\r | \r | $ | \r578,831 | \r
NOTE 5 – DEFERRED RENTS RECEIVABLE
\r\r\r\r
The Company leases its regulatory-compliant\rlegal cannabis facilities to its cannabis-licensed clients generally under 20-year non-cancelable lease agreements which contain\rrent holidays, escalating rents over time, options to renew, and the requirement to pay property taxes, insurance and/or maintenance\rcosts. These leases also contain contingent rental payments that are based on a percentage of monthly tenant revenues.
\r\r\r\r
The Company recognizes fixed rental receipts\rfrom such lease agreements on a straight-line basis over the expected lease term. Differences between amounts received and amounts\rrecognized are recorded under Deferred Rents Receivable on the balance sheet. Contingent rentals are recognized only after\rtenants’ revenues are finalized and if such revenues exceed certain minimum levels.
\r\r\r\r
The Company leases the following owned properties:
\r\r\r\r
| \r | ● | \rDelaware – a 45,000 square foot facility purchased in September 2016 and built into a cannabis cultivation, processing, and dispensary facility which is leased to a cannabis-licensed client occupying 100% of the space under a 20-year triple net lease expiring in 2035. |
| \r | \r | |
| \r | ● | \rIllinois – two 3,400 square foot free-standing retail dispensaries in the cities of Anna and Harrisburg and leased to two licensed cannabis dispensary clients each under a 20-year lease expiring in 2036. |
| \r | \r | |
| \r | ● | \rMaryland – a 180,000 square foot former manufacturing facility purchased January 2017 and rehabilitated by the Company into a cultivation and processing facility which is leased to a licensed cannabis client under a 20-year triple net lease that started in January 2018. |
\r\r
The Company subleases the following properties:
\r\r\r\r
| \r | ● | \rDelaware – 4,000 square feet of retail space in a multi-use building space which the Company developed into a cannabis dispensary which is subleased to its cannabis-licensed client under a under a five-year triple net lease with a five-year option to extend. |
| \r | \r | |
| \r | ● | \rNevada – 10,000 square feet of an industrial building that the Company built-out into a cannabis cultivation facility and is subleased to the Company’s cannabis-licensed client under a sublease for 10 years expiring in 2024. |
\r\r
As of December 31, 2018 and 2017, cumulative\rfixed rental receipts under such leases approximated $5.4 million and $2.8 million, respectively, compared to revenue recognized\ron a straight-line basis of approximately $7.5 million and $3.4 million. Accordingly, the deferred rents receivable balances at\rDecember 31, 2018 and 2017 approximated $2.1 million and $611,000, respectively.
\r\r\r\r
Future minimum rental receipts for non-cancelable leases and subleases\ras of December 31, 2018 were:
\r\r\r\r
| 2019 | \r\r | $ | \r1,261,181 | \r|
| 2020 | \r\r | \r | 1,287,257 | \r|
| 2021 | \r\r | \r | 1,315,686 | \r|
| 2022 | \r\r | \r | 1,193,990 | \r|
| 2023 | \r\r | \r | 1,179,641 | \r|
| Thereafter | \r\r | \r | 14,571,268 | \r|
| Total | \r\r | $ | \r20,809,023 | \r